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Abstract 
 
Organ transplantation is a procedure that has the potential to extend the life 
expectancy of people experiencing end-stage organ failure. First pioneered in the 
1960s, surgical procedures and immunosuppressive technologies have now been 
refined to a level at which long-term survival after organ transplantation is the norm 
rather than the exception. As such, researchers and medical practitioners alike have 
moved away from measuring the success of transplantation purely by patient survival. 
Rather, patient quality of life (QOL) has become a widely accepted criterion by which 
to measure achievement in the field of organ transplantation.  
Quality of life refers to an individual’s subjective experience of functioning in 
the domains of physical, psychological, and social wellbeing. The QOL of transplant 
patients has been widely researched, and there is general agreement that 
transplantation is associated with QOL benefits, with transplant recipients enjoying a 
better QOL than transplant candidates. However, despite burgeoning academic 
interest in this area, several conceptual and empirical aspects of QOL within the field 
of organ transplantation have not yet received adequate attention. First, no previous 
research has attempted to explain ubiquitous QOL findings from a theoretical 
perspective, resulting in a significant deficit of knowledge in this much-researched 
area. Second, most research has focused on QOL experiences purely from the 
perspective of transplant patients, with little consideration of the way in which 
patients’ QOL issues are perceived by health professionals. Last, while the QOL of 
pediatric transplant patients is covered extensively within the literature, little 
sustained attention has been paid to the relevance of young patients’ families and the 
home environment in the context of QOL.  
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The present thesis is comprised of three separate studies, which together aim to 
present a holistic exploration of the QOL of organ transplant patients. Chapter 1 
provides an introduction to the field of organ transplantation. The conceptual and 
theoretical background to QOL is detailed, and its application and relevance to organ 
transplantation is explained. The three studies encompassed in this thesis are briefly 
introduced, together with the rationale and aims for each.  
Study 1, entitled ‘Using crisis theory to explain the quality of life of organ 
transplant patients’, is contained in Chapter 2. The aim of this study was to explore 
the QOL of organ transplant patients from a theoretical perspective. Crisis theory was 
used to investigate the relationship between stress, coping, and QOL. A total of 226 
participants representing non-transplant individuals, transplant candidates, and 
transplant recipients participated in the study, providing insights into the unique 
experiences of transplant patients and enabling comparisons of each group’s QOL and 
functioning in the specific domains of physical, psychological, and social wellbeing. 
Results supported the premise of crisis theory, with findings showing that transplant 
candidates experience lower QOL than transplant recipients and non-transplant 
individuals. Further, specific transplant-related stressors identified as worrisome by 
transplant patients were explored and discussed. 
Health professionals’ perspectives on transplant patients’ QOL issues is 
investigated in Study 2, and is presented in Chapter 3. This exploratory study 
examined QOL from the perspective of people who work with transplant patients, and 
sought to investigate the dissemination of copious amounts of QOL research, 
information, and data to clinical practice. The views of 41 health professionals on 
QOL were explored using an adapted questionnaire previously used within oncology 
research. Information elicited included health professionals’ attitudes toward the 
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concept of QOL, reported willingness to use QOL instruments and information, and 
actual use of QOL information in clinical practice. Results revealed inconsistencies 
between health professionals’ attitudes, willingness, and behaviour associated with 
QOL. Several suggestions are made to increase the use of QOL information in clinical 
practice, with a recommendation for future research to further explore the way in 
which health professionals’ views may impact upon the QOL of transplant patients. 
Study 3, contained within Chapter 4, investigated the QOL experiences of 32 
pediatric liver transplant patients. Together with comparing the QOL of young 
transplant patients with 33 non-transplant children in the community, the study sought 
to investigate the way in which families adjust to accommodate children who have 
received liver transplants. The relationship between family functioning and QOL was 
also explored, with results showing an association between decreased QOL and 
increased adjustments to family routines. The finding that transplant families make 
more adjustments to routines to accommodate their children in comparison to other 
families informed several recommendations to ease the burden on transplant families 
and, in turn, enrich the QOL of pediatric liver transplant patients.  
A general discussion is offered in Chapter 5, including conclusions drawn from 
the thesis as a whole, strengths and limitations, methodological issues, and 
suggestions for future research. Theoretical implications of the findings are presented, 
together with suggestions for the implementation of practical applications that may 
optimise the QOL of organ transplant patients. The synthesis of findings presented 
across the three studies informs a strong rationale for the continued expansion of QOL 
research within the field of organ transplantation. Findings indicate a need for 
research to move beyond assessing QOL solely from the perspective of patients. The 
outcomes of these preliminary studies involving health professionals and families 
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point to the importance of understanding the context in which QOL is experience by 
organ transplant patients. Varied investigation is required to achieve a full 
understanding of QOL in the context of organ transplantation, thus enabling all 
patients to enjoy the full QOL benefits afforded by transplantation. 
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Chapter 1 
Organ Transplantation and Quality of Life  
Individuals experiencing end-stage organ failure undergo organ transplantation 
in order to extend life expectancy. In addition to the clear benefit of reducing 
mortality rates among patients with end-stage organ failure, research has consistently 
shown that receiving an organ transplant also results in substantial improvement to 
quality of life (QOL) (Dew et al., 1997). Despite extensive research dedicated to this 
area and ubiquitous findings of the QOL benefits associated with organ 
transplantation, there remain significant gaps in the theoretical and applied knowledge 
of QOL in this field. There has been a distinct shift in academic attention away from 
the medical success of organ transplantation to the study of its psychosocial aspects 
over the past few decades, and researchers are now calling for a further move beyond 
descriptive and comparative studies of organ transplant patients’ QOL to theoretically 
driven investigations that may inform intervention and treatment to assist transplant 
patients to achieve lives of good quality (Engle, 2001; Myaskovsky et al., 2005; 
Wood-Dauphinee, 1999).  
This chapter provides a foundation for the study of QOL in the field of organ 
transplantation. First, information pertaining to the historical developmental of the 
life-saving procedure will be presented, together with a brief overview of the medical 
aspects central to its ongoing success. Second, the concept of QOL will be detailed 
through a summary of its theoretical underpinnings and an overview of the numerous 
fields and ways in which QOL has been studied. Moving forwards, a rationale for the 
study of QOL in the context of organ transplantation will be presented, together with 
an argument for the need to significantly expand the limited scope of current QOL 
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research in this area. Last, the aims of the three studies contained within this thesis are 
introduced, with each offering a unique perspective on the QOL of transplant patients. 
Organ Transplantation 
The idea of transferring body parts has long been expressed as fantasy in art and 
literature. Greek mythology featured centaurs that were half-man and half-horse, 
ancient Egyptians celebrated the Sphinx, and the Hindu deity Ganesha had a human 
body and an elephant’s head. The replacement and repair of body parts also featured 
in the Bible, with Christ restoring the ear of a servant after it had been cut off with a 
sword. In the fifteenth century, Saint Agatha was depicted with reconstructed breasts, 
and the patron saints of doctors, Saints Cosmos and Damian, were illustrated 
transplanting the limb of a deceased donor to a patient afflicted with a tumour of the 
leg. Literature also embraced the theme of transplantation, with Mary Shelley’s 
Frankenstein character creating a monster patched together from body parts collected 
from graveyards and slaughterhouses (Calne, 1970; Magee, 2004; Tilney, 2003). 
Several of the fantastical ideas expressed throughout history are now an 
everyday part of modern medicine. Organ transplantation has been brought into 
reality by years of experimental research and immense scientific advances in medical 
procedures and pharmacology. Transplantation procedures evolved relatively quickly 
from experimental stages marked by limited success to its current prosperous state. 
Experiments on dogs, rodents, and monkeys from the early 1900s to 1970s refined the 
procedures of kidney, liver, and heart transplantation, and canine skin grafts and 
animal blood transfusions were also conducted. Human organ transplantation in its 
current endeavour began in the 1950s, with the first successful kidney transplant 
between young identical twins in 1954. Adult lung and heart transplantations 
followed in 1963 and 1967, respectively. However, initial transplantation efforts had 
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limited success, with patients surviving for only short periods of days or weeks 
following surgery. Early transplantation efforts failed largely due to a lack of 
knowledge and misunderstanding of blood types, tissue matching, and the role of 
immunosuppressant medication in avoiding organ rejection (Engle, 2001).  
The discovery of the powerful immunosuppressant, Cyclosporine, ushered in a 
new era of successful solid organ transplantation. Prior to its introduction, patients 
were routinely treated with total-body radiation. While radiation treatment resulted in 
patients producing fewer antibodies towards the transplanted organ and provided an 
amount of protection against infection, increased awareness of the dangers of 
radiation led to a sharp decline in its use and renewed experimentation with 
immunosuppressive medication. Patient survival incrementally increased following 
the introduction of new immunosuppressant medication in 1959, and another medical 
breakthrough occurred with the 1962 discovery of tissue typing (Magee, 2004). 
Cyclosporine was first used in 1978 and approved for widespread use in 1983, 
revolutionising organ transplantation by limiting infection and subsequent organ 
rejection. The success of Cyclosporine brought about seminal change to both the 
clinical and research fields of organ transplantation; renewed interest in the procedure 
was accompanied by increased research activity, and the provision of clinical services 
increased rapidly with more surgeons and institutions performing transplant 
operations (Tilney, 2003).  
An estimated 105 000 patients are currently on the national organ waitlist in the 
United States (US), with a new name added every 14 minutes. With 56 000 solid 
organ transplant procedures performed in the US annually, 11 Americans die each day 
before receiving a transplant (Wynn & Alexander, 2011). Australian statistics also 
show a divide between supply and demand of organs for transplantation, despite an 
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increase in transplant rates in recent years due to improved rates of posthumous 
donation. While 1599 individuals are currently awaiting transplantation, only 991 
people underwent transplantation in Australia in 2011, meaning that some Australian 
organ transplant candidates are likely to die before receiving a suitable organ (Excell, 
Hee, & Russ, 2011). Table 1 provides a summary of the most common solid organ 
transplantation procedures, together with the historical context and survival rates 
related to each type of transplant. The vast majority of transplant candidates in 
Australia are awaiting a kidney transplant, followed by liver, lung, and heart 
transplants. A small number of Australian candidates are also awaiting intestinal and 
pancreas transplants, and a further few require heart/lung or pancreas/kidney double 
transplants (Excell, et al., 2011). 
Organ transplantation is widely considered to be the best treatment option for 
end-stage organ failure. End-stage organ failure is a medical condition in which a 
person’s organs do not function adequately (Molzahn, Northcott, & Dossetor, 1997), 
and may be precipitated by emphysema and chronic obstructive pulmonary disease 
(lungs); cardiomyopathy and congestive heart failure (heart); hepatitis (liver); and 
polycystic kidney disease and chronic renal failure (kidneys). Illnesses that constitute 
end-stage organ failure can occur in people of any age and background. Individuals 
experiencing such disease are extremely unwell, and are generally unable to meet the 
demands of everyday life, cannot gain or keep employment, and require intensive 
treatment and care. The typical course of end-stage organ failure is marked by gradual 
decrease in daily functioning and acute deterioration in health, and patients typically 
experience pervasive symptoms of fatigue, breathing difficulties, insomnia, and 
chronic pain. End-stage organ failure is a terminal illness, and a fine line exists 
between the need for an organ transplant and palliative care (Janssen, Spruit, Wouters, 
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& Schols, 2008). Patients usually undergo treatment while waiting for transplantation, 
including dialysis for kidney patients; respiratory treatment for lung patients; and anti-
inflammatory medication for liver patients. However, these treatments are used to 
manage symptoms in the short-term, and are not long-term alternatives to 
transplantation (Janssen, et al., 2008).   
Organ transplantation has the potential to rapidly restore the health and 
wellbeing of individuals experiencing end-stage organ failure. However, organ 
transplantation is not considered a cure for end-stage organ failure, but an alternative 
form of treatment that unfortunately presents ongoing medical and psychosocial 
challenges for transplant recipients (Engle, 2001). With this in mind, all potential 
transplant candidates undergo medical and psychosocial evaluation before being 
added to the national waitlist to receive a transplant. In some countries an economic 
assessment is also conducted, but in Australia and most Western countries the 
estimated $200 000 cost of transplantation is covered by public health policy. 
However, pre- and post-transplant monthly medication costs of up to $3000 are only 
partially covered (Hafliger, 2005). Candidacy assessments aid in the identification 
and management of patients who meet criteria consistent with a reasonable 
probability for a favourable surgical outcome, and provide baseline measures that can 
be used for medical or psychosocial intervention should either be required at a later 
stage in the transplant process.  
Medical assessments are used to evaluate current health and physical 
functioning. Contraindications to transplantation may also be identified during this 
process, including cancer in an organ other than the one being transplanted, human 
immunodeficiency virus (HIV), and chronic progressive neurological illness 
(Hafliger, 2005). Psychosocial assessment is usually conducted by a psychiatrist
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Table 1 
Summary of Transplantation by Organ Type 
 
      Donor source Survival rate 
 
Organ 
type 
 
Common precipitants 
to transplantation 
First human 
transplant 
procedure 
Average 
waitlist 
time 
Australian 
waitlist 
2011 
Australians 
transplanted 
in 2010 
 
 
Cadaver 
 
 
Living 
 
 
1 year 
 
 
5 year 
Kidney Diabetes  
Hypertension 
Gomerulorephritis 
1954 7 years 1223 842 X X 97% 91% 
Liver Hepatitis C 1967 2-5 years 167 203 X X 80-90% 80% 
Lung Cystic Fibrosis 
Chronic Obstructive 
  Pulmonary Disorder 
Pulmonary Fibrosis 
1963 
(patient 
survived for 
18 days). 
 
First double 
lung 
transplant in 
1989. 
1-2 years 110 123 X X 75% 50% 
Heart Cardiomyopathy 1967 
(patient died 
18 days later 
from 
septicemia) 
>1 year 46 65 X  90% 80% 
Note. Information sourced from Hafliger (2005) and Excell, et al. (2011).
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or other mental health clinician, and aims to assist in the selection of patients capable 
of handling the stress of transplantation, assess patients’ knowledge and capacity for 
consent, assess ability to comply with complex medical regimens, and determine the 
need for family support (Klapheke, 1999). The extensive interactions between 
patients and health professionals has been posited as an important contributing factor 
to QOL, and requires further attention in the field of organ transplantation (Bezjak et 
al., 2001). Psychosocial assessment is particularly important to the transplantation 
process, as patients require extensive social support and assistance. Given that 
potential candidates without family or partners capable or providing care are not 
usually accepted for transplantation (Hafliger, 2005; Olsbrich, 1996), further attention 
on the relationship between families and transplant patients’ QOL is also warranted.  
Assessment may also inform recommendations for pre- and post-transplantation 
interventions designed to optimise patients’ candidacy and prevent morbidity and 
mortality. Waitlist priority and organ allocation is based on organ availability, organ 
size, donor and recipient biological compatibility, the degree of patient need, patients’ 
nearness to death, and time on waitlist (Olsbrich, 1996). The organ allocation system 
has received criticism, with Neuberger (2012) arguing the need for greater balance 
between the rights of the dying and those patients with an intolerable QOL, stating 
that patients with dire medical needs are given preference over patients who have 
good organ function but unacceptable QOL. While candidates may wait up to several 
years to receive an organ transplant, post-transplant recovery time is relatively brief, 
with most recipients able to return home from hospital within weeks and resume work 
within six months of transplantation (Hafliger, 2005).  
Organs for transplantation are obtained from three potential sources, including 
brain-dead donors, non beating-heart donors, and living donation (Hafliger, 2005). 
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Posthumous organ donation in Australia is governed by an opt-in system, in which 
individuals indicate their intention to become an organ donor in the case of death via 
the Australian Organ Donor Registry (AODR). Final decisions regarding organ 
donation are made by next-of-kin, who are informed by medical personnel of the 
deceased person’s wishes according to the AODR (Excell, et al., 2011). The vast 
majority of organs transplanted are harvested from brain-dead donors. In this type of 
donation, brain functioning has completely ceased, and the donor has been certified 
legally dead by two independent medical doctors (Hafliger, 2005). The heart, kidneys, 
lungs, pancreas and intestines of brain-dead donors can be harvested, potentially 
benefitting up to seven transplant candidates. Non beating-heart donors are in 
persistent terminal, vegetative states or are already deceased. The discontinuation of 
life support induces cardiac arrest in non beating-heart patients, after which time the 
liver and kidneys may be harvested (Lopez-Navidad, Domingo, & Viedma, 1997). 
Lastly, living donation involves a whole or part organ from a healthy person being 
removed and donated to a transplant candidate, and is currently possible for kidney, 
lung, and liver transplantation. Living donation was pioneered in the 1980s and is 
widely encouraged to offset the current relative deficit of cadaver organs. Living 
individuals can donate one of their two kidneys, or a section of lung or liver, with the 
liver regenerating itself to 80-90% of its original size within six to eight weeks. The 
procedure of organ removal is tolerated well by donors, with few postoperative 
complications and a low mortality rate of 0.4% (Cotler et al., 2003; Schiano, Kim-
Schluger, Gondolesi, & Miller, 2001). Beyond the technical aspects of organ 
transplantation, extensive research has explored many aspects of transplantation, 
including medication, psychological wellbeing, and donation rates. 
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Organ transplantation research. Transplantation research is prolific, with 
dozens of journals dedicated to its progress and many other organ transplantation 
studies published in a variety of academic journals. The research covers many fields, 
including science, medicine, nursing, psychology, social science, and health 
economics. Common areas of research include immunosuppression, the psychological 
wellbeing of transplant patients, medication compliance, and organ donation rates. 
Studies assessing the QOL of transplant patients proliferated in the 1980s, with the 
increased survival rates brought about by Cyclosporine permitting researchers to turn 
attention to life quality in addition to longevity. However, the study of transplant 
patients’ QOL has been marred by several factors, including a lack of consideration of 
conceptual or theoretical models of QOL, and a tendency to reaffirm established QOL 
findings rather than focus on new areas of study. The study of QOL in organ 
transplantation will be covered in further detail in Chapter 2. 
Prior to the advent of Cyclosporine, organ transplant research focused almost 
exclusively on surgical techniques and the development of immunosuppressant 
medications (Joralemon & Fujinaga, 1997). Much research is still dedicated to the 
continued development and refinement of the medical aspects of transplantation 
(Falger, Latal, et al., 2008; Hafliger, 2005; Otte, 2002). Continued efforts to improve 
immunosuppressant technology are designed to eradicate the incidence of organ 
rejection; transplants can be thought of as ‘borrowed’ organs, and the recipient’s body 
and immune system will always treat the transplanted organs as foreign tissue and 
will act to reject the transplant. Organ rejection has serious implications and is best 
prevented rather than cured, and as such transplant teams and surgeons employ 
careful donor-recipient matching as part of the thorough pre-transplant preparation 
process. Rejection episodes are difficult to treat, and may result in a relapse to end-
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stage organ failure and a return to the waitlist for retransplantation. Further, patients 
who have experienced an organ rejection do not respond as well to alternate 
treatments such as dialysis (Engle, 2001).  
In addition to the potential for organ rejection, morbidity and mortality rates 
among transplant patients are greatly impacted by medication compliance and 
adherence to medical advice. To this end, compliance is voluntary and transplant 
patients have an important and active role in avoiding infection and organ rejection. 
The rate of noncompliance among transplant patients has been described as 
unacceptably high, placing patients at increased risk of protracted illness and possible 
death (Dew et al., 2007). Research has focused on factors that affect adherence to 
medical advice and medication, with compliance found to be impacted by a variety of 
factors, including socio-demographic variables, the complexity of the 
immunosuppressive regimen, medication side-effects, time since transplantation, and 
psychosocial variables such as depression, anxiety, social relationships, and stress 
(Achille, Ouellette, Fournier, Vachon, & Hebert, 2006; Frazier, Davis-Ali, & Dahl, 
1995; Griffin & Elkin, 2001). The ethical considerations associated with 
retransplantation is also an emerging area of research, with a call for clinical 
guidelines and decision-making structures surrounding the controversial issue of 
retransplanting patients in instances where organ failure was caused by non-adherence 
to treatment and medication (Dobbels, Hames, Aujuoulat, Heaton, & Samyn, 2012). 
Similarly, Neuberger (2012) called for clear systems to be in place to assess and 
respond to patient noncompliance. 
The incidence of psychopathology among transplant patients has received a 
good amount of attention in the literature. Approximately 50% of all transplant 
candidates meet criteria for a psychiatric disorder, with most diagnosed with 
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adjustment disorder in the context of the incredibly stressful experience of the 
transplantation process (Olbrisch, Benedict, Ashe, & Levenson, 2002). Most 
transplant patients have some extent of neuropsychiatric impairment due to end-stage 
organ failure, with symptoms of cognitive impairment typified by concentration and 
memory problems. Kidney transplant candidates undergoing dialysis are at risk of 
depression, and renal failure is associated with neuropsychiatric problems, such as 
attention difficulties and the development of psychosis. Lung transplant candidates 
are also likely to experience anxiety and depression, and have an increased risk of 
developing panic disorder. One in five heart transplant candidates experience major 
depressive disorder, while one in four continue to experience depression following 
heart transplantation (Dew et al., 2001). Delirium is quite common in the 
postoperative phase for all transplant patients, with lung transplant candidates 
especially susceptible to experiencing delirium due to hypoxia (Hafliger, 2005; 
Klapheke, 1999). 
Serious psychopathology may interfere with the transplantation process and has 
implications for patients’ morbidity and mortality. Schizophrenia, personality 
disorders, and major depression may be associated with self-care difficulties among 
patients and in some cases results in instances of self-harm and suicide (Olsbrich, 
1996). Alcohol and substance abuse issues also need to be carefully considered, 
especially among liver transplant patients. Personality disorders are usually 
considered to be a contraindication to transplantation, as patients generally have poor 
coping skills that place them at a higher risk of psychiatric morbidity following 
transplantation, and the manipulative tendencies and impulsive behaviour common to 
individuals with personality disorders generally disrupts the transplantation process. 
Further, excessive need for reassurance and overreliance on professional and personal 
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support systems may lead to rapid and intense transference reactions, which, in turn, 
can evoke countertransference among members of the transplant team. Individuals 
experiencing active psychosis are also usually considered unsuitable for 
transplantation; however, successful transplantation in psychotic patients can be 
achieved with careful medication management and suitable professional and personal 
support. Mood disorders must also be carefully monitored among transplant patients, 
as depressive episodes can have a detrimental impact upon motivation to adhere to 
treatment and attend medical appointments (Klapheke, 1999). Rejecting candidates 
for transplantation based on personality features or psychiatric wellbeing has 
repercussions for the ethical decision making of transplant teams, and as such 
literature on the ethics of transplantation has received increased attention in recent 
years (Cotler, et al., 2003; Kaufman, Shemesh, & Benton, 2010; Olbrisch, et al., 
2002).  
Transplantation also has implications for the prescription and dosage of 
psychotropic drugs and other medications used to treat common psychological 
disorders such as depression and anxiety. End-stage organ failure and 
immunosuppressant medications are associated with changes to transplant patients’ 
blood flow, medication uptake, excretion of medication, and metabolism. Steroidal 
immunosuppressant medication can induce mania, and therefore candidates who 
experience depression should be monitored for labile mood and irritability after 
transplantation (Hafliger, 2005). Given such possible complications and the 
probability of adverse reactions, the prescription of psychiatric medication to organ 
transplant patients requires careful assessment and comprehensive, ongoing 
management from a psychiatrist (Klapheke, 1999). 
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Lastly, organ donation rates and decision-making related to becoming an organ 
donor have attracted much academic attention. The worldwide shortage of organs for 
transplantation results in the death of thousands of people with end-stage organ failure 
each year, and the uncertainty of receiving an organ has been posited as contributing 
to the development of psychological problems among transplant candidates (Engle, 
2001). Current organ donation rates in Australia are among the lowest in the 
developed world, with 13.8 donors per million population (DPMP) substantially 
lower than that of the US rate of 25.6 DPMP and Portugal’s rate of 30.4 DPMP 
(Excell, et al., 2011). Research has shown that organ donation rates in Australia have 
been affected by hospital-based problems such as poor identification of potential 
organ donors, shortage of intensive care beds, and non-prioritisation of donor cases 
(Mathew, 2004). Further research has investigated factors affecting individuals’ 
willingness to register as posthumous organ donors, including knowledge of the 
transplantation process, attitudes towards transplantation, religiosity, perceived beliefs 
of family and friends toward organ donation, and fear of death (Hyde & White, 2007; 
Minniefield, Yang, & Muti, 2001; Sanner, 1994). Such research has important 
implications for QOL research, as increased wait time and uncertainty around 
receiving a transplant is associated with low QOL among transplant patients (Barr et 
al., 2003; Zipfel et al., 1998). 
Quality of Life 
The pursuit of a life of good quality is a hallmark of human civilisation. As 
such, a vast amount of academic attention has been dedicated to the study of QOL and 
its conceptualisation and measurement. The construct of QOL offers an organised 
framework for investigating and describing people’s lives and experiences (King, 
2012). Quality of life has been investigated in many contexts and settings, including 
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politics, education, sociological studies, advertising, healthcare, oncology, and 
disability. An evaluation of patients’ QOL is now included as an outcome measure in 
many clinical trials, and QOL has also been the central focus of extensive research in 
a variety of healthcare settings. The QOL of patients has long been central to research 
in the field of organ transplantation, with increased interest in the topic following the 
resolution of many difficulties associated with the medical and pharmacological 
aspects of the transplantation procedure.  
The philosopher Aristotle was among the first to write of the concept of QOL, 
remarking that the quality of a person’s life is determined by its activities (Roop, 
Payne, & Hazard Vallerand, 2012). More recently, the term QOL entered popular 
vernacular through US socio-economic research in the 1950s in which it was defined 
in terms of employment, housing, and income. Around this time, medicine also began 
to counterbalance its traditional role of extending quantity of life with attempts to also 
improve the quality of patients’ lives. Heralding the move from ‘mechanistic 
medicine’ to ‘humanistic medicine’ in the 1960s, British physician Sir Robert Platt 
lectured on the need for doctors to enquire about patients’ life satisfaction. The 
concept of QOL slowly gained increased attention during the 1970s, and the 1980s 
marked widespread awareness of QOL (Basu, 2004). More importantly, the World 
Health Organisation’s (WHO) initial and enduring definition of health laid the 
foundation for the conceptualisation of QOL and future research in the field, with 
WHO’s 1948 definition of health as a state of complete physical, mental, and social 
wellbeing moving well beyond early interpretations that focused purely on health and 
physical functioning (Orley & Kuyken, 1994). Health and QOL quickly became 
central to debates on a variety of issues, including the role of national parks in 
promoting health and wellbeing, international development plans, immigration, and 
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ethically acceptable medical treatment for incapacitated and comatose patients (Engle, 
2001).  
It may be argued that the increased attention afforded to QOL across many 
areas of study is a direct result of vast improvements to life expectancy, with life 
expectancy in Western countries rising from 49.2 to 77 years over the past 30 years. 
Further, today’s population generally live with a sequela of injury or chronic illness 
for several years before death, contrasting the experiences of previous generations 
who generally succumbed quickly to death following an acute illness. Increased life 
expectancy has been brought about by factors such as public health campaigns, rising 
standards of living, improved sanitation, eradication and control of communicable 
diseases, and new medical therapies (Joralemon & Fujinaga, 1997; Roop, et al., 
2012). 
The study of QOL has been lauded for its salutogenic focus. Its attention to 
positive adaptation and resolution of stress aimed at improving the wellbeing of 
transplant patients is a contrast to deficit models that concentrate on pathology and 
illness (Albrecht & Devlieger, 1999). While the focus on resilience and wellbeing is 
reminiscent of the stance of positive psychology, studying QOL also has important 
practical implications, including informing interventions designed to maximise life 
quality. Thorough consideration of QOL also yields a more complete picture of the 
nature of health and disease by linking QOL to life expectancy and longevity, thus 
promoting a holistic approach to healthcare. Orley and Kuyken (1994) contend that 
raised awareness of QOL issues among health professionals results in more 
meaningful and fulfilling interactions with patients and more comprehensive patient 
care; this will be explored in Chapter 3 of this thesis. On a broader level, QOL 
research informs national and international public health policy by allowing 
 20
comparisons beyond cost and survival rates, and provides guidance at micro and 
macro levels of health economics to ensure limited financial resources are allocated in 
the best possible manner (Fox-Rushby, 1994).  
While the benefits of QOL research are widely accepted, psychosocial research 
in the field of organ transplantation has thus far been limited. The research has lacked 
a theoretical basis, with little academic attention afforded to the conceptual nature of 
transplant patients’ QOL. Bean and Wagner (1996) used a model of self-
transcendence to account for liver transplant patients’ positive QOL; others have used 
the Roy Adaptation Model (Lefaiver, Keough, Letizia, & Lanuza, 2007) and the 
Orem nursing theory to explore the impact of caregivers on transplant patients’ QOL 
(Norris, 1991). Crisis theory may also be used to explore transplant patients’ QOL 
(Moos & Schaefer, 1986).  
 Further, the focus on transplant patients’ perspectives has led to a lack of 
consideration of the way in which other factors, including health professionals and 
families, contribute to QOL outcomes following transplantation. The agenda for 
transplant QOL research has changed little since its initial proliferation in the 1980s, 
and must expand its focus in order to contribute meaningful information to the 
understanding of the lives of transplant patients.  
Definition of quality of life. The concept of QOL has been embraced by 
various disciplines across the social sciences, medicine, and economics. Each 
discipline has fostered its own distinct understanding of QOL, with the social sciences 
largely rejecting medicine’s focus on physical health and instead embracing 
humanistic notions of normalisation, social role valourisation, and empowerment 
(Cummins, 2005). Despite these differences, there is general agreement on the 
conceptualisation of QOL as a construct that has several core elements. It is 
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multidimensional, and comprised of both objective and subjective components. It is a 
universal measure containing the same components for all people, and is influenced 
by personal and background factors and the interaction between individuals and their 
environment. Lastly, self-determination, resources, purpose in life, and a sense of 
belonging enhance QOL.  
In keeping with WHO’s definition of health, QOL is considered to be more than 
the absence of disease (Burra & De Bona, 2007; Cummins, 2005). Indeed, WHO 
provide the most widely used definition of QOL, stating that it is “an individual’s 
perception of his/her position in life in the context of the culture and value systems in 
which he/she lives, and in relation to his/her goals, expectations, standards, and 
concerns” (Orley & Kuyken, 1994, p. 43). The broad-ranging concept incorporates 
physical health, psychological state, level of independence, social relationships, 
personal beliefs, and a person’s relationship to salient features of their environment 
(Orley & Kuyken, 1994). Albrecht and Devlieger (1999) offer a more simplistic view 
of QOL, stating that a good QOL implies being in good health and experiencing 
subjective wellbeing and life satisfaction. 
Assessment of quality of life. Awareness of the concept of QOL has been 
accompanied by interest in the measurement of QOL. The purpose of measuring QOL 
is to provide accurate assessments of individuals’ wellbeing, and is most usually 
measured in the context of healthcare. The most widely used application of QOL 
measures is in clinical trials, with the concept less often measured in routine clinical 
care or medical audits. Both disease-specific and generic measures of QOL have been 
developed, with WHO’s continued QOL research integral to the development and 
validation of measures across cultures and populations (Orley & Kuyken, 1994). In 
addition to considering the multidimensional nature of QOL, measures must also meet 
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requirements of reliability and validity, and be appropriate and practical for the 
population or health problem being investigated (Basu, 2004). The measurement of 
QOL in relation to organ transplantation will be discussed further in Chapter 3. 
Theoretical model of quality of life. Figure 1 presents a conceptualisation of 
QOL that integrates the essential components of the definition of QOL. Felce (1997) 
theorised QOL to be an expression of general wellbeing comprising objective 
descriptors and subjective evaluations of physical, psychological, and social health, 
all weighted by a personal set of values. The model consists of three major 
components: objective life conditions, subjective feeling of wellbeing, and personal 
values and aspirations. The model represents WHO’s definition of QOL through the 
inclusion of physical, psychological, and social functioning, and the subjective nature 
of QOL is also considered. According to the model, the three components are 
interdependent and have the potential to interact and impact upon QOL.  
Life conditions refer to the objective description of individuals and their 
circumstances. The objective conditions in which an individual or group live may be 
observed or measured by comparing their position to the total population distribution 
in any given area. Living conditions may impact upon personal satisfaction, but do 
not necessarily define a person’s happiness and wellbeing. As such, objective 
standards cannot be used to reliably rate an individual’s QOL (Felce, 1997). There is 
an uncertain relationship between objective and subjective views of QOL, and a 
person’s perception of personal health, wellbeing, and life satisfaction are often 
discordant with their objective health status and physical functioning (Albrecht & 
Devlieger, 1999). For example, an individual with an income double that of their 
neighbour is not necessarily twice as satisfied with their earnings, and two individuals 
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with the same objective health status may potentially report widely divergent QOL 
(Burra & De Bona, 2007; Cummins, 2005).  
 
  
 
Figure 1. An overall model of quality of life. Adapted from Felce (1997) 
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The subjective nature of QOL has long been recognised, with Mark Twain 
writing in 1902 that the value of life must be discerned from the individual’s 
perspective (Edgar, 1996). Subjectivity has been described as fundamental to the 
conceptualisation of QOL and the understanding of an individual’s wellbeing 
(Cummins, 2005). An individual’s expectation of their health and wellbeing can be 
greatly affected by a person’s perception of health and satisfaction with life. An 
assessment of QOL goes beyond symptomatology by considering the subjective 
impact of illness and life circumstances on an individual. This subjective evaluation is 
embedded in a cultural, social and environmental context, resulting in individuals and 
groups emphasising the importance of particular aspects of life (Orley & Kuyken, 
1994). In a healthcare situation, a patient’s QOL is informed by an individual’s 
perspective of illness, perception of treatment, expectation of self, and appraisal of 
potential risk or harm that may arise (Roop, et al., 2012). 
Lastly, the model illustrated in Figure 1 indicates the importance of personal 
values and aspirations in determining an individual’s QOL. This represents the 
relative weight or importance an individual attaches to various aspects of their 
objective life conditions and subjective wellbeing, and recognises individual 
differences in life goals and enjoyment derived from various activities (Felce, 1997). 
Individuals’ personal goals and aspirations may also differ across the lifespan, further 
adding to the conceptualisation of QOL as a fluid and subjective construct. 
Domains of quality of life. Quality of life is almost always conceptualised as 
consisting of several dimensions, as shown in Figure 2. The most frequently cited are 
physical, psychological, and social wellbeing. A somatic/disease domain is included 
in some studies, in addition to a spirituality domain that refers to existential thoughts 
and seeking meaning through intra-, inter- and transpersonal connection (King, 2012; 
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Roop, et al., 2012). Other studies of QOL have also included material wellbeing 
(wealth, income, housing quality), productive wellbeing (competence, employment, 
hobbies), and civic wellbeing (privacy, public roles and responsibilities) (Felce, 
1997). Each domain can be objectively assessed and subjectively perceived, and an 
global rating of QOL is often included to indicate a person’s overall wellbeing. 
Similarly to overall QOL, the facets of QOL domains are universal, but differ in their 
relative importance between and within individuals (Orley & Kuyken, 1994).  
 
 
 
Figure 2. The global construct of quality of life and the quality of life domains of 
physical, psychological, and social functioning 
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sensory functions, overall health, nutrition, mobility, and fitness. The psychological 
domain includes positive and negative feelings, self-esteem, body image and 
appearance, and the cognitive functions of thinking, learning, memory and 
concentration. Lastly, the social domain considers personal relationships, practical 
social support, role as provider or supporter, the quality and breadth of interpersonal 
relationships, intimacy, community involvement, social inclusions, and friends, 
relatives and acquaintances (Orley & Kuyken, 1994). 
Rationale, Aims, and Research Questions 
The literature previously reviewed suggests that organ transplantation is a well-
researched area of study. Previous investigations have contributed to incredible 
advances in the medical aspects of organ transplantation, with today’s transplantation 
procedures affording excellent survival rates. Further research has investigated the 
psychiatric aspects of organ transplantation, medical compliance among transplant 
patients, and low posthumous donor rates.  
The QOL of organ transplant patients has also been extensively studied, 
however, there has been no attempt to explain the QOL of transplant patients from a 
theoretical perspective, leading to much research simply re-establishing findings of 
differences in transplant patients’ QOL levels rather than seeking to identify the 
underlying factors associated with patients’ QOL (Dew, et al., 1997; Joralemon & 
Fujinaga, 1997). Furthermore, previous literature has been marred by a limited variety 
in research themes; most research has concentrated solely on QOL experiences from 
the perspective of transplant patients and has not considered the contribution or role 
of other people involved in the transplantation process, including health professionals 
and family members. As such, a comprehensive understanding of the many factors 
that contribute to the wellbeing of transplant patients has not yet been reached (R. 
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Taylor, Franck, Gibson, & Dhawan, 2005; Wood-Dauphinee, 1999). A more 
comprehensive understanding of the QOL issues of transplant patients from 
theoretical and empirical perspectives may also assist with improved intervention 
efforts, thereby assisting transplant patients to achieve optimal QOL.  
In summary, the overall aim of the current thesis is to contribute to the 
understanding of the QOL of organ transplant patients by investigating new aspects of 
this widely researched topic. Thus far, a virtual plethora of research has failed to 
consider transplant patients’ QOL experiences from a theoretical perspective, and has 
largely failed to consider the perspectives of important others who play integral roles 
in the transplantation process. Adopting a theoretical perspective to investigate 
transplant patients’ QOL is incremental in filling a significant gap in this field of 
knowledge, and may also proffer an explanation of individual variability in the QOL 
reported by transplant patients. Further, consideration of QOL within the contexts of 
clinical practice and family life provides an opportunity to reach a more complete 
understanding of transplant patients’ QOL, thus enabling transplant patients to enjoy a 
life of optimal quality.  
This thesis comprises three studies detailed in separate chapters. Each 
contributes unique knowledge to our understanding of the QOL experiences of organ 
transplant patients by focusing on QOL from the unique perspectives of transplant 
patients, medical professionals, and family members of pediatric transplant recipients. 
The aims and research questions pertaining to each study are herein detailed.  
Study 1 adopted a theoretical stance, using the framework of crisis theory to 
consider the relative impact of stress and coping on the QOL outcomes for transplant 
patients. Consideration of the stress, coping, and QOL of transplant candidates and 
recipients was accompanied by comparisons with non-transplant individuals. 
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Transplant-specific stressors were also evaluated. The following research questions 
were posed: 
1. Can the QOL of transplant patients be explained by crisis theory?  
2. Do candidates, recipients and non-transplant individuals experience 
different levels of physical, psychological, and social functioning? 
3. Do candidates, recipients, and non-transplant individuals experience 
different levels of everyday stress? 
4. What are the coping strategies employed by candidates, recipients, and 
non-transplant individuals?  
5. What are the prevalent transplant-specific stressors experienced by 
transplant patients? 
Study 2 was an exploratory study that aimed to investigate QOL from the 
perspectives of health professionals working in the field of organ transplantation. 
With the aim of exploring health professionals’ attitudes towards QOL and their 
sensitivity towards the QOL issues of transplant patients, four research questions were 
posed: 
1. How do health professionals define QOL? 
2. What are the attitudes of health professionals towards transplant patients’ 
QOL issues? 
3. Are health professionals willing to use QOL information in clinical 
practice? 
4. To what extent do health professionals use QOL information in clinical 
practice, and what factors are associated with health professionals’ use of 
QOL information? 
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Study 3 investigated QOL from another perspective, with pediatric liver 
transplant patients’ QOL evaluated via parent proxy report. Additionally, pediatric 
transplant patients’ QOL was compared to a normative sample. This study also 
considered the way in which family routines are adjusted to accommodate for 
children following transplantation, and investigated the association between QOL and 
family functioning. Research questions for this study include: 
1. Does the QOL of children who have received liver transplants differ from 
children in the community? 
2. In which specific QOL areas do pediatric liver transplant recipients 
experience relative deficits? 
3. Does the family functioning of pediatric liver transplant recipients differ 
from other children in the community? 
4. Do family functioning and QOL improve with time-elapsed post-
transplantation? 
5. What is the relationship between family functioning and QOL of pediatric 
liver transplant recipients? 
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Chapter 2  
Study 1 – Using Crisis Theory to Explain the Quality of Life of Organ 
Transplant Patients. 
Study 1 investigates the QOL of adult transplant patients from a theoretical 
perspective, using crisis theory in an attempt to explain the ubiquitous QOL findings 
in the transplantation literature. Considerable previous research has reported that 
despite ongoing physical and psychological issues, transplant recipients report a much 
higher QOL than transplant candidates, and a comparable QOL to the healthy 
population (Burra & De Bona, 2007; Dew, et al., 1997; Edgar, 1996; Falger, Landolt, 
et al., 2008; Forsberg, Lorenzon, Nilsson, & Backmana, 1999; Kousoulas et al., 2008; 
Molzahn, 1991). However, these findings have not been explained from a theoretical 
perspective, leaving a considerable gap in the understanding of the QOL experiences 
of transplant candidates and recipients in comparison to others in the community. The 
introductory section of this chapter will follow the framework of crisis theory to detail 
the substantial previous research on transplant patients’ QOL, leading to a 
consideration of the relationship between stress, coping, and QOL. 
Crisis Theory 
Ecologists, sociologists and psychologists alike have long studied crisis, with 
diverse work from theorists such as Darwin and Freud concerned with the way 
humans react to unexpected and emergency situations and other predicaments (Moos 
& Schaefer, 1986). Derived from the Greek word krinein, meaning ‘to decide’, crisis 
is defined as a temporary state of upset and disorganisation, characterised by an 
inability to cope with a particular situation, and by the potential for a radically 
positive or negative outcome (Slaikeu, 1984). Examples of crises include threats to 
bodily integrity by illness, accident, or surgical operation (Moos & Schaefer, 1986); 
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organ transplantation, which typically involves waiting a substantial period of time 
for a suitable organ before undergoing transplant surgery, is a prime example of a life 
crisis. Caplan (1964) notes that crises are defined by being both serious and 
unavoidable situations that lead to a turning point in life development, likening a 
crisis experience to the storyline of a theatrical play, with life disrupted by some 
unexpected happening and a lead character portrayed as seeking a resolution yet 
struggling to find his way out of a quandary. 
Crisis theory originated from Erich Lindemann’s (1944, cited in Caplan, 1964) 
seminal work on grief management, in which he theorised that teaching adequate 
mourning skills could prevent unhealthy coping among bereaved individuals. Caplan 
(1964) employed Lindemann’s broad conceptual framework to investigate life crises 
in adult psychopathology. Observing the history of psychiatric patients, he noted that 
those who coped with problems in an adaptive manner experienced better 
psychological outcomes. 
 Crisis theory is based on the assumption that individuals require a steady 
psychological equilibrium, similar to the need for physiological homeostasis. The 
theory contends that crisis disrupts psychological homeostasis, with an imbalance 
between problem severity and resources available to manage the situation often 
resulting in feelings of helplessness and ineffectuality. Similar to its physiological 
equivalent, psychological equilibrium must be restored relatively quickly in order to 
avoid distress or the developmental of psychopathology, and as such individuals 
experiencing a crisis must develop coping skills and resources outside their normal 
repertoire (Moos & Schaefer, 1986). The crisis may be a harmful experience, 
resulting in a reduced capacity to deal effectively with future crises, or a positive one, 
in which the individual applies newly-developed skills to other areas of life (Caplan, 
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1964). Returning to Caplan’s analogy of crisis as a theatrical production, equilibrium 
is signified by the central character settling down at the conclusion of the play, being 
portrayed as clearly better or worse off than at the play’s beginning. 
 In summary, crisis theory is concerned with how people cope with major life 
crises and transitions (Moos & Schaefer, 1986). Reflecting its beginnings, crisis 
theory continues to be applied to preventative psychiatry (Hobbs, 1984), and its 
framework has also been used to investigate coping in stressful employment settings 
(Sparks, 1988), parental stress and coping in pediatric critical care (LaMontagne, 
Johnson, & Hepworth, 1995), elderly persons’ transition to aged care facilities 
(Oleson & McGlynn Shadick, 1993), and the stress and coping of a pediatric burns 
patient and his caregivers (Fette, 2005). Crisis theory has also been used to explain 
cancer patients’ QOL, with the theory’s supposition supported by findings that 
patients undergoing treatment experience poorer QOL than patients in remission 
(Sprangers, Tempelaar, van den Heuvel, & de Haes, 2002). 
Understanding the crisis of physical illness. Building on the initial crisis 
theory conceptualised by Caplan (1964), Moos and Schaefer (1986) developed an 
integrative framework in which serious physical illness is understood as a life crisis. 
Physical illness is a serious upset to a steady state that may extend over a long period 
of time and can potentially lead to permanent changes for patients. Ultimately, serious 
physical illness threatens life and wellbeing, and may involve additional stressors 
such as hospitalisation, medical procedures, reliance on medication, and extended 
separation from family and friends. 
 According to crisis theory, individuals experiencing physical illness use 
cognitive appraisal to assess the significance of the crisis, and then apply strategies to 
contend with its various stressors. As illustrated in Figure 3, crisis theory proposes 
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that an individual’s evaluation of these stressors and selection of effective coping 
strategies are influenced by demographic and personal characteristics, aspects of the 
illness, and the physical and social environment in which the illness occurs. These 
factors shape the individual’s appraisal of stressors and selection of coping 
mechanisms, leading to the crisis outcome (Moos & Schaefer, 1986). Echoing the 
sentiment of Caplan (1964), Moos and Schaefer (1986) noted that most people cope 
adequately with the crisis of severe physical illness, with many survivors reporting 
excellent post-crisis outcomes.  
 
Figure 3. Crisis theory model. Adapted from Holahan, Moos, and Schaefer (1990) 
COPING 
TRANSPLANT-RELATED 
STRESS 
QUALITY OF LIFE 
Cognitive appraisal 
(perceived meaning of 
illness) 
 
Adaptive tasks 
Illness-related  
factors 
Physical and social 
environmental factors 
 
OUTCOME OF 
CRISIS 
 34
Using crisis theory to understand the quality of life of transplant patients. 
Moos and Schaefer’s (1986) crisis theory may be used to explore the QOL of 
transplant candidates and recipients. Crisis theory is particularly well suited to testing 
the QOL of transplant candidates; its supposition of the impact of crisis on QOL is 
congruent with the notion of end-stage organ failure and subsequent organ 
transplantation being an extreme health crisis, and the consideration of the 
contribution of stress and coping to the QOL of transplant patients is consistent with 
previous research in this field. The theory suggests that the QOL of transplant 
candidates (who are in crisis) will be impaired, as they possess insufficient coping 
skills to manage the crisis of being on the transplant waiting list. Candidates 
experience various stressors, including but not limited to the prospect of not receiving 
a transplant. The homeostatic equilibrium of a transplant candidate has been 
disrupted, and coping skills must be developed to restore psychological balance. 
Crisis theory suggests transplant recipients (post-crisis) have developed coping skills 
to overcome the crisis state and have adapted to their condition, resulting in overall 
QOL not being impaired despite probable physical and psychosocial restrictions 
(Holahan, Moos, & Schaefer, 1996). 
Quality of Life After Organ Transplantation  
Most studies report drastic improvements in QOL following organ 
transplantation. A comprehensive meta-analysis of 218 independent studies published 
between 1972 and 1996 reported transplant recipients generally experience improved 
QOL and show QOL advantages over transplant candidates (Dew, et al., 1997). 
Research has consistently found candidates’ QOL to be far worse in comparison to 
transplant recipients and the healthy population. Awaiting a transplant limits social 
and everyday activities, leading to a marked decline in QOL (Diaz-Dominguez, 
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Perez-Bernal, Perez-San-Gregorio, & Martin-Rodriguez, 2006; Zipfel, et al., 1998). 
Myaskovsky and colleagues (2003) found lung transplant candidates reported a lower 
QOL than two normative samples from the healthy population, with specific QOL 
deficiencies of lower general health, lower physical functioning, less vitality, more 
bodily pain, and greater difficulties with work, daily functioning, and social activities. 
Kalman, Wilson, and Kalman (1983) did not find a significant difference between the 
QOL of kidney recipients and dialysis patients, yet a comprehensive meta-analysis of 
published literature on the QOL of liver recipients found a significant improvement in 
overall QOL from pre- to post-transplant (Bravata, Olkin, Barnato, Keeffe, & Owens, 
1999). While liver recipients report being satisfied with their lives (de Kroon, Drent, 
van den Berg, & Haagsma, 2007), findings of liver recipients’ QOL being comparable 
to that of the general population (Burra & De Bona, 2007; Dew, et al., 2007; Nickel, 
Wunsch, Egle, Lohse, & Otto, 2002) are tempered by longitudinal studies suggesting 
long-term deficits in liver recipients’ overall QOL (Kousoulas, et al., 2008; Lewis & 
Howdle, 2003). 
More recent studies also note vast improvements between pre- and post-
transplantation (Bortman et al., 1999; Diaz-Dominguez, et al., 2006; Kita & Tamaki, 
1998; Limbos, Joyce, Chan, & Kesten, 2000; Moore, Mc, & Burrows, 2000; 
Rodrigue, Baz, Kanasky, & MacNaughton, 2005; Russ et al., 2007). However, the 
likelihood of observing post-transplant QOL benefits partially depends on the specific 
QOL domain and transplantation area under consideration. Beyond acknowledging 
such differences, previous research offers little consensus regarding QOL 
discrepancies between organ types, and a wide variety of research methodologies, 
tools and sample sizes make results difficult to reconcile. Limited investigation of 
candidates’ QOL has shown heart transplant candidates to have the worst QOL in 
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comparison to other groups (Pinson et al., 2000), however, heart recipients are 
thought to have good long-term QOL prospects (Burra & De Bona, 2007). Previous 
research on transplant recipients’ QOL has yielded varying results: Forsberg, 
Lorenzon, Nilsson, and Backmana (1999) found no difference between the QOL of 
lung, heart, and kidney recipients, but Diaz-Dominguez and colleagues (2006) noted 
significant differences between kidney, lung, and heart groups. Further, a recent study 
found no difference between the QOL of heart and liver recipients (Langenbach, 
Schmeisser, Albus, & Decker, 2008), while lung recipients have been found to enjoy 
a more optimal QOL than heart and liver recipients (Nickel, et al., 2002). Some 
studies report renal patients to experience the best overall QOL improvements post-
transplant, with 23% of recipients reporting very good QOL, and 57% and 20% 
reporting QOL as good or satisfactory, respectively (Burra & De Bona, 2007; 
Lazzaretti, Carvalho, Mulinari, & Rasia, 2004; Wainwright, Fallon, & Gould, 1999). 
In addition to an overall measurement, QOL can also be investigated in terms of 
physical, psychological, and social wellbeing. 
Quality of life domains: Physical, psychological, and social wellbeing. Meta-
analysis indicated important differences between the physical, psychological, and 
social functioning of organ transplant patients (Dew, et al., 1997). Statistically 
significant improvements were noted in the physical and social domains across all 
organ types, but not in psychological wellbeing. Similarly, other studies have noted 
deficits in recipients’ psychological wellbeing, with marked gains in physical and 
social functioning but modest improvements in psychological health (Burra & De 
Bona, 2007; Dew, Myaskovsky, et al., 2004). Conversely, a study comparing the 
QOL of 371 liver, heart, kidney, and lung recipients identified significant physical 
deficits but normal mental and emotional functioning (Pinson, et al., 2000). Heart 
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recipients studied 10-18 years after transplantation reported excellent overall QOL, 
but impaired physical health compared to the healthy population (Fusar-Poli et al., 
2005). In contrast, an Italian study of 276 heart recipients surviving 10 years post-
transplant found psychological wellbeing equal to the general population, while 
physical functioning was compromised (Politi et al., 2004). Denny and Kienhuis’ 
(2011) summary of the widely-investigated differences between the physical, social, 
and psychological functioning of heart, kidney, lung, and liver transplant patients 
further demonstrates the way in which transplant patients may experience differing 
QOL on each of the individual domains. 
Is recipients’ quality of life equal to the non-transplant population? Crisis 
theory suggests transplant recipients will experience a superior QOL to candidates 
and a comparable QOL to the healthy population (Sprangers, et al., 2002). The former 
point has been demonstrated many times. The latter is partly dependent upon the type 
of organ transplanted, but literature suggests transplantation does not fully restore 
QOL to levels of the non-transplant population (Dew, et al., 1997). However, 
transplant recipients competing in the 1996 US Transplant Games reported an overall 
QOL higher than the general population, suggesting recipients have the potential to 
achieve excellent QOL (Painter et al., 1997). Several studies have explained similar 
findings with terminology consistent with crisis theory: recipients adjust to living with 
ongoing health problems, and begin to live a ‘new kind of normal’ life (Kugler et al., 
2005; Moore, et al., 2000; Nickel, et al., 2002). While Kugler and colleagues (2005) 
reported recipients’ QOL to be comparable to the healthy population, a longitudinal 
study of 66 lung recipients found QOL did not reach normal levels of the US 
population (Rodrigue, et al., 2005). As QOL is a subjective experience (Murphy, 
Herrman, Hawthorne, Pinzone, & Evert, 2000), it may be that despite physical and 
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psychosocial problems, recipients perceive their lives as comparable to the healthy 
population (Dew, et al., 2007). After all, the alternative to organ transplantation is 
certain death. 
Stress 
Considerable research has attempted to link transplant patients’ QOL with 
coping strategies, yet few studies have systematically investigated the impact of stress 
on QOL outcomes. Only studies considering stressor characteristics can achieve a full 
understanding of the relationship between coping processes and illness outcome (S. 
Maes, Leventhal, & de Ridder, 1996). 
Stress and crisis theory. Stress plays an important role in the conceptualisation 
of serious physical illness as a crisis. According to Moos and Schaefer (1986), an 
individual’s perception of stressors contributes to the selection of coping strategies. 
Seminal research on stress highlighted the important relationship between stress and 
coping mechanisms, noting that performance between individuals exposed to similar 
stressors was not uniformly impaired or facilitated (Lazarus & Folkman, 1984). Stress 
comprises physiological and psychological responses, and may be defined as the 
relationship between the person and the environment that is appraised by the person 
as taxing or exceeding his or her resources and endangering his or her wellbeing 
(Lazarus & Folkman, 1984). This definition acknowledges the subjective nature of 
stress, complementing the conceptual framework of crisis theory. 
Stress and organ transplantation. Stress experienced by transplant patients 
has received little attention, but its importance should not be understated. Limited 
research suggests that the type and severity of patients’ stress influences the selection 
of coping styles and strategies, which ultimately impact upon QOL. Previous research 
has related transplant candidates’ increased stress to greater use of coping styles 
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judged to be ineffective, such as confrontation, evasion, and self-reliance (Porter et 
al., 1994). Furthermore, high levels of stress have been found to interfere with 
medication adherence in kidney recipients, highlighting the importance of promoting 
optimal stress management in this population (Achille, et al., 2006).  
Transplant candidacy is a stressful experience. Financial problems, social 
issues, weight loss, and ongoing medical treatment are likely to result in reduced QOL 
(Myaskovsky, et al., 2003). Previous research has identified that candidates worry 
most about deteriorating physical health, employment loss, reduced activity tolerance, 
relationship difficulties, medication side effects, and frequent hospitalisation (Moore, 
et al., 2000; Porter, et al., 1994). Additionally, candidates have valid concerns about 
their own mortality: the disparity between the supply and demand for transplantable 
organs means that it is likely that some transplant candidates will die before receiving 
a suitable organ (Excell, et al., 2011). 
Transplantation does not eliminate stress. Recipients report ongoing concerns 
about organ rejection, financial worries, and adherence to rigid immunosuppressive 
regimens (Lindqvist, Carlsson, & Sjoden, 2004; Sutton & Murphy, 1989). Limited 
research has found liver recipients report higher stress levels than heart recipients 
(Langenbach, et al., 2008), while heart transplant recipients report similar amounts of 
stress compared to the healthy population (Grady, Jalowiec, & White-Williams, 
1999). 
Coping 
 Coping is an integral element of crisis theory, and the definition of coping as 
“a stabilising factor that can help individuals maintain psychosocial adaptation during 
stressful periods,” (Holahan, Moos, & Schaefer, 1996, p. 25) directly relates to the 
concept of psychological equilibrium. Most investigations of transplant patients’ 
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coping strategies employ Lazarus’ transactional approach, evaluating coping as 
responses to stress resulting from interactions with the environment (Lazarus & 
Folkman, 1984). Coping encompasses all cognitive and behavioural efforts to manage 
stress, and the development of coping skills is the focus of many psychotherapeutic 
and educational programs. Coping is subjective, and coping skills are contextual 
rather than a stable feature of personality: “… constantly changing cognitive and 
behavioural efforts to manage specific external and/or internal demands that are 
appraised as taxing or exceeding the resources of the person” (Lazarus & Folkman, 
1986, p. 141).  
Coping styles have been defined and categorised in many ways. Lazarus and 
Folkman (1986) distinguished between two general types of coping, with problem-
focused coping aimed at taking action to alter the source of the stress, and emotion-
focused coping aimed at reducing or managing emotional stress associated with a 
situation. While the broad distinction between problem- and emotion-focused coping 
is important, the initial dichotomy proved too simplistic, with further analysis 
revealing several activities pertinent to each (Carver, Scheier, & Weintraub, 1989). 
Based on the Lazarus model of stress, Carver and colleagues (1989) sampled 
undergraduate college students’ coping strategies, identifying five conceptually 
distinct aspects of problem-focused coping (active coping, planning, suppressing 
competing activities, restraint coping, seeking social support), five aspects of 
emotion-focused coping (seeking emotional support, positive reinterpretation, 
acceptance, denial, religion), and three aspects related to less useful coping strategies 
(venting of emotion, behavioural disengagement, mental disengagement). Carver’s 
conceptualisation of stress is widely used throughout the organ transplantation 
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literature (Burker, Evon, Marroquin Loiselle, Finkel, & Mill, 2005; Golfieri et al., 
2007; Kaba, Thompson, & Burnard, 2000; Lindqvist, et al., 2004). 
Coping strategies of organ transplant patients. Studies investigating 
transplant patients’ coping strategies consistently report frequent use of problem-
focused coping (Golfieri, et al., 2007; M. Maes, Sokal, & Otte, 1997; Myaskovsky, et 
al., 2003; Sutton & Murphy, 1989). Differing measures and categorisations of coping 
complicate comparisons, however, most can be identified as problem-focused or 
emotion-focused. Further, few studies consider the relationship between stress and 
coping with QOL, leaving no significant explanation of the major QOL differences 
observed between transplant patients and other members of the community.  
Previous research has consistently found that transplant patients favour 
problem-based coping strategies. Myaskovsky and colleagues (2003) reported lung 
transplant candidates were likely to use problem-based coping strategies such as 
seeking support or taking action to deal with the problem, and Sutton and Murphy 
Pelletier (1989) found American renal patients often use prayer and problem-oriented 
skills such as looking at the problem objectively and seeking information. Intestinal 
transplant patients are also likely to seek support (Golfieri, et al., 2007). Transplant 
patients use emotion-focused coping less than the healthy population (Lindqvist, et 
al., 2004), with few patients using avoidance, humour, or excessive venting of 
emotions (Golfieri, et al., 2007; Myaskovsky, et al., 2003). However, transplant 
patients have been found to use acceptance, a form of emotion-based coping (Kaba, et 
al., 2000).  
Many studies have made the general distinction between adaptive and 
maladaptive coping styles; however, it should be noted that a coping style itself is not 
effective or ineffective, and should be considered in relation to the stressor. Adaptive 
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coping styles, a subset of problem-focused coping characterised by planning, taking 
action and making the best of a situation, have been linked to physical and 
psychological wellbeing in medical patients (Stilley, Miller, Manzetti, Marino, & 
Keenan, 1999), but its relation to the QOL of transplant patients’ remains unclear. 
Scheier and Carver (1985) found that adaptive coping styles correlated with lower 
physical and psychological distress in heart transplant recipients, but further research 
found this coping style did not significantly predict QOL (Myaskovsky, et al., 2003). 
It is also important to consider the coping strategies not being employed by transplant 
patients, as decreased use of active coping skills has been related to low QOL (Stilley, 
et al., 1999; Telles-Correia, Barbosa, Mega, & Monteiro, 2009).  
Additionally, the term maladaptive coping has been used to describe a variety of 
coping skills leading to undesirable QOL outcomes, and has been defined as not 
making use of medical, psychosocial, or personal resources (Nickel, et al., 2002). 
Avoidant coping, characterised by denial and attempts to shun stressful situations, is 
correlated with low QOL in HIV-positive individuals (Leiberich et al., 1997). 
Furthermore, in their comprehensive evaluation of psychiatric aspects of 
transplantation, Levenson and Olbrisch (1993) warn that candidates who avoid the 
reality of their situation do not cope effectively in cases of post-transplant 
complications or prolonged time on the waiting list. 
Burker, Evon, Morroquin Loiselle, Finkel, and Mill (2005) investigated 
depression and disability as an outcome of heart candidates’ coping strategies, finding 
negative coping styles, such as behavioural disengagement and denial, significantly 
predicted depression. Further, mental disengagement and venting of emotions 
significantly predicted illness-related disability. Myaskovsky and colleagues (2003; 
2005) found lung candidates’ avoidant coping significantly predicted overall poor 
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QOL. Specifically, avoidant coping, which is emotion-focused, significantly predicted 
physical (bodily pain) and psychological wellbeing (depression). These studies 
highlight an important fact: maladaptive coping skills, such as denial or 
disengagement, lead to poor QOL. 
Rationale, Aims, and Research Questions of the Current Study 
Exhaustive research has consistently reported significant overall improvements 
to QOL after organ transplantation. Studies generally report improvements in physical 
wellbeing and deficits in psychological functioning following transplantation. Limited 
research has established that transplant candidates and recipients encounter significant 
stressors, but a relative paucity of research has explored the relationship between the 
stress and coping of transplant patients. Literature has consistently shown frequent 
use of problem-focused coping skills among transplant patients, however, these have 
been considered as separate constructed in previous research, and as such there has 
been no attempt to investigate the implicit association between stress, coping skills 
and QOL. 
The synthesis of information presented here allows the appraisal of well 
established findings in the literature, however, there remain significant gaps in our 
knowledge regarding the interaction between stress, coping styles, and QOL of organ 
transplant patients. Overall, previous research lacks a strong theoretical approach, and 
has failed to methodically consider the relationship between transplant patients’ 
stress, coping, and QOL. Crisis theory provides an ideal framework with which to 
explore this relationship, and has the potential to lead to a better understanding of the 
intricacies between transplant patients’ stress, coping, and QOL. This may assist in 
the design and implementation of psychosocial interventions aimed at improving 
patients’ coping skills and QOL by targeting specific stressors and coping styles. 
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The overall aims of Study 1 were to use crisis theory to explain organ transplant 
patients’ QOL and explore the differences in coping strategies, stress, and QOL 
between transplant candidates, transplant recipients, and the non-transplant 
population. A further aim was to explore the transplant-specific stressors experienced 
by transplant candidates and recipients. The following research questions were posed: 
1. Can the QOL of transplant patients be explained by crisis theory?  
2. Do candidates, recipients and non-transplant individuals experience 
different levels of physical, psychological, and social functioning? 
3. Do candidates, recipients, and non-transplant individuals experience 
different levels of everyday stress? 
4. What are the coping strategies employed by candidates, recipients, and non-
transplant individuals?  
5. What are the prevalent transplant-specific stressors experienced by 
transplant patients? 
Method 
Participants 
The sample consisted of 226 participants representing three groups: (i) 
individuals currently on the waiting list for an organ transplant (‘transplant 
candidates’); (ii) individuals who have received an organ transplant (‘transplant 
recipients’); and (iii) individuals who have never been transplant candidates or 
recipients (‘non-transplant individuals’). Forty-five participants (19.8%) were 
transplant candidates, ninety-nine participants (43.6%) were transplant recipients, and 
eighty two (36.1%) participants comprised the non-transplant population. Full 
demographic details, including age, gender, annual income and country of origin of 
participants from each of the three groups is contained in Table 2. Most participants 
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were Australian and married, and had an average age 45 years. Information pertaining 
to candidates’ and recipients’ specific organ types and time since transplant or time on 
waiting list is also provided in Table 2. Most participants were awaiting or had 
received a kidney transplant. The average time of candidacy was over two years, 
while recipients were transplanted an average of six years prior to participating in the 
study. 
Table 2 
Demographic Characteristics of Study 1 Participants 
 
 
 
 
Candidates 
 
Recipients 
Non-
transplant 
 
Total 
 
Variable 
n = 45 
(19.8%) 
n = 99 
(43.6%) 
n = 82 
(36.1%)  
N = 226 
Gender     
   Male 20 (44.4%) 58 (59.2%) 28 (26.4%) 106 (46.7%) 
   Female 25 (55.6%) 40 (41.1%) 54 (45.4%) 120 (52.9%) 
Mean age in years (SD) 52.52 (10.15) 53.91 (13.82) 31.92 (8.52) 45.60 
(15.41) 
Country of residence     
    Australia 37 (84.4%) 50 (57.1%)  58 (72%) 145 (67%) 
    United States 5 (11.4%) 27 (33.7%) 6 (12.2%) 38 (19.4%) 
    United Kingdom  1 (2.3%) 4 (4.1%)  3 (3.7%) 8 (3.5%) 
    Canada 1 (2.3%)  2 (2%) 10 (12.2%) 13(5.7%) 
    Other - 3 (5%) 2 (4%) 5 (4.6%) 
Marital status     
   Married 26 (59.1%) 69 (69.7%) 19 (24.7%) 114 (50.7%) 
   In a relationship 5 (9.1%) 5 (5.1%) 30 (38.3%) 40 (17.6%) 
   Single 8 (18.2%) 12 (12.1%) 25 (30.9%) 45 (19.8) 
   Divorced/separated 6 (11.4%) 9 (9.1%) 4 (6.2%) 19 (8.4%) 
   Widowed 1 (2.3%) 4 (4%) - 5 (2.2%) 
Organ type     
   Heart 1 (3%) 32 (32.3%) - 33 (22.3%) 
   Lung(s) 2 (4.7%) 21 (21.2%) - 23 (16.2%) 
   Kidney 32 (74.4%) 19 (19.2%) - 51 (38.5%) 
   Spleen - 1 (1%) - 1 (.8%) 
   Liver 2 (4.7%) 15 (15.2%) - 17 (10.8%) 
   Heart and lung - 3 (3%) - 3 (1.5%) 
   Heart and pancreas - 1 (1%) - 1 (.8%) 
   Pancreas and kidney 6 (14%) 5 (5.1%) - 11 (7.7%) 
   Lung and kidney - 2 (2%) - 2 (1.5%) 
Mean time in months on 
waitlist (SD) 
25.42 (22.49) - - - 
Mean time in months 
since transplant (SD) 
- 73.92 (63.68) - - 
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Materials 
Participants completed a questionnaire comprising measures related to stress, 
coping, and QOL. Two versions of the questionnaire were available: the first was 
completed by non-transplant participants, and included measures of perceived stress, 
coping, and QOL (see Appendix A); the second was completed by participants from 
the transplant group (candidates and recipients), and included an additional measure 
related to stressors experienced by transplant patients and the perceived strain of the 
transplant experience (see Appendix B). The questionnaires were available online and 
in hardcopy format. 
 Demographic information was collected from all participants. Additionally, 
transplant candidates were asked to indicate the length of time spent on the transplant 
waiting list and organ type required, and transplant recipients were asked to indicate 
time elapsed since the transplant procedure and organ type received. 
General stress. The Perceived Stress Scale (S. Cohen, Kamarck, & 
Mermelstein, 1983) is a 14-item scale used to assess general perceived stress related 
to day-to-day life, that is, stress not necessarily related to the transplant process. 
Respondents were asked to indicate the degree to which they have experienced 
symptoms of stress over the past month (0 = never, 4 = very often). With a possible 
overall score ranging from zero to fifty-six, higher scores denote higher levels of 
perceived stress. The reliability rating for the original measure and the current study 
was Cronbach’s α = .86 and α = .77, respectively (S. Cohen, et al., 1983). 
Coping. The 28-item Brief Coping Orientation to Problems Experienced Scale 
(Carver, 1997) was used to evaluate participants’ coping styles. The Brief COPE is 
derived from the original COPE inventory (Carver, et al., 1989), and assesses fourteen 
coping strategies such as active coping, denial, positive reframing, humour, and self-
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blame. Respondents were asked to indicate on a four-point scale (1 = I don’t do this at 
all, 4 = I do this a lot) how often they use particular way of coping. For example, “I 
get emotional support from others” is an item indicative of active coping. The 
fourteen coping strategies are grouped into three coping categories by summing 
relevant items, with higher scores indicating greater preference for the use of the 
coping strategy. The three coping strategies and associated subscales (with items and 
Cronbach’s α from the original scale and current study, respectively) were problem-
focused coping (active coping, planning, instrumental support, and religion; α = .80, 
α = .76), active emotional coping (venting, positive reframing, humour, acceptance, 
and emotional support; α = .81, α = .74), and avoidant coping (self-distraction, denial, 
behavioural disengagement, self-blame, and substance use; α = .88, α = .70).  
Quality of life. The WHO Quality of Life Scale – BREF (Murphy, et al., 2000) 
was used to gather information about participants’ perception of their global QOL, 
and QOL in the domains of physical, psychological, and social functioning. The 
WHO-QoL BREF also includes a subscale of environmental QOL; this was not 
calculated in the current study as to maintain consistency with previous 
transplantation studies. Participants were asked to consider their standards, hopes, 
pleasures and concerns in relation to their life within the last two weeks, with all 
items rated on a 5-point scale (1 = very poor, 5 = very good). A profile of domain 
scores and an individually scored global QOL was produced for each participant. To 
allow for comparisons across domains, items pertaining to physical, psychological, 
and social functioning are summated and transformed to a 0-100 scale. The original 
scale demonstrated high levels of internal consistency on the measures of overall 
QOL, and the QOL domains of physical (α = .87), psychological (α = .81), and social 
functioning (α = .68) (Murphy, et al., 2000). The current study also showed high 
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levels of reliability: global QOL (α = .75), and the domains of physical (α = .83), 
psychological (α = .82), and social functioning (α = .75).  
Transplant-specific stress. Transplant candidates and recipients also 
completed an additional measure to quantify the type and severity of transplant-
related stress. The Transplant Patients’ Perceived Stress Scale (TPPSS) was adapted 
for use in the current study from the Transplant-Related Stressors Scale (TRSS) 
(Frazier, et al., 1995). The TRSS was originally designed to measure stress in kidney 
transplant recipients. Respondents rated sixteen items on a five-point scale, with 
higher scores from a total possible score of 80 indicating higher levels of transplant-
related stress. The scale also comprises five sub-scales of potentially stressful events, 
including future health issues (fear of organ rejection, susceptibility to other illnesses, 
uncertainty about future health), finances (handling insurance, financial pressure), 
medication side effects and physical limitations (dietary restrictions, medication side 
effects, weight gain, appearance change, energy levels), interpersonal relationships 
(lack of social support, relationship with significant others, being a burden), and 
following a medical regimen and dealing with the medical community (following 
doctors’ orders, having medical questions answered, travelling to appointments). 
Subscale scores were obtained by summing relevant items and averaging by the 
number of items in each subscale. The overall reliability of the original scale was 
Cronbach’s α = .89, and with the exception of financial stress subscale (α = .56) all 
stressor subscales of the original scale showed acceptable internal consistency, 
ranging from α = .70 to α = .84. In the current study, the overall reliability was α = 
.87, with all measures except the financial subscale (α = .32) demonstrating 
acceptable levels of internal consistency. The modest internal consistency of this 
TPPSS subscale may be a reflection of its low number of items.  
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Procedure 
Participants completed the questionnaire in paper-and-pencil format or online 
using SurveyMonkey software. Fifty three (23.35%) participants completed hardcopy 
questionnaires returned via reply-paid postage, while one hundred and seventy four  
(75.65%) completed the questionnaire online. All participants completed a 
demographic section, followed by measures related to stress, coping, and QOL. 
Transplant candidates and recipients also completed the measure of transplant-related 
stress, the TPPSS.  
Participants were recruited from a variety of sources; non-transplant participants 
were recruited via a convenience sample (online and public advertisements), and 
transplant patients were recruited from online and community support groups 
frequented by transplant patients. Additionally, the Monash Medical Centre’s (MMC) 
Department of Nephrology assisted with recruitment by distributing information and 
questionnaire packs to approximately 100 patients currently waiting for a transplant. 
Approval from the Southern Health Research Directorate Ethics Committee was 
obtained prior to recruitment. An MMC employee was responsible for distribution of 
questionnaire packs to patients, thus ensuring confidentiality and anonymity.  
An information sheet (see Appendices C and D) accompanying both forms of 
the questionnaire advised participants of the general purpose of the study and the 
requirement that participants be aged 18 years or over. Patients from MMC received a 
plain language statement that adhered to the regulations of the Southern Health 
Research Directorate Ethics Committee (Appendix E). All participants were also 
advised of the voluntary nature of the study and their right to withdraw from the study 
anytime prior to submitting the completed questionnaire. Consent to participate in the 
study was implied through return of the questionnaire. The questionnaire included no 
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identifiable information, and anonymity and confidentiality was further assured by 
reply-paid postage or online questionnaire submission.  
Results 
 Preliminary Data Analysis 
The questionnaire data were analysed using Statistical Package for the Social 
Sciences (SPSS) version 18.0. Due to a large amount of missing data pertaining to the 
transplant-specific stress scale, data relating to this scale was removed from the 
dataset in order to limit the effect of missing data on the overall dataset and to allow 
for separate analysis of transplant-specific stressors.  
Fifteen cases were removed from the sample prior to data analysis being 
performed, as they were missing more than 30% of data on at least one scale. The 
fifteen cases represented two participants from the non-transplant population and 
thirteen transplant recipients. The total sample for analysis, therefore, comprised 212 
participants, including 45 transplant candidates (21.2%), 87 transplant recipients 
(41%), and 80 non-transplant participants (37.7%). 
Remaining cases were analysed for the presence of missing data. Analysis 
showed data to be missing at random, and as such missing values were replaced with 
the sample mean for that variable, thus ensuring a complete dataset. The data were 
then examined to ensure assumptions regarding normality, outliers, linearity, 
homogeneity of variance, and multicollinearity were met. Examination of histograms 
and z scores revealed divergence from normality for the variables of stress, global 
QOL and the three QOL subsets, and problem-focused coping and avoidant coping. 
The QOL variables were not transformed, as previous research suggests global QOL 
and its domains to be generally rated positively. Transformation on the remaining 
variables did not improve skewness. Further, the sample size was large (N = 212), and 
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the primary methods of data analysis employed in the present study are relatively 
robust to normality violations when a large sample is used (Tabachnick & Fidell, 
2007). Inspection of the P-P Normality plot suggested no major deviations from 
normality. Several multivariate outliers were identified (Mahalanobis’ Distance 
values at p < .001), but as the original and trimmed means were very similar for all 
variables, the outlying cases were retained in the dataset (Tabachnick & Fidell, 2007). 
Collinearity statistics showed no multicollinearity or singularity.  
Descriptive Statistics 
Descriptive statistics for the present sample are also presented in Table 3. 
Overall, participants reported a high global QOL, together with comparably high self-
reports in the QOL domains of physical, psychological and social functioning. 
Participants reported experiencing low to moderate levels of everyday stress. Most 
participants reported predominantly using an active-emotional coping style, with 
fewer employing avoidant coping strategies.  
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Table 3 
Descriptive Characteristics of Study 1 Variables 
 
Measure/Variable Candidates 
n = 45 
Recipients 
n = 87  
Non-transplant 
n = 80 
 M SD M SD M SD 
PSS       
   Stress 25.80 .93 22.67 7.61 25.29 5.77 
Brief-COPE       
   Problem-focused 2.46 .57 2.67 .66 2.57 .51 
   Active-emotional  2.66 .49 2.70 .47 2.71 .55 
   Avoidant 1.82 .49 1.68 .41 1.85 .17 
WHO-QoL BREF       
   Global QOL 71.11 20.70 84.14 15.90 85.25 17.36 
   Physical QOL 61.46 16.94 71.92 15.83 80.11 13.37 
   Psychological QOL 70.58 15.91 77.47 16.73 72.70 15.11 
   Social QOL 65.04 19.34 70.96 20.18 72.75 18.32 
TPPSS       
   Overall transplant 
     -related stress 
42.58 12.93 35.01 10.29 - - 
   Future-health 2.90 1.05 2.19 .83 - - 
   Finances 2.60 1.04 2.31 .95 - - 
   Medication side- 
     effects and physical 
     limitations 
2.76 .96 2.37 .70 - - 
   Interpersonal 
     relationships 
2.78 1.00 2.25 .91 - - 
   Medical regimen 
     and medical 
     community 
2.28 .91 1.92 .73 - - 
Note. PSS – Perceived Stress Scale; Brief COPE; WHOQoL BREF – World Health Organisation 
Quality of Life Scale BREF; TPPSS – Transplant Patients’ Perceived Stress Scale. 
 
Testing Crisis Theory 
A one-way between-groups ANOVA was conducted to explore the impact of 
transplant status on Global QOL, as measured by the WHO-QoL BREF. Participants 
were divided into three groups according to their transplant status: transplant 
candidate, transplant recipient, or non-transplant individual. As the assumption of 
homogeneity of variance was violated (Levene’s  p = .043), the Brown-Forsythe 
result was interpreted, F = 9.75 (2, 137) = 9.75, p = .000, η2 = .01. While a 
statistically significant difference was detected, the effect size was small, showing a 
modest actual difference between the groups. Post-hoc comparisons using the Tukey 
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HSD test indicated that the mean Global QOL score for transplant candidates was 
lower and statistically different (p = <.001) from transplant recipients and non- 
transplant respondents. There was no significant difference (p =.91) detected between 
transplant recipients’ and non-transplant respondents’ Global QOL ratings. 
To test crisis theory (see Figure 3, p. 33), a standard multiple regression was 
performed to determine the relative contribution of stress and coping to the overall 
QOL of transplant patients. The groups of candidates and recipients were collapsed in 
order to form the group of transplant patients, due to the relatively small number of 
candidates participating in the study. Firstly, the relationships between QOL and the 
variables of transplant-related stress (future health, finances, medicine side-effects 
and physical limitations, interpersonal relationships, medical regimen and medical 
community), stress, and coping (problem-focused, active-emotional, avoidant coping) 
were investigated using Pearson product-moment correlation coefficients (see Table 
4). No significant relationships were detected between QOL and any of the transplant-
related stress variables. Significant relationships were identified between avoidant 
coping and QOL (r = -.358, n = 132, p <.001), and everyday stress and QOL (r = -
.522, n = 132, p <.001). This indicates that less use of an avoidant coping style was 
associated with higher QOL, and that lower levels of stress were also associated with 
higher QOL. 
Based on the crisis theory’s supposition of the roles of coping and stress in 
relation to QOL, the variables of avoidant coping and general stress that were found 
to be significantly associated with transplant patients’ QOL were entered into the 
regression to test the predictive abilities of the theory (Moos & Schaefer, 1986). 
Results, presented in Table 5, show that the two variables significantly predicted 
QOL, R2 = .23, F (2, 131) = 25.07, p = .000. Together, the two variables accounted for 
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22.5% of variance in the model. Only the variable of everyday stress was found to 
contribute significantly to the prediction of transplant patients’ QOL. Avoidant coping 
was not shown to have a significant effect on QOL. 
Quality of Life Domains 
A one-way between-groups multivariate analysis of variance (MANOVA) was 
performed to investigate the differences in the QOL domains of physical, 
psychological, and social functioning between the three groups of transplant 
candidates, transplant recipients, and non-transplant individuals. There was a 
statistically significant difference between the three groups on the combined QOL 
domains: F (3, 207) = 12.31, p = .00; Wilks’ Lambda = .72, η2 = .15. When the results 
for the QOL domains were considered separately, the only difference to reach 
statistical significance, using the Bonferroni adjusted alpha level of .01, was physical 
functioning, F (2, 209) = 21.92, p = .006, η2 = .013. Follow-up comparisons using 
Tukey HSD showed the mean scores for physical functioning were statistically 
significantly different between all groups: candidates and recipients (p = .001), 
candidates and non-transplant individuals (p = .000), and recipients and non-
transplant individuals (p = .002). These differences are depicted in Figure 4, which 
shows the levels of physical, psychological, and social functioning of the three 
groups. 
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Table 4 
Intercorrelations Between Transplant Patients’ Global Quality of Life, Coping, Transplant-Related Stress, and Everyday Stress (N = 132) 
 
 1 2 3 4 5 6 7 8 9 10 
1. Global QOL 
 
-          
2. Problem-focused 
    coping  
.16 -         
3. Active-emotional 
    coping  
.15 .57** -        
4. Avoidant coping 
 
-.36** .17* .26* -       
5. Transplant stress  
    - future health  
-.06 .054 .06 .02 -      
6. Transplant stress 
    - finances 
.05 .13 -.04 .01 .46** -     
7. Transplant stress 
    - physical 
-.07 .08 .11 .05 .60** .38** -    
8. Transplant stress 
    - interpersonal 
.07 .12 .09 -.09 .46** .45** .65** -   
9. Transplant stress 
    - med regimen 
.04 .03 .13 .05 .45** .37** .60** .49** -  
10. Everyday stress 
 
-.52** .06 -.04 .64** .03** .133 -.01 -.06 -.06 - 
Note: *p <.01, **p <.05. 
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Table 5 
Summary of Standard Multiple Regression Analysis of Organ Transplant Patients’ 
Quality of Life (N = 132) 
 
Variable B SE(B) β 95% CI 
Avoidant coping 3.23 3.16 .08 [-3.01, 9.47] 
Everyday stress -1.25 .19 -.52* [-1.64, -.87] 
Note. R2 = .23, *p < .001, CI = confidence interval 
 
 
 
Figure 4. Physical, psychological, and social functioning of candidates, recipients, 
and non-transplant individuals. 
 
General Stress 
Inspection of the mean scores of everyday stress experienced by transplant 
candidates, as measured by the PSS, showed that candidates experience the most 
stress related to everyday activities, followed by non-transplant individuals. 
Transplant recipients report experiencing the least everyday stress. A summary of the 
mean PSS scores for each group can be found in Table 3. 
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A one-way between groups ANOVA was conducted to explore the differences 
between the everyday stress experienced by transplant candidates, transplant 
recipients, and non-transplant individuals. Normality assumptions were met, however, 
as the assumption of homogeneity of variance was violated (Levene’s p <.05), 
Brown-Forsyth results were interpreted. Using the Bonferroni adjusted alpha level of 
.01, differences in perceived stress between the groups did not reach statistical 
significance, F(2, 166) = 4.44, p =.013, η2 = .04. However, results showed a trend 
towards differences between recipients experiencing different levels of stress than 
candidates (p = .035) and non-transplant individuals (p = .037). 
Coping Styles 
The mean scores of coping styles, summarised in Table 2, showed that all 
groups reported most frequently using active-emotional coping, followed by problem-
focused coping and avoidant coping. Transplant candidates were least likely to use 
problem-focused coping in comparison to transplant recipients and non-transplant 
individuals. Similarly, transplant candidates reported being least likely to use active-
emotional coping in comparison to transplant recipients and non-transplant 
individuals. Avoidant coping was most employed by non-transplant individuals and 
transplant candidates, while transplant recipients were least likely to use avoidant 
coping.
 
One-way between-groups MANOVA was performed to investigate differences 
in coping styles between transplant candidates, transplant recipients, and non-
transplant individuals. Three coping styles were investigated: problem-focused, 
active-emotional, and avoidant coping. Using the conservative alpha level of .01 due 
to the violation of the assumption of homogeneity of variance, no statistically 
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significant differences were found between the groups’ coping styles, F (6, 414) = 
2.07 p = .056; Wilks’ Lambda = .94, η2 = .03. 
Transplant-Specific Stress 
One hundred and seventeen transplant patients completed the TPPSS measure 
of transplant-specific stress, including 65 males (56%) and 51 females (44%). Eighty 
six (73.5%) were transplant recipients, with most having received a heart (27), lung 
(18), kidney (18), or liver (13). Thirty one (26.5%) were transplant candidates, with 
most awaiting a kidney (20). 
An independent samples t-test was conducted to compare the transplant-related 
stress of transplant candidates and recipients. Results indicated transplant candidates 
experience greater transplant-specific stress compared to transplant recipients, t(115) 
= 3.27, p = .001 , η2 = .08. Figure 5 shows candidates’ and recipients’ comparative 
experiences of transplant specific stressors, and descriptive statistics are detailed in  
Table 2. Transplant candidates’ most prevalent concern was future health, followed 
by interpersonal relationships, finances, medication side effects and physical 
limitations, and medication regimen and dealing with the medical community. 
Transplant recipients ranked medication side effects and physical limitations as the 
most prevalent concern, followed by finances, interpersonal relationships, future 
health, and medical regimen and medical community. The comparative variability in 
scores across the groups, as shown in Figure 5, indicates a greater variation in stress  
experienced by transplant candidates and implies less predictability in their 
experience of transplant-specific stress.  
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Figure 5. Transplant patients’ ratings of transplant-specific stressors with 
corresponding 95% confidence intervals  
 
Discussion 
Much previous research has investigated the QOL of transplant patients, and the 
differences between candidates’ and recipients’ QOL has been repeatedly noted in the 
literature. However, by considering the intricate relationship between stress, coping, 
and transplant patients’ QOL through the framework of crisis theory (Moos & 
Schaefer, 1986), the current study is the first to offer a theoretical perspective on this 
heavily researched topic. Comparisons between transplant recipients, transplant 
candidates, and non-transplant individuals were made with respect to general and 
domain-specific QOL, in addition to an exploration of the transplant-specific concerns 
of transplant patients. Each research question will now be considered in turn, leading 
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to generalised conclusions. Limitations of the current study and suggestions for future 
research will also be discussed. 
Using Crisis Theory to Explain Organ Transplant Patients’ Quality of Life 
Findings of the current study show that crisis theory provides a valid 
explanation of the QOL of transplant patients. Applying crisis theory to this 
population validates the theory, and provides an explanation for the QOL of organ 
transplant patients. Crisis theory postulates that people in crisis will experience lower 
QOL in comparison to people who are no longer in crisis and those who have not 
experienced a crisis. In keeping with this hypothesis, the results of the current study 
showed transplant candidates reported the lowest levels of overall QOL. Additionally, 
post-crisis transplant recipients reported a similar overall QOL to non-transplant 
individuals. Further, the results indicate the change in QOL across the transplant 
experience: QOL is compromised prior to transplantation, with transplantation 
enabling a restoration of QOL to levels comparable with the general population. This 
provides support for the notion of resiliency gained through experience; transplant 
recipients generally consider their QOL to be reasonably high despite living with 
likely ongoing health difficulties and managing ongoing medical appointments and a 
regimen of medication.  
These findings support much previous research, and endorse the results of an 
earlier meta-analysis which espoused great QOL improvements from pre- to post-
transplantation across all organ-types (Dew, et al., 1997). The findings of transplant 
recipients reporting much better overall QOL in comparison to transplant candidates 
is also congruent with more recent findings regarding QOL improvements among 
lung, liver, kidney, and heart recipients (Bravata, et al., 1999; Limbos, et al., 2000; 
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Moore, et al., 2000; Myaskovsky, et al., 2003; Rodrigue, et al., 2005; Russ, et al., 
2007).  
Further supporting the framework of crisis theory, the current study revealed 
comparable QOL ratings of transplant recipients and non-transplant individuals. This 
finding lends credence to crisis theory’s hypothesis that post-crisis individuals 
experience QOL akin to that of individuals who have not experienced a crisis. Several 
studies investigating the QOL of transplant patients have also reported the QOL of 
transplant recipients to be comparable to non-transplant individuals (Burra & De 
Bona, 2007; Dew, et al., 2007; Nickel, et al., 2002). However, these findings are 
contrary to previous research that concluded long-term deficits in the QOL of kidney 
(Kalman, et al., 1983) and liver recipients (Kousoulas, et al., 2008; Lewis & Howdle, 
2003). 
The current findings add to a convincing body of research that has demonstrated 
the QOL benefits of transplantation. Despite lifestyle restrictions and uncertainty 
regarding organ rejection and illness relapse, it appears that recipients are able to 
quickly adapt to post-transplantation life. Similarly to the experience of transplant 
patients in the current study, much literature has focused on the positive benefits and 
post-traumatic growth experienced by individuals following adverse events such as 
cancer, strokes, natural disasters, criminal victimisation, grief, and combat (McMillen, 
1999). Several explanations posited for experiencing benefit from adversity may also 
be applied to the QOL experiences of transplant patients. Recollections of a life-
threatening illness are not likely to be easily forgotten, giving recipients a context in 
which post-transplantation life may be considered ideal, despite ongoing health 
difficulties. Views on the importance of valuing self and others may be changed 
following a serious health crisis such as end-stage organ failure and transplantation. 
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Further, transplant recipients may be responding to pre-transplant expectations held 
by themselves and others by exceeding their previous QOL. Recipients’ goals for life 
may be altered following a life-threatening illness, leading to increased participation 
and enjoyment of activities not previously undertaken. Research has also pointed to 
the experiences of people realising a spiritual awakening or increased religiosity 
following serious health crises, with changes to life structure and personal values 
associated with improved physical and mental health (McMillen, 1999). Such 
conjecture echoes Caplan (1964): struggling with a crisis may lead to increased 
coping skills, enhanced self-efficacy, and improved ability to cope with future adverse 
events.  
Contribution of coping and stress to transplant patients’ quality of life. The 
current study demonstrates the usefulness of explaining QOL from a theoretical 
perspective, with crisis theory’s supposition partly supported by findings that stress 
contributes significantly to transplant patients’ QOL. The experience of stress was 
identified as an important determinant of transplant patients’ QOL. These findings 
add to considerable previous literature concerning the relationship between transplant 
patients’ coping strategies and QOL. 
Avoidant coping was not found to make a significant contribution to the QOL 
of organ transplant patients. Specifically, while an association was detected between 
an avoidant coping styles and lower levels of overall QOL, results of the standard 
multiple regression revealed that avoidant coping does not significantly predict 
transplant patients’ QOL. Current results partly support previous findings of avoidant 
coping being associated with poor QOL in transplant patients (Levenson & Olbrisch, 
1993), however, contradict previous findings of lung candidates’ avoidant coping 
predicting overall poor QOL (Myaskovsky, et al., 2003). While not found to 
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significantly predict QOL, the finding of an association between avoidant coping and 
QOL implores researchers and health care professionals to heed Stilley and 
colleagues’ (1999) advice to pay special attention to the wellbeing of all transplant 
patients, as not seeking help or declining assistance may be evidence of avoidant 
coping.  
Transplant-specific stress was not found to be associated with transplant 
patients’ QOL. However, the present study demonstrated the significant impact of 
experiences of general stress, such as handling personal problems and feeling 
overwhelmed by demands, on transplant patients’ QOL. Little prior research has 
investigated transplant patients’ experiences of general stress; it may be that the focus 
on keeping transplant patients alive during candidacy overshadows consideration of 
the impact of stressful daily experiences impact upon wellbeing.  
Several practical implications for assisting transplant patients arise from this 
finding. Transplant patients may require support with daily activities, as it appears 
they are susceptible to becoming overwhelmed by life’s irritations and hassles. 
Patients may benefit from learning stress-reduction techniques, such as relaxation 
strategies, anger management or problem-solving strategies. Previously found to be 
important to medication adherence (Achille, et al., 2006), the relevance of promoting 
stress management among patients is now further substantiated by current findings of 
the adverse impact of stress on transplant patients’ QOL. 
Physical, Psychological, and Social Functioning 
In addressing the second research question, non-statistically significant 
differences were observed across candidates, recipients and non-transplant 
populations with regard to QOL in the domains of physical, psychological, and social 
functioning. Statistically significant differences were observed only in the domain of 
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physical functioning. The current findings corroborate previous assertions of 
improvements in QOL being dependent on the specific domain under consideration 
(Dew, et al., 1997).  
Overall, the trend of results in the current study indicated transplant candidates 
to have the lowest levels of functioning in each of the QOL domains, however, 
differences between the groups did not reach statistical significance. Non-transplant 
individuals experienced the best physical and social functioning, however, transplant 
recipients reported the highest level of psychological functioning. These findings are 
contrary to those shown in meta-analysis, which noted significant improvements in 
physical and social domains across all organ types, but not psychological QOL (Dew, 
et al., 1997). A possible explanation for these inconsistent findings may be differing 
levels of community psychological awareness and greater access to psychological 
care at the time of the current study in comparison to the studies comprising the meta-
analysis. Improved life expectancy following transplantation due to advances in 
immunosuppressive medicines may also lead to lower levels of psychological distress. 
Recipients’ worries about organ rejection and the need for retransplantation may be 
partly alleviated by increased donor rates and reduced waiting times (Excell, et al., 
2011), with previous research linking increased time spent waiting for an organ with 
higher levels of anxiety and depression (Vermeulen, Bosma, Bij, Koeter, & 
Tenvergert, 2005). 
Physical functioning. Given the compromised physical health and dire medical 
condition of people awaiting a transplant, it was expected that transplant candidates’ 
QOL related to physical functioning would be rated lower than that of transplant 
recipients and non-transplant individuals. Symptoms of end-stage organ failure 
include fatigue, insomnia, pain, nausea, weight loss, and immobility. Palliative care is 
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often necessary for patients who do not receive a transplant in adequate time (Janssen, 
et al., 2008). 
Current results indicate that transplantation improves physical QOL, but does 
not restore it to the pre-illness levels. This finding is congruent with previous research 
that identified vast differences in physical QOL between heart candidates and 
recipients (Fusar-Poli, et al., 2005), and also upholds meta-analysis findings (Dew, et 
al., 1997).  
Psychological functioning. The psychological functioning of transplant 
recipients in the current study was found to be high, with self-ratings of psychological 
QOL higher than those of transplant candidates and non-transplant individuals. 
However, the differences in the current study were not found to be statistically 
significant, with the trend of results contributing to mixed findings in the literature; 
Burra and De Bona (2007) stated that recipients gained only modest improvements in 
psychological health while others noted good mental and emotional wellbeing and 
psychological functioning equal to the general population (Pinson, et al., 2000; Politi, 
et al., 2004). 
Psychological functioning encompasses emotional, cognitive and behavioural 
status, taking into account overall distress, depressive and anxiety symptoms, and 
self-image. Transplant candidates’ psychological difficulties may be explained by the 
emotional turmoil and uncertainty of waiting for an organ transplant. The trend of low 
psychological QOL reported by transplant candidates in the current study is consistent 
with the finding of a high prevalence of depression, anxiety, alcohol or substance 
abuse or dependence, and adjustment disorders among transplant candidates (Telles-
Correia, et al., 2009).  
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It is intriguing that the trend of results showed that transplant recipients reported 
experiencing better psychological functioning than non-transplant individuals. While 
this difference did not reach statistical significant, this may be explained in a similar 
manner to which post-crisis experiences of overall QOL are conceptualised; resiliency 
following an adverse life event such as organ transplantation appears to enhance 
psychological coping skills and enable better psychological functioning. 
Alternatively, the cross-sectional design of the present study may be reflecting the 
long-term psychological wellbeing of patients who underwent organ transplantation a 
considerable time ago, as the average time since transplant among recipients in the 
current study was six years. Previous research has indicated that onset of psychiatric 
conditions such as major depressive disorder, posttraumatic stress disorder (PTSD) 
and adjustment disorder is rare beyond the first twelve months following 
transplantation (Dew et al., 2005).  
The findings related to the psychological QOL of transplant patients suggests 
adequate psychological assistance is afforded to transplant recipients, however, there 
appears to be an increased need for assessment and treatment of psychological illness 
among transplant candidates. Further, serious pre-transplant psychological disorders 
have been shown to indicate risk for post-transplant psychological distress (Dew, et 
al., 2005), and is a good indicator of medication adherence (Fredericks, Lopez, 
Magee, Shieck, & Opipari-Arrigan, 2007). Potential transplant candidates undergo 
psychological evaluation to identify probable risk factors to postoperative compliance 
and recovery, such as substance use, serious psychopathology, and cognitive 
impairment. While a great deal of variation exists in the format of psychological 
screening between transplant centres, there is general consensus of the importance of 
this procedure to ensure scarce donor organs are used wisely with respect to morbidity 
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and mortality outcomes (Olbrisch, et al., 2002). Similarly, there is acknowledgment of 
the need for immediate post-transplant support for transplant recipients with reference 
to medication adherence, employment rehabilitation, and possible organ rejection. 
However, ongoing psychological assessment and support of transplant candidates is 
not normally provided beyond initial preoperative screening (Zipfel, et al., 1998). 
Formal assistance for family members is limited and many transplant teams do not 
employ a psychologist or psychiatrist, despite the finding that up to 47% of transplant 
candidates express a need for counselling (Goetzmann et al., 2006). Previous research 
and findings of the present study indicate a clear need for the investigation and 
implementation of intensified psychological treatment for organ transplant candidates.  
Social functioning. Statistically significant differences were not observed 
between the social functioning of candidates, recipients, and non-transplant 
individuals. Based on an individual’s perception of their role and relationship with 
others, social functioning reflects social interactions, leisure, intimate relationships, 
and experiences with friends and family. Low ratings of social functioning among 
transplant candidates in the current study may be explained by lifestyle restrictions 
experienced by people waiting for an organ transplant, with patients typically unable 
to work or participate in usual leisure activities such as sport. Medical appointments 
and frequent hospitalisation disrupt the independence of daily living activities, and 
transplant candidates must remain nearby the transplant centre or hospital, as organs 
must be transplanted within a relatively short amount of time (Engle, 2001). The low 
social functioning among candidates in the present study is congruent with established 
findings of substantial changes in relationships between transplant patients and their 
spouses and family members following high levels of stress and adjustment (Frazier, 
et al., 1995).  
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Given the lifestyle restrictions faced by transplant candidates, the findings of no 
significant differences in their social functioning in comparison to recipients and non-
transplant individuals was surprising; perhaps this indicates the low value candidates 
place on social functioning during a time when physical health and waiting for a 
transplantation dominates life. While the current findings suggest transplantation does 
not fully restore social functioning to the level of non-transplant individuals, the trend 
of results appear to suggest that transplantation grants recipients freedom to pursue 
social interaction, partake in relationships, and fulfil role based goals such as 
employment and leisure activities. 
General Stress 
Findings of the current study substantiate the important role of general stress in 
relation to the capacity of crisis theory to explain the QOL of organ transplant 
patients. While no significant differences were detected between the levels of general 
stress experienced by transplant candidates, recipients, and non-transplant individuals, 
it is noteworthy that transplant candidates reported lowest levels of everyday stress. In 
keeping with Caplan’s (1964) explanation of resiliency following crisis, it may be 
speculated that the stressful experience of organ transplantation equips recipients with 
adaptive coping strategies that are maintained following transplantation. Further, the 
everyday hassles leading to general stress may be perceived as less burdensome for 
recipients who have endured the trauma of end-stage organ failure and the 
transplantation process.  
Coping Styles 
The important relationship between coping style and QOL has been evidenced 
in the current study and prior research (Burker, et al., 2005; Myaskovsky, et al., 
2003). Current findings are consistent with previous research that found few 
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transplant patients employ avoidant coping, such as behavioural disengagement and 
mental disconnection (Golfieri, et al., 2007; Myaskovsky, et al., 2003).  
While postulations regarding coping styles are tempered by no findings of 
statistical difference between the group’s coping styles in the current study, it is 
noteworthy that there was a trend towards recipients reporting the lowest levels of 
avoidant coping. This lends a modicum of credence to crisis theory’s hypothesis of 
increased adaptive coping skills following the experience of a crisis, and supports the 
notion of coping being a contextual rather than stable feature of personality (Lazarus 
& Folkman, 1984). This flexibility provides an ideal opportunity for health 
professionals to intervene in the early stages of the transplantation process in order to 
enhance patients’ adaptive coping skills. With the present study supporting previous 
research pointing to an association between coping style and QOL of transplant 
patients, future research should concentrate on interventions to increase patients’ use 
of adaptive coping skills. Preliminary research has indicated that participation in cost-
effective web-based and telephone-based interventions is associated with increased 
use of adaptive coping skills among transplant patients (Dew, Goycoolea, et al., 2004; 
Napolitano et al., 2002). While limited, such research points to the need for further 
investigation and development of interventions aimed at encouraging transplant 
patients to develop adaptive coping skills.  
Transplant-Specific Stress 
Although experiences of transplant-specific stress were not found to be 
predictive of transplant patients’ QOL, important differences were noted between the 
types and amount of transplant-specific stress experienced by candidates and 
recipients. Overall, transplant candidates reported significantly higher levels of 
transplant-specific stress. Furthermore, recipients’ reports of ongoing stress appear to 
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support the notion of stress not being completely eliminated by transplantation 
(Lindqvist, et al., 2004; Sutton & Murphy, 1989). 
The transplant-specific concerns of candidates and recipients also differed. 
Candidates worried most about future health, interpersonal relationships, and 
finances, and were least worried by medication side effects and physical limitations, 
and medication regimens and dealings with the medical community. However, 
recipients were most worried about medication side effects and physical limitations, 
finances, and interpersonal relationships, worrying least about future health and 
medication regimen and dealings with the medical community. These findings 
endorse previous research that found candidates worried most about deteriorating 
physical health, relationship difficulties, employment, and medication side effects 
(Moore, et al., 2000; Porter, et al., 1994). Not surprisingly, candidates worried most 
about future health, including receiving an organ transplant in a timely manner. 
Further, candidates’ worries regarding interpersonal relationships are congruent with 
compromised social functioning,  
Interestingly, candidates and recipients were both least concerned with 
medication regimens and dealings with the medical community. This is contrary to 
previous studies that reported transplant patients’ concerns with adhering to 
medication regimens (Lindqvist, et al., 2004; Sutton & Murphy, 1989). While life-
long medication continues to be necessary for all transplant patients, this discrepancy 
may be explained by recent advances in immunosuppressive medication that has led 
to reductions in long-term medication dosages. Finances remain a pertinent concern 
during candidacy and following transplantation. This is an unsurprising finding with 
regards to transplant candidates, given the impact of end-stage organ failure on 
patients’ ability to work. Recipients’ concerns regarding finances may indicate the 
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long-term effect of the transplantation process on employment and the ability to 
generate an income, and may also reflect the long-term costs of transplantation 
including medical appointments and medication expenses.  
Limitations of the Current Study and Directions for Future Research 
The present study has added new knowledge to a considerable body of literature 
by investigating QOL from a theoretical perspective. However, several limitations 
should be noted when considering the generalisability of the current findings. First, 
while some studies point to differences in the QOL of transplant patients related to 
type of organ, differences between candidates and recipients of specific organ types 
was not considered in the current study due to variation in numbers of participants 
related to each specific organ. Additionally, demographic factors such as gender and 
income were not considered. Second, the cross sectional nature of the study meant 
that differences related to time on waiting list to receive a transplant or time elapsed 
were not controlled for. A longitudinal design would be ideal to investigate the 
intricate differences in QOL between pre- and post-transplantation, however, time 
constraints and the unpredictable nature of candidates’ time spent on waiting list 
make such studies difficult in the field of transplantation research. While the inclusion 
of the non-transplant comparison group is a particular strength of the current study, 
these individuals may indeed have experienced another type of serious medical illness 
or other life crisis not controlled for in the current study. Such crises may have 
impacted upon their responses, thus effecting results of the current study. Third, a 
large number of participants did not complete the transplant specific stress 
questionnaire; this may be due to difficulty understanding the questions or a belief on 
the behalf on transplant recipients that the questions were applicable only to 
transplant candidates. Last, the current study tested crisis theory related to all 
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transplant patients, as the relatively small number of transplant candidates recruited to 
the study meant that separate multiple regressions could not be conducted on the 
individual groups of transplant candidates and recipients. Further to this, there were 
different levels of QOL across the groups. Ideally, a larger sample size would have 
allowed separate regressions for both groups, which may possibly identify differences 
in the way in which stress and coping predict QOL in transplant candidates and 
recipients. 
Although the current study is the first to consider transplant patients’ QOL from 
a theoretical perspective, there remain many possibilities for innovative research 
within this field. Similar to most previous research, the current study has investigated 
the general experiences of transplant patients as a group. However, as experiences 
vary between individuals more specific investigations should be conducted. 
Qualitative research that details individual experiences of the transplantation process 
may enable a richer understanding of patients’ QOL. Further, with the QOL benefits 
of transplantation well established by decades of research, one of the next logical 
research steps may be to investigate effective interventions to optimise QOL among 
candidates and recipients. With preliminary research heralding the promising 
outcomes of internet and telephone based interventions, other interventions may 
include evaluation of existing support groups for candidates and recipients, and 
appraisal of bibliotherapy in the form of self-help books and brochures. Such 
interventions should aim to decrease patients’ use of avoidant coping by engaging 
individuals. Given current findings regarding the impact of general stress on QOL, 
interventions should also aim to assist transplant patients to overcome difficulties with 
everyday tasks. Lastly, future research aiming to explore transplant patients’ QOL 
from a theoretical perspective may include a measure of self-esteem, as previous 
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research has implicated the role of self-esteem in patients’ ability to maintain optimal 
QOL during and after a crisis (Sprangers, et al., 2002). 
Concluding Comments and Practical Implications 
The current study has explored several concepts related to transplant patients’ 
QOL that have previously been researched as separate constructs. The relationship 
between stress, coping, and QOL was explored using the framework of crisis theory, 
showing that the QOL of transplant patients can be explained from a theoretical 
perspective. The findings of the current study supported crisis theory’s supposition of 
enhanced coping strategies following a crisis, and results were congruent with the 
hypothesis that people experiencing a crisis have compromised QOL in comparison to 
people who have endured a crisis and those who have not experienced crisis. Results 
highlighted the important interplay between coping, stress, and QOL, with the 
revelation of a relationship between avoidant coping, perceived stress, and lower 
QOL. These findings offer clear directions for future research and interventions to 
assist transplant patients achieve optimal QOL during candidacy and post-
transplantation. 
Overall, the current study has clearly demonstrated the QOL benefits of 
transplantation. With the medical intervention of transplantation producing excellent 
survival rates, the next challenge for transplant personnel is to apply new knowledge 
regarding the complex relationship between stress and coping to ensure every 
transplant patient experiences optimal QOL and can make the most of their second 
chance at life. 
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Chapter 3 
 Study 2 – Health Professionals’ Attitudes Toward Transplant Patients’ Quality 
of Life Issues 
Our understanding of the QOL experiences of transplant patients has been 
enriched by decades of research, with investigations such as Study 1 of this thesis 
proving the QOL benefits of the life-saving procedure of transplantation. However, 
the emphasis of much previous research on the QOL of transplant candidates and 
recipients belies an important fact: transplantation is a process rather than an event. 
Many people, including a large number of health professionals, accompany patients 
throughout the transplantation process and may potentially impact upon the QOL of 
transplant patients, yet literature in this field is primarily focused on patients’ 
perspectives and largely fails to reflect health professionals’ views of QOL issues.  
The current study investigates health professionals’ perceptions of QOL and 
willingness to consider transplant patients’ QOL issues. Additionally, perceived 
barriers to health professionals’ use of QOL information in clinical practice with 
transplant patients are evaluated, leading to a consideration of the incongruence 
between attitudes, willingness, and behaviour with regard to clinical use of QOL 
information.   
Health Professionals Involved in Organ Transplantation 
Receiving a suitable organ and undergoing transplant surgery is the pinnacle 
event of the transplantation process, yet the time preceding and following surgery 
comprises the enduring experience of organ transplantation. This lengthy process 
involves the provision of care and support from an indefinite number of health 
professionals with a variety of expertise and experience. The type, intensity, and 
longevity of contact between health professionals and patients and their families 
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contribute to the unique nature of the relationship between healthcare providers and 
organ transplant patients. 
Known collectively as a ‘transplant team’, the group responsible for the care of 
transplant patients is an interacting network of health professionals who work 
collaboratively with patients for the sole purpose of optimising transplant care and 
education. Transplant teams are an essential part of the transplantation process, and 
can be credited with contributing to the improved lives of patients with end-stage 
organ failure through lowering mortality and morbidity rates and improving 
psychosocial experiences for patients and families (Back, 2000; Paris et al., 1995). 
The main charge of the transplant team is the careful selection and management 
of patients likely to survive and thrive with transplant surgery. The exact composition 
and nature of each transplant team varies within and between institutions and is 
dependent upon local demands and the availability of resources, however, it is usually 
a multidisciplinary team including specialists from surgery, internal medicine, 
nursing, psychology or psychiatry, and social work. Each member of the team holds 
specific duties and responsibilities according to their individual training and expertise. 
Back (2000) provides an interesting commentary on the challenges and rewards of 
working on a multidisciplinary transplant team. Professionals from other fields such 
as anesthesia, occupational or physical therapy, and nutrition, are often also involved 
in the care of transplant patients (Olbrisch, et al., 2002). Hospital chaplains also play 
an integral role in many organ procurement cases (Carey, Robinson, & Cohen, 2009). 
Donor and transplant coordinators manage the activities of the transplant team by 
identifying potential donor recipients, overseeing the donor consent process, 
arranging surgical retrieval of donor organs, providing for the safe transport of 
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organs, organising ongoing care for families, supporting the team of health 
professionals, and maintaining records (Paris, et al., 1995).  
Regardless of differences within and between transplant teams, all Australian 
health professionals working with transplant patients are ethically bound to ensure a 
complete separation of the roles between those involved with care of the deceased 
donor and their family and those involved with the care of recipients. A governance 
position is assigned to one professional within the team to ensure all procedures are 
duly followed, with thorough records of process kept to maintain confidentiality and 
privacy of both donors and recipients (Rudge, Matesanz, Delmonico, & Chapman, 
2012).  
Quality of Life and Clinical Practice 
Despite general recognition of the essential role of healthcare professionals in 
the transplantation process, there has been little formal consideration of the way in 
which health professionals working within the transplantation field view QOL issues, 
nor has there been any investigation of the extent to which clinical practice is 
sensitive to transplant patients’ QOL needs. Previous research of health professionals 
working within the field of transplantation has not considered QOL issues, instead 
focusing on the training needs of transplant surgeons (Reich et al., 2011) and medical 
matters such as surgical techniques and survival rates (Cotler, et al., 2003; Levine, 
2004; Schiano, et al., 2001).  
Studies of QOL within oncology and general medicine have brought attention to 
the importance of considering the way in which QOL information is used within 
clinical practice. Health professionals frequently make judgments about QOL when 
making decisions about patient care, and their perceptions of patients’ QOL may be a 
key factor in determining whether effective treatment for life threatening conditions 
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should be given or withdrawn (Addington-Hall & Kalra, 2001). While the patient 
represents the most appropriate source of knowledge regarding their own QOL, some 
patients may be unwilling or unable to provide QOL information due to cognitive 
impairments, communication deficits, or severe distress (Wilson, Dowling, Abdolell, 
& Tannock, 2000). Indeed, it is precisely for these patients that QOL information is 
most needed to inform appropriate decision-making. From a theoretical perspective, 
QOL is defined from the patient’s view, however, it is essential to investigate QOL 
from all aspects, as health professionals’ interpretation of QOL status is frequently 
used as a proxy and is therefore integral to the care and treatment of organ transplant 
patients. 
As agents of change, health professionals have the potential to help patients 
achieve optimal QOL. Detmar, Aaronson, Wever, Muller, and Schornagel (2000) 
found that higher patient satisfaction and better health outcomes among oncology 
patients were related to health professionals enquiring about emotional concerns in 
addition to physical health concerns, with patients expressing a desire for their doctors 
to understand the impact of disease on their daily functioning and QOL. Routine 
consideration of QOL also allows for the monitoring of changes in wellbeing over 
time, and encourages patients and health professionals to work collaboratively on 
prioritising problems, facilitating communication, and identifying treatment 
preferences (Janse et al., 2004). King, Ferrell, Grant, and Sakurai (1995) contend that 
health professionals must seek to understand patients’ perceptions of illness in order 
to avoid over-emphasis on technical and medical oriented treatment. Consideration of 
QOL issues encourages holistic care that assists patients to achieve psychological 
wellbeing and social functioning in addition to physical wellness.  
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Understanding patients’ QOL has important implications for treatment and 
therapy options. However, Farquhar (1995) points to a lack of agreement among 
clinical, research, and patient perspectives of QOL, noting that consensus on a 
definition and an agreed upon understanding of the term is rare. Further, several 
studies have identified discrepancies between patients’ and health professionals’ 
observations of QOL. Meta-analysis revealed that patients’ and doctors’ perceptions 
of QOL are not normally matched (Janse, et al., 2004), and a study of European 
nephrologists treating renal transplant patients found that doctors generally 
underestimated the extent of patients’ QOL difficulties (Ekberg et al., 2007). Further, 
doctors and patients have been found to disagree on symptom severity, a factor that 
may influence QOL; a study within a palliative care setting showed increased 
disagreement on symptomatology between doctors and patients as symptom severity 
increased, with doctors showing a consistent bias towards underestimating illness 
severity (Stephens, Hopwood, Girling, & Machin, 1997). Despite this finding, 
previous research has indicated that doctors usually achieve greater accuracy in 
identifying objective domains such as physical QOL in comparison to subjective 
domains such as psychological wellbeing (Janse, et al., 2004). Conversely, Wilson 
and colleagues (2000) found good general agreement between one-hundred oncology 
patients and their physicians regarding QOL, however, cautioned that several cases of 
substantial discordance in doctor and patient QOL ratings were observed. Studies 
investigating nurses’ observations of the QOL of end-stage renal disease patients and 
bone marrow transplant recipients indicate that nurses generally perceive patients to 
have lower QOL in comparison to patients’ subjective ratings (King, et al., 1995; 
Molzahn, 1991; Molzahn, et al., 1997).  
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The way in which health professionals interpret and apply QOL information is 
important to the treatment and care of organ transplant patients. With previous 
research indicating that health professionals rely on potentially inaccurate QOL 
judgments when making decisions about the wellbeing and management of patients, 
the use of QOL information within transplantation medicine warrants investigation. 
Understanding Attitudes to QOL Issues and Willingness to Use QOL in Clinical 
Practice 
Thus far, ample coverage of QOL within the organ transplantation literature has 
excluded any investigation of health professionals’ attitudes to QOL issues or 
willingness to consider QOL information in clinical practice. Health professionals’ 
consideration of QOL within clinical practice has received a comparatively greater 
amount of attention within the oncology literature, with previous research indicating 
the importance of ascertaining health professionals’ perspectives on QOL and 
demonstrating the way in which such information can be used improve the QOL 
experiences of patients (Bezjak, et al., 2001). 
Health professionals’ understanding of the term QOL has implications for the 
measurement and assessment of QOL and may also impact upon interpretation and 
understanding of QOL information. However, it is currently unclear whether health 
professionals share a unanimous understanding of the term that is widely 
acknowledged as a nebulous concept and has been defined in a variety of ways 
(Cummins, 2005; Orley & Kuyken, 1994). Farquhar (1995) argues that the diversity 
of individuals’ definitions of QOL is influenced by cultural factors, age, professional 
and personal experiences, leading to likely divergence among health professionals’ 
understanding and use of the term.  
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Investigations of health professionals’ understanding of QOL have been 
extremely limited, and the way in which organ transplant health professionals define 
the term has not yet been evaluated. While 88% of oncologists reported being able to 
define QOL, the remainder reported it to be a fluid, changing, abstract concept that 
could not be measured (K. M. Taylor, Macdonald, Bezjak, Ng, & DePetrillo, 1996). 
Oncologists defined QOL in relation to patients’ sense of wellbeing, performance 
status, and illness status. Conversely, McKevitt, Redfern, La-Placa, and Wolfe (2003) 
reported that only 2% of health professionals (doctors, physiotherapists, occupational 
therapists) working with stroke patients described QOL as indefinable. Most 
respondents defined QOL as patients’ happiness, related to enjoyment of life, having 
life choices, personal dignity, and lack of worry in life. Considerably fewer 
considered the social, physical, and psychological domains of QOL, and only 13% of 
respondents commented on the subjective nature of QOL. 
Attitudes towards QOL issues and willingness to use QOL information have 
also received scant attention. Attitude towards QOL is defined as health 
professionals’ thoughts about the concept of QOL, opinion of QOL instruments, and 
perception of benefits and disadvantages of using QOL in clinical practice. 
Willingness refers to health professionals’ reported intention to use QOL information 
in clinical practice (Bezjak, et al., 2001). Studies consistently report that health 
professionals hold a positive attitude towards QOL and view QOL issues as highly 
important: 97% of general practitioners (GPs) report QOL to be fairly important or 
very important (Skevington, Day, Chisholm, & Trueman, 2005), while the vast 
majority of oncologists also viewed QOL considerations as important (K. M. Taylor, 
et al., 1996). Further, Lee and colleagues (2004) found that most doctors reported 
feeling very comfortable discussing QOL issues with patients, with 73% reporting 
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regular discussions regarding QOL issues with patients when making treatment 
decisions. These results appear to reflect relatively frequent consideration of QOL 
issues among health professionals, however, little is known about the way in which 
QOL issues are linked to clinical decision-making, nor are clear details provided 
regarding the nature, frequency, or extent of QOL discussions between doctors and 
patients.   
Health Professionals’ Use of QOL Information in Clinical Practice 
While QOL issues appear to be held in high regard by health professionals, 
there is an apparent incongruence between the positive attitude towards QOL issues 
and the use of QOL information in clinical practice. Results of an Australian study 
exemplify this disparity: 80% of oncologists reported that QOL data should be 
collected prior to the commencement of treatment, yet only 50% reported actually 
doing so (Morris, Perez, & McNoe, 1998). A study of the QOL attitudes of physicians 
working in the field of hematopoietic stem cell transplantation also reflected disparity 
between intent and behaviour regarding QOL information; most purported QOL 
consideration to be important yet only 28% of physicians reported using QOL 
information to inform treatment decisions (Lee, et al., 2004).  
Previous research has also shown that health professionals typically apply QOL 
assessment in a variety of ways, with many reaching QOL decisions through informal 
assessment. In keeping with their medical training, doctors generally assess QOL 
during unstructured clinical interviews. Doctors tend to imply QOL through 
evaluation of observable aspects such as physical functioning, absence of symptoms, 
laboratory test results, and social indicators of wellbeing such as returning to work 
(Frost, Bonomi, Ferrans, Wong, & Hays, 2002; Skevington, et al., 2005). The use of 
such traditional medical markers to imply QOL complicates the evaluation of health 
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professionals’ use of QOL, as informal assessment limits the ability to accurately 
report and analyse information pertaining to the use of QOL information in clinical 
practice. 
Use of QOL measures in clinical practice. Quality of life measures have long 
been used in research with organ transplant patients (Dew, et al., 1997; Molzahn, 
1991), yet little is known about the use of such measures within clinical practice. The 
use of QOL measures in clinical practice has been strongly advocated in previous 
research, as results provide a quantification of change over time, and can be used as a 
foundation for QOL discussions with patients (Frost, et al., 2002). Further, while 
research has indicated health professionals’ preference for informal assessment of 
QOL through clinical interview, such assessments may be adversely impacted by 
health professionals’ inaccurate judgments or subjective feelings of optimism or 
negativity (Addington-Hall & Kalra, 2001). Stephens and colleagues (1997) are 
adamant about the need to employ formal QOL measures in clinical practice, stating 
that only the enforced use of questionnaires can reconcile levels of agreement on 
QOL ratings between doctors and patients, leading to optimal treatment decisions and 
best patient outcomes. However, it appears such measures are not highly utilised by 
health professionals: oncologists report infrequently using formal measures (Frost, et 
al., 2002), and 52% of British GPs surveyed by Skevington and colleagues (2005) 
reported no knowledge of QOL scales.  
The feasibility and usefulness of administering QOL questionnaires in routine 
clinical practice with transplant patients has been investigated in two previous studies. 
Santana and colleagues (2010) conducted a randomised control trial (RCT) 
investigating the inclusion of a QOL measure in the clinical care of lung transplant 
patients. Findings revealed that patients who completed QOL measures discussed 
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more QOL issues with doctors, and rated the quality of communication with their 
doctor higher than other patients. However, no association was found between routine 
completion of QOL measures and improved QOL. Similarly, an earlier study assessed 
the use of QOL measures within routine clinical practice with renal patients 
undergoing dialysis treatment, in which nurses administered and reviewed a 
specialised measure of renal patients’ QOL (Wild, Grove, Keogh, & Farina, 2000). 
Responses from 46% of patients were flagged as requiring follow-up for issues 
including depression, fatigue, and mobility problems. Of patients contacted by nurses 
to discuss QOL issues, 70% agreed to onward referrals to other professionals. The 
study concluded that measurement of QOL is practical and worthwhile in routine 
clinical nursing practice with transplant patients.  
A number of QOL measures are available for use in clinical practice, including 
several generic QOL measures that are suitable for use with organ transplant patients. 
While the majority of oncologists report being concerned with the validity and 
reliability of such scales (K. M. Taylor, et al., 1996), most measures have excellent 
psychometric properties. The Quality of Life Uniscale (Spitzer et al., 1981) is an 
efficient assessment that allows patients to rank areas of life according to lowest and 
highest quality. The SF-36 (McHorney, Ware, & Raczek, 1993) assesses physical, 
social, emotional and functional wellbeing, and while commonly used in research it 
may also be used with individual patients. The Patient-Generated Index (Ruta, 
Garratt, Leng, Russell, & MacDonald, 1994) allows patients to list up to five areas of 
life significantly affected by their medical condition, with ratings then assigned to 
each according to the extent of difficulties experienced. Transition scales and time 
trade-off scales (Joyce, O'Boyle, & McGee, 1999) offer a novel approach to assessing 
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QOL; patients provide direct judgments about QOL improvement or deterioration, 
and are able to express preference for QOL over longevity of survival.  
A small number of transplant-specific measures of QOL that allow for 
assessment of clinically relevant factors are also available. Transplant-specific 
measures are designed to identify patients at different levels of morbidity, determine 
the differential impact of treatment options, identify patients at risk of emotional 
difficulties and regimen adherence, and posit potential long-term difficulties 
(Weissberg-Benchell et al., 2010). The PedsQLTM Transplant Module (Weissberg-
Benchell, et al., 2010) was designed in response to the lack of pediatric QOL 
measures, and is a well-validated and highly reliable measure of pediatric transplant 
patients’ QOL. Specific measures have also been developed for gastrointestinal 
transplant patients (Borgaonkar & Irvine, 2000). The End-Stage Renal Disease-
Symptom Checklist and the Kidney Disease Quality of Life Questionnaire are useful 
in the assessment of renal patients’ QOL (Butt, Yount, Caicedo, Abecassis, & Cella, 
2008). With a broad range of measures available, clinicians and researchers should 
carefully select measures to reflect their intended use and allow for comparisons with 
other transplant patients and non-transplant individuals. 
Dissemination of transplant research to clinical practice. The substantial 
increase in the publication of QOL studies within the transplantation literature over 
the past few decades is indicative of the considerable research attention that has been 
afforded to the QOL of transplant patients. Improvements in the QOL of transplant 
patients may be implicitly attributed to the propagation and application of QOL 
research findings. However, there has been no formal study of the dissemination of 
research to clinical practice, and as such the usefulness of continued research in this 
area has not yet been ascertained.  
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Findings that 65% of hematopoietic stem cell transplant doctors do not read 
studies reporting QOL results (Lee, et al., 2004) are indicative of concerns regarding 
the divide between QOL research and clinical practice. Guyatt and Schunemann 
(2007) suggest that clinicians often do not read published studies due to difficulty of 
interpreting findings. As such, researchers have been urged to present QOL findings 
in simple, accessible terms that delineate a level of QOL requiring intervention 
(Koller, Klinkhammer-Schalke, & Lorenz, 2005). However, the suggestion of 
dividing QOL scores into dichotomous categories of ‘good’ and ‘bad’ contradicts the 
conceptualisation and definition of QOL as a subjective construct that is shaped 
within a cultural and personal context. Till, Osaba, Pater, and Young (1994) 
summarised the issues related to lack of dissemination of health-related QOL research 
into practical applications, noting an imbalance between the interests and priorities of 
researchers and clinicians, and encouraging increased multidisciplinary collaboration 
to ensure mutual interest and practicality in research topics. Lenfant (2003) also 
observed problems with the dissemination of research to clinical practice, urging 
researchers and clinicians to come together to ‘close the loop’ between theory and 
practice by applying established research findings in clinical practice. This transition 
would also enable QOL research to expand its focus to other areas related to 
transplantation, such as the design and evaluation of interventions focused on 
increasing health professionals’ use of QOL information in clinical practice.  
The utility of ongoing research in the field of organ transplantation heavily 
depends on the applicability and usefulness of research findings to clinical practice. 
Conceptual debates and replication of established findings are futile unless these can 
be applied to efforts to understand and improve transplant patients’ QOL. As such, an 
investigation of the way in which QOL research is disseminated among 
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transplantation health professionals is needed to clarify the current standing of 
research and inform the future direction of study. 
Perceived Barriers to the Collection and Use of QOL Information 
Health professionals frequently cite time constraints and workload burdens as 
the main barriers to collecting and using QOL information. Concerns about time 
required for longer consultations to discuss QOL issues have been reported, together 
with extra time required to administer and score QOL measures (Skevington, et al., 
2005). Morris and colleagues (1998) found that oncologists’ perceptions of lack of 
appropriate instruments impacted upon assessment of QOL, together with the belief 
that QOL evaluation is unnecessary and should remain the domain of other health 
professionals, such as psychologists. The perceived added burden to workload also 
encompasses the need to acquire knowledge and skills about QOL assessment, 
together with the obligation to follow-up patients’ QOL concerns with an intervention 
or referral to another health professional. Similarly, Unruh, Wesibord, and Kimmel 
(2005) state that health professionals face multiple challenges in assessing and 
applying QOL information, including understanding the conceptual model of QOL, 
assessing the quality of literature, and the logistic difficulties associated with 
incorporating QOL data into the routine of busy clinical practice. 
While health professionals’ main concerns with incorporating QOL assessment 
into clinical practice are associated with additional time and workload burdens, 
research has shown routine assessment of QOL does not require prolonged patient 
consultations (Santana, et al., 2010). The inclusion of routine QOL assessment may 
actually lower health professionals’ time and work commitments, as it has been found 
to be associated with more efficient and effective medication changes and increased 
rate of referral to other specialists.  
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Rationale, Aims, and Research Questions of the Current Study 
As detailed in this chapter, there has been a scarcity of research investigating 
QOL issues from the perspective of health professionals working within the field of 
transplantation. Discord between patients’ and health professionals’ QOL ratings 
revealed in previous research indicates a pressing need to investigate the way in 
which QOL is perceived and used within clinical practice with transplant patients. 
Further, there has been no assessment of the dissemination or application of copious 
amounts of published research related to the QOL of transplant patients, leading to the 
replication of studies and little knowledge of the utility of accrued research.  
The overall aim of the current study was to extend knowledge of transplant 
patients’ QOL experiences by considering QOL from the perspective of health 
professionals working within transplantation medicine. It is anticipated that this 
exploratory investigation will provide an indication of the way in which QOL is 
considered in transplantation clinical practice, and will inform strategies to ensure 
transplant patients’ QOL remains a treatment priority. Four research questions were 
posed in this exploratory study: 
1. How do health professionals define QOL? 
2. What are the attitudes of health professionals towards transplant 
patients’ QOL issues? 
3. Are health professionals willing to use QOL information in clinical 
practice? 
4. To what extent do health professionals use QOL information in clinical 
practice, and what factors are associated with health professionals’ use 
of QOL information? 
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Method 
Participants 
The sample consisted of 41 health professionals working in the field of 
transplantation. All participants were working in Australia at the time of the study. 
Nine were doctors, twenty-six nurses, four allied health professionals including 
physiotherapists and dietitians, and two did not state profession. The majority of 
participants (78%) were female. Twenty-seven (65.9%) worked in pediatrics, 11 
(26.8%) with adults, and 3 (7.3%) in combined pediatric/adult settings. Most worked 
primarily in patient care (58.5%) while others were employed in roles that combined 
patient care, administration, and teaching. Thirteen health professionals (31.7%) 
worked specifically with liver transplant patients, and four each (9.8%) with cardiac, 
renal, and lung patients, respectively. Remaining participants worked across a range 
of combined organ types. With an average age of 40.54 years (SD = 10.19), most 
health professionals completed training between 1991 and 2000 (34.1%) or after 2000 
(31.7%), while others trained between 1980 and 1990 (24.4%) or prior to 1980 
(9.8%). 
Materials 
Participants completed a questionnaire designed to evaluate attitudes, 
willingness, and behaviour towards the QOL issues of organ transplant patients (see 
Appendix F). Additionally, participants were asked to provide a definition of QOL. 
Demographic information related to age, gender, profession, area of expertise, clinical 
population, and practice responsibilities was also collected.  
MD-QOL. The MD-QOL (Bezjak, et al., 2001) was used to measure attitudes 
to QOL, willingness to use findings of QOL, and behaviour related to QOL in clinical 
practice. The MD-QOL is a 47-item measure designed to quantify health 
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professionals’ attitudes to QOL in the three main areas of attitude, willingness, and  
behaviour related to the use of QOL information in clinical practice. Attitude towards 
QOL was defined as measuring health professionals’ thoughts about the concept of 
QOL, opinion of QOL instruments, and perceptions of the benefits and drawbacks of 
using QOL in clinical practice. Willingness was conceptualised as the intention to use 
QOL information, while behaviour incorporated the extent to which health 
professionals used formal and informal QOL information in clinical decision-making. 
Several items were negatively worded and subsequently reverse scored, with all items 
measured on a 4-point Likert scale from strongly disagree to strongly agree. The MD-
QOL has shown good psychometric properties, with internal consistency reliabilities 
of Cronbach’s α = .80, α = .75, and α = .81 for the subscales of attitude, behaviour, 
and willingness to use QOL, respectively. The current study demonstrated 
comparable reliabilities of Cronbach’s α = .66, α = .86, and α = .86 for the subscales 
of attitude, behaviour, and willingness to use QOL, respectively.  
Procedure 
All participants completed the questionnaire online using SurveyMonkey 
software and returned the survey electronically. Following approval from RMIT 
University Human Research Ethics Committee (HREC), participants were recruited 
from Australian hospitals that have transplant units. Transplant coordinators were 
notified of the study via an email containing an outline of the research and an 
electronic link to the questionnaire, and were requested to share the information with 
colleagues eligible to participate in the study.  
An information sheet accompanying the questionnaire advised participants of 
the general purpose of the investigation and explained the reason they had been 
approached to participate (Appendix G). Participants were informed about the 
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voluntary nature of participation in the study, and the anonymous and confidential 
nature of participation through the collection of only non-identifiable information was 
explained.  
Results 
Preliminary Data Analysis 
Data were analysed using SPSS version 18.0. While 34 of the original 41 
participants (82%) provided a definition of QOL, a large number did not respond to 
the MD-QOL questionnaire items. Therefore, 17 cases that were missing more than 
30% of data were removed prior to quantitative data analysis. The final sample for 
analysis, therefore, was 24 participants, including 16 nursing staff, 5 medical staff, 
and 3 allied health professionals. 
Small amounts of missing data were replaced with the sample mean of 
variables, ensuring a full dataset. Two outliers were detected, however, these were 
retained in the data set as their inclusion did not alter final results. Normality of the 
MD-QOL subscales was assessed, with results of the Kolmogorov-Smirnov tests 
showing the behaviour and willingness scales satisfied normality requirements (p > 
.05) (Tabachnick & Fidell, 2007). The assumption of normality was violated on the 
MD-QOL attitude scale, however, this skew was expected as previous research has 
consistently indicated the high regard in which health professionals hold QOL. 
Descriptive Statistics 
Descriptive statistics and scale scores are presented in Table 6. The table also 
displays respondents’ mean scores from the groups of nursing, medicine, and allied 
health. Overall, health professionals reported a positive attitude to QOL, and 
willingness to use QOL information in clinical practice was also relatively high. 
However, self-reported use of QOL was lower than willingness, with the trend of 
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results indicating that medical health professionals reported the highest levels of use 
of QOL information in clinical practice. The mean and standard deviation pertaining 
to each item of the MD-QOL are presented in Table 7. 
 
Table 6 
Descriptive Statistics of MD-QOL Scale 
 
Subscale N M SD 
Attitude 24 48.21 5.24 
 Nursing 16 49.31 4.91 
 Medicine 5 46.40 4.51 
 Allied health 3 45.33 8.07 
Willingness 24 29.17 6.38 
 Nursing 16 28.31 7.13 
 Medicine 5 31.40 5.55 
 Allied Health 3 30.00 2.65 
Behaviour 24 26.79 9.07 
 Nursing 16 26.06 8.71 
 Medicine 5 31.40 11.40 
 Allied Health 3 23.00 6.24 
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Table 7 
Descriptive Statistics of MD-QOL Items (N = 24) 
 
 MD-QOL Subscale and Item  M (SD) 
 ATTITUDE  
1. Resources currently allocated to QOL should be used for basic transplant research 2.50 (1.06) 
2. Using published QOL information is essential to good transplant patient care 3.50 (.59) 
3. QOL is a subjective concept that cannot be quantified 2.50 (.83) 
4. New QOL instruments are simply variations of previously ineffective tools 1.96 (.86) 
5. Published QOL data are not useful for individual patient care 2.04 (.55) 
6. The emphasis on QOL is a passing fad that will diminish over time 1.42 (.50) 
7. QOL should be a required outcome measure for all Randomised Control Trials 
(RCTs) in transplant research 
3.17 (.96) 
8. The role of the health professional as an independent decision maker is jeopardized 
by the emphasis on QOL 
2.12 (.54) 
9. The emphasis on QOL is warranted in view of the lack of success in improving 
survival of transplant patients 
2.75 (.85) 
10. Adding QOL to RCTs will make transplant patients more willing to participate 2.29 (.91) 
11. Adding QOL to RCTs in transplantation research will decrease health professional 
participation 
2.00 (.78) 
12. Most of my patients are willing to accept a poor QOL for even a small chance of 
receiving a transplant 
2.29 (1.30) 
13. Discussing QOL makes patients feel that they themselves are cared about, not just 
their disease 
3.46 (.66) 
14. My primary responsibility in treating transplant patients is to save lives 2.63 (.77) 
15. Follow-up visits are primarily for monitoring the health of the patients, and not to 
assess QOL 
2.08 (1.14) 
16. Attention to QOL makes treatment decisions difficult 2.54 (.83) 
17. In my opinion, prolonging survival with poor QOL is still a success 1.83 (.57) 
18. The most important benefit of QOL is that one can ‘really treat the whole patient’ 3.08 (.72) 
19. When I initiate QOL discussions, my patients interpret this to mean that transplant 
is not possible 
1.87 (.61) 
20. Having to consider QOL sometimes reduces the medical professional’s ability to 
make optimal medical decisions 
2.17 (.82) 
 BEHAVIOUR  
21. I generally encourage my patients to complete QOL questionnaires 1.67 (1.55) 
22. The information that QOL research provides about the relative impact of treatment 
options determines my treatment recommendation 
1.79 (1.41) 
23. I rely on my clinical experience to assess QOL 2.58 (.72) 
24. I often read studies reporting QOL results 2.54 (.88) 
25. I use published QOL results to modify my practice patterns 1.83 (1.24) 
26. I am more likely to use toxicity information than QOL information when making 
treatment decisions 
1.42 (1.25) 
27. I use formal QOL questionnaires in my practice 1.67 (.80) 
28. My decision to initiate QOL discussions does not depend on whether the 
circumstances are curative or palliative 
2.71 (.99) 
29. When I have to choose between prolonging survival or improving QOL, I usually 
attempt to prolong survival 
1.54 (1.25) 
30. When transplant is possible but unlikely, I intend to discuss QOL issues much less 
than when dealing with an incurable situation 
1.50 (.86) 
31. When a treatment offers a high chance of cure in conjunction with potential long-
term survival, I downplay its negative impact on QOL 
1.62 (.88) 
32. I do not discuss QOL issues with my patients unless they ask about it first 1.96 (.86) 
33. When I feel that QOL considerations are important in particular cases, I discuss 
QOL issues with patients even if they did not indicate an interest 
2.58 (1.18) 
34. I use QOL to justify not giving toxic treatments that are of questionable benefit 1.38 (.87) 
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WILLINGNESS 
35. Even if QOL instruments had established validity and reliability, I would be 
reluctant to extrapolate the results to my patients 
1.79 (.88) 
36. Since quantifying QOL is problematic, I will not use QOL data 1.96 (.81) 
37. Even if I were given more resources, I would not collect QOL information 2.00 (.66) 
38. If collecting QOL data were less demanding of my resources, I would be more 
willing to collect it from my patients 
2.62 (1.25) 
39. I would not ask ill patients to complete QOL questionnaires 1.96 (.55) 
40. If I were responsible for training health-care professionals, I would advocate the use 
of formal QOL measures 
2.88 (1.04) 
41. Generally, I will spend my time on clinical care and leave QOL to others 2.50 (.83) 
42. I do not plan to incorporate QOL data in my practice 2.04 (.62) 
43. It is unlikely that I will increase my use of QOL in the care of future patients 2.92 (.83) 
44. If QOL results were easier to understand, I would be more likely to use them 2.50 (1.10) 
45. Even if published QOL results are shown to be clinically relevant, I am not likely to 
use them 
1.88 (.61) 
46. The more physicians are aware of the complexities of analyzing QOL, the less 
likely they will be to use them 
2.00 (.98) 
47. I would only be willing to use formal QOL assessment if required to do so by my 
institution or regulatory body 
2.13 (.90) 
 
The relationship between demographic factors and the QOL variables of 
attitude, willingness and behaviour were explored using Pearson product-moment 
correlation coefficients (see Table 8). All observed correlations between variables 
were well below .90, satisfying multicollinearity requirements. The only significant 
positive relationship between demographic and QOL variables was detected between 
gender and QOL attitude, r (24) = .44, p <.05. Inspection of the mean scores of 
attitude revealed that female health professionals (M = 49.65, SD = 4.72) hold QOL 
in higher regard than male health professionals (M = 44.71, SD = 5.09). However, this 
result should be interpreted with caution due to the large number of variables (type I 
error), and large sample size differences between genders. 
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Table 8 
Intercorrelations Between MD-QOL Subscales and Health Professionals’ Demographic Variables (N = 24) 
 
 1 2 3 4 5 6 7 8 9 
1. QOL attitude 
 
-         
2. QOL willingness 
 
.21 -        
3. QOL behaviour 
 
.11 .20 -       
4. Gender 
 
.44* -.20 -.10 -      
5. Age  
 
.05 .06 -.18 -.07 -     
6. Organ type  
  expertise 
-.24 -.12 -.13 .03 -.12 -    
7. Patient 
  population 
-.22 .22 .06 -.19 .23 .03 -   
8. Year training 
  completed 
-.05 .09 .36 -.23 -.86** .11 -.03 -  
9. Practice 
  responsibilities 
-.20 .10 .31 -.24 .20 -.38 .25 -.17 - 
Note: **p<.01, *p <.05.  
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Defining Quality of Life 
Thirty-four participants supplied definitions of QOL. Several themes emerged 
from the data, with pertinent themes grouped according to factors noted by health 
professionals as important to their understanding of QOL (Table 9). Interpretations of 
the term varied widely, with the majority of respondents emphasising patients’ 
enjoyment of life. One health professional purported QOL to be “a measure of 
‘happiness’”, while others noted its relation to patients’ “ability to enjoy life” and 
“how much you enjoy life”. 
 
Table 9 
Health Professionals’ Definitions of Quality of Life (N = 34) 
Definitions % of respondents who 
included this term 
Patients’ enjoyment of life 53% 
Patients’ performance status 41% 
Related to illness or pain 32% 
Defined by patients’ subjective judgment 17% 
Multidimensional; mention of physical, psychological,  
  and/or social wellbeing domains 
17% 
Note. Most responses included multiple descriptors of QOL 
 
 
Definitions related to pain or illness was also common, with several health 
professionals mentioning that a life of high quality is one “measured on the 
limitations the patient may experience due to their illness”, dependent on “limited 
capacity”, and related to “being healthy enough…” and “without the limitations of ill 
health”. 
Functional status, including ability to work or attend school, was frequently 
commented upon. One health professional commented that QOL is defined by ability 
to “partake in… normal activities such as school, friendships and family life”, while 
others noted QOL to be related to doing “what’s required on a daily basis to sustain 
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life comfortably”, “being able to do the things in life… they want”, and “participation 
in desired activities.”  
Fewer health professionals remarked on the subjective nature of QOL. One 
respondent noted that QOL is “dependent on the experiences of the patient”, while 
two others clearly stated QOL to be “a person’s subjective view of their life” and 
based on “an individual’s perception”. Another explained the potential of the 
subjective nature of QOL to cause discrepancies between individuals’ ratings of the 
impact of disability or ill health. 
Health professionals in the current study infrequently noted the multi-
dimensional nature of QOL. One described QOL as “physical, psychological and 
social wellbeing”, while another described QOL as “a measure of a person’s 
psychological and physiological health”. One made mention of the social domain by 
stating that QOL is“…their ability to participate within their own family and wider 
social circle and community”. 
Attitude Towards Quality of Life  
As summarised in Table 6, health professionals reported a generally positive 
overall attitude towards QOL, with the trend of results suggesting nurses hold a 
slightly higher level of regard towards QOL in comparison to medically trained health 
professionals, such as doctors. Respondents rejected the notion of QOL being a 
passing fad that will diminish over time. The vast majority disagreed with the 
statement that prolonging survival with poor QOL is still a success. Health 
professionals overwhelmingly agreed that using published QOL information is 
essential to good transplant care, yet a small percent of respondents believed 
published QOL data are not useful for individual patient care. Most held neutral views 
regarding the inclusion of QOL as an outcome measure in RCTs, reporting that it 
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would not decrease health professional participation but would not necessarily 
increase patient participation.  
Willingness to Use Quality of Life Information  
Results revealed mixed opinions among health professionals regarding 
willingness to use QOL information in clinical practice. Most (83.4%) stated they 
were unlikely to increase use of QOL data in the care of future patients. Half of 
respondents agreed that they would likely leave QOL issues to other health 
professionals, however, somewhat conversely 83.3% of health professionals stated 
that training of health professionals should include instruction on the use of formal 
QOL measures.  
Use of Quality of Life Information in Clinical Practice 
Results suggest that health professionals infrequently use formal QOL 
measures. Less than a quarter of the health professionals surveyed in the current study 
reported generally encouraging patients to complete QOL questionnaires, with most 
reported relying on clinical experience to assess QOL. While more than half stated 
that they often read studies reporting QOL results, fewer reported using QOL research 
to determine treatment recommendations, and even fewer used QOL findings to 
modify practice patterns.  
Perceived Barriers to Using Quality of Life Information 
Results of the MD-QOL imply that factors influencing health professionals’ use 
of QOL information in clinical practice include demands on resources, and difficulty 
in interpreting QOL results. Psychometric properties of QOL measures do not appear 
to be associated with the low frequency of use, with the majority of health 
professionals reporting that validity and reliability does not influence their intent to 
extrapolate research findings to patient treatment. 
 98
Discussion 
While previous studies have sought to quantify the QOL improvements 
associated with transplantation and investigate the QOL experiences of transplant 
patients, the current study adopted a new perspective on QOL within transplantation 
by exploring health professionals’ views on QOL and surveying their use of QOL 
information in clinical practice. This exploratory study identified overall positive 
attitudes towards QOL and also pinpointed several possible barriers to health 
professionals using QOL information when treating transplant patients. The current 
findings inform possible methods to improve health professionals’ use of QOL 
information in clinical practice, and also point to several areas requiring further 
research. 
Defining Quality of Life 
Health professionals’ varied definitions of QOL reinforce its reputation as a 
nebulous concept. There were substantial differences in the responses regarding the 
key components of QOL, with respondents emphasising a range of parameters. Most 
did not include the key concepts of the WHO’s widely-used definition of QOL as a 
subjective view and a broad-ranging concept incorporating the person’s health, 
psychological state, level of independence, social relationships, and relationship to 
salient features of the environment (Orley & Kuyken, 1994).  
Most health professionals emphasised patients’ enjoyment of life as an 
important aspect of QOL. The ability of transplant patients to function in capacities 
related to employment, school and leisure was closely tied to the idea of enjoying life, 
with many respondents including both constructs within their definition. Some 
commented on the importance of being able to complete daily tasks and participate in 
activities related to school and family life. The notion of independence that is central 
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to the definition of QOL is implicit in such remarks. Health professionals’ inclusion 
of patients’ level of functioning in the QOL definition lends support to previous 
research that reported doctors’ tendency to base QOL ratings on social indicators such 
as returning to work or attending school (Frost, et al., 2002; Skevington, et al., 2005). 
The ability to function is important to overall QOL, with a return to work, school or 
leisure activities potentially associated with improved psychological or physical 
functioning and social opportunities. Health professionals working with transplant 
patients may be especially likely to use performance status as a marker of QOL, as 
many transplant candidates are hospitalised and generally incapacitated prior to 
transplantation, making their return to everyday life a significant sign of recovery.  
Many health professionals emphasised the relation of QOL to illness or physical 
pain. This is somewhat contrary to the definition of QOL as being based on more than 
simply the absence of ill health or disease (Murphy, et al., 2000). Health 
professionals’ emphasis on the importance of physical and illness related factors are 
congruent with previous research that identified doctors as reliant on ratings of 
physical health in their determination of QOL (Ekberg, et al., 2007; Janse, et al., 
2004). While physical health is an important element of QOL, overemphasis on the 
domain on physical functioning may impede health professionals’ judgments about 
patients’ QOL, and may restrict their ability to assist patients to find meaning or 
enjoyment in life when illness or treatment results in physical problems such as 
immobility or restricted physical capacity. 
Few respondents overtly commented on the subjective nature of QOL. 
Recognition of the subjectivity of QOL is important, as individuals’ experiences may 
impact upon illness or wellbeing and has the potential to inform treatment. Moreover, 
only a small number of health professionals noted the multi-dimensional nature of 
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QOL. Of respondents that did acknowledge it, several mentioned one domain while 
neglecting others. This may be a reflection of the specific expertise and experience of 
individual health professionals who normally consider one aspect of a patients’ life, 
such as doctors who concentrate on physical wellbeing or recovery following 
transplantation. However, a lack of consideration of the multi-dimensional nature of 
QOL may have implications for the way in which health professionals assess and 
consider QOL issues. Consideration of all aspects of QOL facilitates holistic care and 
may result in referral to other professionals for treatment of issues impacting on 
specific domains of QOL. 
Definitions of the term QOL appear to be as subjective as the experience of 
QOL itself. Health professionals working in the field of transplantation considered a 
broad range of factors in defining QOL, including enjoyment of life, functionality, 
and illness and pain. Such inconsistent definitions of QOL may lead to substantial 
differences in the way in which QOL is assessed and discussed in clinical practice. 
Attitude and Willingness 
Findings of the MD-QOL in the current study suggest that health professionals 
place important value on the QOL issues of organ transplant patients. This was also 
evident in health professionals’ definitions of QOL, with consideration shown to 
many aspects of transplant patients’ lives and a general focus on assisting patients to 
achieve the best possible outcomes related to health, functional status, psychological 
wellbeing, and social and leisure activities. The positive attitudes expressed in this 
study are congruent with previous findings indicating that oncologists, stem cell 
transplant specialists and GPs have high regard for patients’ QOL issues (Bezjak, et 
al., 2001; Lee, et al., 2004; Skevington, et al., 2005; K. M. Taylor, et al., 1996). Such 
positive attitudes may be explained by health professionals’ general disposition to 
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help and care for ill people, and the inherent nature of healthcare as focused on the 
ability to improve health and wellbeing. Regardless of differences in the exact 
definition of QOL, health professionals’ general agreement on the importance of 
transplant patients’ ability to enjoy life and achieve a good standard of living reflects 
good patient care and an implicit recognition of QOL.  
In terms of willingness to use QOL information, results of the current study 
suggest that health professionals are generally unwilling to alter the way in which 
they collect QOL information and seem satisfied to assess QOL informally rather than 
use QOL measures. This discrepancy between attitude and willingness has also been 
observed in previous research, with Morris, Perez, and McNoe (1998) finding that 
oncologists’ beliefs about the importance of collecting QOL data was not matched by 
actual collection levels. Possible reasons for this discrepancy are reviewed later in this 
chapter. 
Use of Quality of Life Information in Clinical Practice 
Despite positive attitudes towards QOL issues, health professionals reported 
infrequent use of QOL information and a clear preference for informal assessment 
over use of validated QOL measures. Respondents in the current study reported 
relying on clinical experience to assess QOL in an informal manner, with only a small 
number of health professionals using formal QOL measures in clinical practice. This 
is congruent with previous research, as oncologists and GPs also reported informal 
assessment of QOL (Bezjak, et al., 2001; Skevington, et al., 2005). This may be a 
reflection of health professionals’ training, as doctors generally use unstructured 
interviews while nurses usually engage in conversation to elicit information. 
Similarly, Frost and colleagues (2002) reported infrequent use of formal measures 
among oncologists, and GPs were found to have little knowledge of QOL measures 
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suitable for clinical practice (Skevington, et al., 2005). With only a small number of 
health professionals choosing to use formal measures to assess QOL, further research 
is needed to ascertain perceived benefits of such measures and the way in which the 
data is applied to clinical practice.  
Previous research has warned against informal assessment of QOL due to 
inaccurate judgments and a lack of agreement between patient and health 
professionals on the patients’ QOL. However, another perspective may be to accept 
that an informal assessment of QOL is at its very least an acknowledgment of 
patients’ QOL issues. It is important to note that the use of QOL measures merely 
complements clinical judgment and does not replace it. Without information on the 
exact way in which data obtained from such measures is used between and within 
health professionals in clinical practice, it cannot be assumed that the use of formal 
measures necessarily constitutes better practice.  
Most health professionals in the current study clearly stated that they are 
unlikely to use formal QOL measures despite good psychometric properties or 
encouragement from their institution; rather than force the use of such measures on 
unwilling professionals, another tact may be to thoroughly investigate the use of 
informal assessment of QOL to ascertain its usefulness. Providing health 
professionals with knowledge of the concept of QOL and informing them of targeted 
questions related to QOL that may be used in clinical interviews may be an adequate 
compromise for health professionals with expressed reluctance to employ QOL 
measures. Such information could be delivered via professional workshops or in the 
context of postgraduate training. However, while health professionals in the current 
study appeared to be unwilling to use formal measures of QOL, most advocated for 
the training of health professionals to include the use of such measures. This is 
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perhaps indicative of QOL not being regarding as a passing fad, and may show that 
health professionals expect QOL to be an increasingly important concept in the future 
of transplantation medicine. 
More than half of the health professionals in the current study reported often 
reading studies pertaining to QOL within the transplant literature. This is higher than 
the readership of QOL studies among stem cell transplant physicians (Lee, et al., 
2004) and oncologists (K. M. Taylor, et al., 1996), and may be a reflection of the 
large amount of QOL information published in relation to transplantation. While 58% 
of transplantation health professionals reported reading QOL studies, only 37.5% 
reported using such research to determine treatment recommendations. The reason for 
this disparity is unclear, however, the suggestion in previous research of results being 
difficult to interpret (Till, et al., 1994) also appears to apply to health professionals 
working with transplant patients, with many respondents in the current study stating 
that results are difficult to interpret. This may be a reflection of a lack of 
understanding of statistical analysis, as most health professionals receive only basic 
training in research. Further, the finding that health professionals continue to read 
studies that seem to have little utility to clinical practice is surprising and should be 
investigated in further research.  
Perceived barriers to using quality of life information. The challenging and 
stressful nature of working as a health professional in the field of organ 
transplantation was evidenced by the majority of health professionals in the current 
study citing demands on resources as the main barrier to using QOL information in 
clinical practice. It appears that incorporating the use of QOL information may seem 
daunting to a health professional with an already heavy workload. However, Santana 
and colleagues (2010) showed that inclusion of QOL information in clinical practice 
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need not require additional time. The issue of extra time to administer, score and 
interpret results of QOL measures may be overcome by allowing administrative or 
other staff to collate data, in a similar to which pathology tests are relayed to health 
professionals. While Morris and colleagues (1998) found that oncologists believed 
that QOL evaluation should remain the responsibility of other health professionals, 
respondents in the current study largely disagreed with the statement that their 
‘primary responsibility in treating patients is to save lives’, implying concern for 
general wellbeing of patients in addition to the prevention of illness or mortality. This 
may have been brought about by the multidisciplinary nature of the team on which 
transplant personnel work, as the distinct training and orientation of team members 
may influence the whole team. 
Interventions to Improve Use of Quality of Life Information 
Results of the current study suggest ways in which interventions may be used to 
promote the use of QOL information in transplantation clinical practice. With an 
apparent variation in the attitudes, willingness, and behaviours of health professionals 
to use QOL information, interventions to facilitate the use of QOL may benefit 
transplant patients by ensuring QOL issues are considered in clinical practice. 
The majority of health professionals in the current study reported limited 
knowledge of QOL measures and reliance on clinical experience to assess QOL. 
Familiarisation with the concept of QOL may lead to increased consideration of it in 
clinical practice. This may be achieved through instruction on QOL issues being 
incorporated into the training of health professionals, a notion supported by the 
majority of health professionals in the current study. Previous research has shown that 
doctors’ communication skills are not necessarily innate and are indeed teachable, 
with coaching of communication skills leading to increased empathy, increased 
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appropriate responses to patients cues, and fewer leading questions (Lee, Back, Block, 
& Stewart, 2002). This lends credence to the idea that health professionals’ sensitivity 
to transplant patients’ QOL issues may be able to be shaped by training and 
intervention. 
With regards to increasing the dissemination of research to clinical practice, 
results of the current study suggest that readership of QOL studies among transplant 
health professionals is already reasonably high. However, the application of research 
to clinical practice was observed to be relatively low. This may be increased by 
presenting research in a format that is easier for health professionals to understand, 
including using appropriate clinical language to express findings and reporting results 
in a succinct manner. Consulting health professionals in the design and application of 
research projects may assist in reducing the duplication of QOL studies and would 
ensure topics of interest are central to new research. While previous research has 
suggested obtaining assistance from health professionals in the development of QOL 
measures (Eccles, Grimshaw, Walker, Johnston, & Pitts, 2005), current results that 
showed little concern with reliability and validity of existing measures appear to 
contradict the need for development of new QOL assessment tools. Rather, providing 
health professionals with education and information about existing QOL measurement 
may be more appropriate. 
Providing health professionals with the knowledge and tools to assess QOL 
must be accompanied by information regarding assistance for patients who are 
identified as experiencing QOL difficulties. This may include details of professionals 
to whom patients could be referred. With current and previous research (Morris, et al., 
1998) showing that some health professionals regard QOL considerations as the 
responsibility of other professionals, easing the process of making an onward referral 
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may allay health professionals’ trepidation regarding assuming accountability for 
QOL factors that may be perceived as beyond clinical capacity or duty. 
Limitations of the Current Study and Suggestions for Future Research 
The results of this exploratory study indicate the viability of future research in 
this field. Replication or expansion of this preliminary investigation may enlighten 
researchers on the way in which health professionals use QOL and may result in an 
increased understanding of the impact of health professionals on transplant patients’ 
QOL. The relatively small and perhaps biased sample of the current study restricted 
analysis to data exploration; a more sustained and focused recruitment strategy may 
lead to a greater number of participants and the opportunity to conduct predictive 
statistical analysis. This would also allow for more thorough comparisons of the QOL 
attitudes and behaviour of, for example, medical staff and nurses, with such 
information useful for targeting interventions to improve use of QOL in clinical 
practice. Further, attrition was a major problem in this study that heavily impacted 
upon sample size. While most respondents provided a definition of QOL, many did 
not complete the MD-QOL. This may be a reflection of the time constraints on health 
professionals, and as such the use of a shorter questionnaire or selection of only 
pertinent questionnaire items should be considered in future studies with this 
population. The use of qualitative face-to-face interviews in future research may 
allow health professionals to better express their understanding of QOL and explore 
issues related to its definition and assessment. 
The current study was the first to explore transplant health professionals’ 
definitions of the construct of QOL, adding to limited knowledge about the way in 
which the term is defined in clinical practice. However, it is should be noted that 
health professionals’ responses may only encapsulate the most pertinent aspects of 
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their knowledge of QOL. Future studies may opt to present respondents with a 
multiple choice list of variables associated with QOL, as respondents may find it 
easier to recognise a definition of QOL rather than recall, hence providing a more 
accurate description of their notion of QOL.  
The Theory of Planned Behaviour (TPB) could be used in a larger scale study to 
explore the apparent discrepancy between health professionals’ overall positive 
attitude towards QOL and intent and behaviour associated with the use of QOL 
information in clinical practice with transplant patients (Ajzen, 1991). The TPB 
considers the role of attitude (positive or negative appraisal), subjective norm 
(perception of important others’ views), and perceived behavioural control (ease or 
difficulty of performing the behaviour) in relation to behaviour. The TPB has been 
used to test many health-related behaviours, including exercise participation, 
excessive alcohol consumption, and smoking cessation. It has also been applied to the 
behaviour of health professionals, including nurses’ ethical decision-making (Randall 
& Gibson, 1991), and has previously been posited as potentially useful to explain the 
unpredictable process of the uptake of research findings among health professionals 
(Eccles, et al., 2005). The worth of using the TPB to explain health professionals’ use 
of QOL information lies within its ability to inform a better understanding of the 
factors that may stop health professionals’ positive attitudes towards QOL being 
converted into use of QOL information in clinical practice. In turn, this information 
can be used to inform interventions at systemic and individual levels.  
Further studies could also consider the impact of health professionals’ clinical 
practice on the QOL of transplant patients, and could corroborate the benefits of the 
use of QOL measures in transplantation medicine indicated by Santana and colleagues 
(2010). Patients’ perceptions of health professionals’ sensitivity to QOL issues could 
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also be investigated, as any intervention aimed to increase health professionals’ 
consideration of QOL is ultimately designed to assist patients. The concept of 
informal assessment of QOL also deserves further consideration. With health 
professionals generally unwilling to use formal QOL measures in practice, further 
information about the composition and content of informal assessment may inform 
training or information to be used to introduce a level of consistency in informal 
assessment.  
Concluding Comments 
In conclusion, the current study has demonstrated the usefulness of considering 
health professionals’ attitudes and behaviours related to QOL. Inclusion of this 
perspective on QOL is helpful in gaining a wider understanding of the concept of 
QOL within the field of organ transplantation. Findings of the current study suggest 
wide variation in the way in which health professionals consider and apply QOL 
information to clinical practice with transplant patients. The apparent disparity 
between positive attitudes toward QOL and minimal use of QOL information in 
clinical practice makes this area of research fertile for future research, with several 
areas of investigation and intervention possible to ensure transplant patients’ QOL 
issues receive adequate attention.  
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Chapter 4  
Study 3 – Quality of Life and Family Functioning Following Pediatric Liver 
Transplantation 
 Study 3’s focus on pediatric transplant patients extends upon the theme of the 
QOL of organ transplant patients investigated in the previous two studies. The current 
study explores a new aspect of QOL by considering the impact of the transplantation 
process on pediatric liver transplant recipients and their families. Families are 
especially important to consider when investigating young transplant patients’ QOL, 
as children grow and develop within a family context, and post-transplantation 
recovery usually occurs in the family home rather than hospital. This chapter provides 
a brief summary of the literature relevant to pediatric liver transplantation, and 
provides a review of the limited research on family functioning in this field. 
Investigations of the relationship between QOL and family functioning in other 
clinical populations are also outlined. The intricate relationship between QOL and 
family functioning is explored, with a focus on adjustments made by families to 
accommodate children who have received liver transplants. 
Pediatric Liver Transplantation 
Since the first liver transplant on a three-year-old girl in 1963, vast advances in 
medical and surgical techniques have made liver transplantation standard treatment 
for children with end-stage liver disease (ESDL) (Otte, 2002). Long-term survival 
following liver transplantation in childhood is now the rule rather than the exception, 
with excellent patient survival rates of up to 82% at five years post-transplant 
(Heffron et al., 2010; Karim, Alex, Smith, & Hardikar, 2000). The medical 
improvements following pediatric liver transplantation are well established, and the 
primary aim of transplantation – to save lives – has clearly been met (Avitzur et al., 
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2004). Indeed, Kelly and Mayer (1998) state that pediatric transplantation has 
revolutionised the outlook for children with ESLD to the point that the primary 
problem in this field is now the shortage of donor organs.  
There are substantial differences between pediatric and adult liver 
transplantation, including distinct underlying primary diseases, process of care, and 
surgical and infectious complications. Chronic liver disease during childhood affects 
the structural and functional development of the nervous system, and as a result 
advanced ESLD may disrupt cognitive processes such as the acquisition of reading 
and writing skills (Tarter, 1998). Age has been found to impact upon success of 
transplantation; adolescents recover more slowly than younger children but more 
quickly than adults, and optimal outcomes are associated with transplantation in 
children under 5 years of age (Cole et al., 2004; Kaufman, et al., 2010). Events 
surrounding transplantation and post-transplant recovery and care differ for pediatric 
patients due to unique growth and development issues, with ESLD and the need for 
transplantation associated with impaired growth. Furthermore, essential 
immunosuppressive medications, such as corticosteroids, have been found to 
adversely impact growth and mood among children and adolescents (Bucuvalas et al., 
2003; Burra & De Bona, 2007). 
With up to 15% of all liver transplants in Europe and the US performed on 
children younger than 18 years of age, many aspects of the long-term implications of 
pediatric liver transplantation have been widely investigated (Bucuvalas, et al., 2003). 
Early attempts to measure its success focused exclusively on medical outcomes and 
survival, and research focused on laboratory experiments to refine preservation 
techniques and immunosuppressive therapies that were integral to increasing the 
survival rates of young liver transplant patients (Starzl et al., 1968). In response to the 
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high mortality rate among small infants due to a shortage of appropriately sized donor 
organs, much early published research concentrated on technical aspects of 
transplantation procedures such as reduced size organs, split liver techniques and live 
donation (Burdelski et al., 1999; Kamath & Olthoff, 2010). Attention later turned to 
overcoming nutritional problems and assessment of pediatric patients’ cognitive 
functioning and academic ability (M. Maes, et al., 1997).  
The benefits of pediatric liver transplantation are well documented. In addition 
to saving the lives of children who would otherwise die as a result of ESLD, liver 
transplantation in children results in decreased hospital visits, fewer hospital 
admissions, and less reliance on drug therapy (Manificat et al., 2003; Sokal, 1995; 
Stone, Beasley, Treacy, Twente, & Vacanti, 1997). The vast majority of children are 
able to return to school after liver transplantation, with a French study involving 280 
pediatric liver transplant recipients finding that 69% experienced no delay in 
education while other children were less than a year behind same-aged peers (Fouquet 
et al., 2005). Pediatric patients’ experiences of psychological adaptation following 
transplantation has also been investigated, with one study concluding that infants 
return to full psychological functioning two years after transplantation (Stone, et al., 
1997). Tornqvist and colleagues’ (1999) study on the long-term psychosocial 
adjustments of 146 pediatric liver transplant recipients concluded that children up to 
the age of 8 years reported no self-esteem or self-competency differences in 
comparison to healthy peers. However, adolescent boys who had received a transplant 
reported significantly lower self-worth and lower perceived athletic competence 
compared to non-transplant peers. Such research and recommendations of 
psychosocial interventions exemplify the continued shift away from pediatric liver 
transplantation being viewed as a purely medical phenomenon. 
 112
Pediatric Quality of Life 
Quality of life is now widely accepted as a fundamental aspect of any medical 
treatment and is a basic criterion for evaluating the success of pediatric transplant 
procedures. Interpreted liberally within medical literature and everyday life, it is 
defined here as a multidimensional construct including physical health, psychological 
functioning, social functioning, and general wellbeing (R. Taylor, et al., 2005). It is 
also important to note that the construct of childhood QOL differs somewhat from 
that of adult QOL, with a child’s QOL incorporating the importance of peer 
relationships, school adjustment, and self-esteem as more salient factors in the lives of 
young people (Tarter, 1998). 
A substantial amount of research has investigated the QOL of pediatric liver 
transplant patients, with Taylor and colleagues (2005) reporting that over 820 studies 
published between 1990 and 2003 specifically focused on the QOL of liver transplant 
patients from birth to 18 years of age. Numerous studies have consistently reported 
that QOL improves significantly after liver transplantation (Burra & De Bona, 2007). 
Avitzur and colleagues’ (2004) study of 35 pediatric recipients at 10-years post-
transplant revealed self-reported QOL to be very good, despite ongoing health 
problems including 77% of participants having mild or moderate liver failure. Cole 
and colleagues (2004) reported significant QOL improvements during the first year 
post-transplant for all patients in the sample of 45 pediatric liver transplant 
candidates, noting that the most drastic QOL gains occurred in the first six months. 
Manificat and colleagues (2003) found that adolescent liver transplant recipients 
reported a very high QOL when completing a structured questionnaire, however, 
during qualitative interviews the children revealed concerns related to appearance, 
health, and difficulties with peer relations. It is unclear whether such concerns are 
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normative problems encountered during adolescence, or symptomatic of liver 
transplantation. 
Zamberlan (1992) assessed the QOL of 20 liver transplant recipients aged 
between 5 and 8 years at 3 to 6 years post-transplant. The finding that children 
reported excellent QOL despite ongoing physical health problems is congruent with 
Avitzur and colleagues’ (2004) study, and substantiates QOL as a subjective 
experience that is usually independent of physical health or medical problems. An 
Australian study noted similar results and emphasised the potential for pediatric liver 
transplant recipients to enjoy excellent QOL (Chin et al., 1991).  
Few studies have directly compared the overall QOL of pediatric liver 
transplant recipients with community-based samples of healthy children. Chin and 
colleagues (1991) used the Vineland Adaptive Behaviour Scales (VABS) to assess the 
QOL of 26 pediatric liver transplant patients at a minimum of 12 months post-
transplant, and concluded the QOL of the clinical population to be equal to the 
normative sample. A later study of 56 children surviving liver transplantation for at 
least 2 years reported that although the group’s QOL was reasonably high, it remained 
significantly lower than the reference population (Midgley, Bradlee, Donohoe, Kent, 
& Alonso, 2000). While findings of a review of several studies concluded no 
statistically significant difference in the QOL of liver transplant and non-transplant 
children (R. Taylor, et al., 2005), limited research and inconsistent findings with this 
population point to the need for further research. 
Limitations of previous research. The QOL of pediatric liver transplant 
patients has been extensively studied, however, a number of previous investigations 
featured flawed methodology that makes results difficult to reconcile. Several fail to 
consider the subjective nature of QOL and instead focused on overt signs of QOL 
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such as medical wellness or the capacity to perform social, vocational and domestic 
tasks. For example, the finding that 82% of all pediatric liver transplant patients 
recipients are symptom free and lead entirely normal lives was wholly based on 
measures of medical health (Asonuma et al., 1998), while Burdelski and colleagues’ 
(1999) loose definition of QOL being associated with lack of morbidity contradicts 
WHO’s clear classification of QOL as comprising more than symptom-free survival 
(Murphy, et al., 2000). Kayler and colleagues’ (2002) claims of excellent QOL for 
most liver transplant recipients was based purely on physical health, and Sokal’s 
(1995) conclusion that children return to normal life and experience marked 
improvement in lifestyle following liver transplantation was entirely inferred from 
educational achievement and physical growth. In addition to broad and occasionally 
misleading definitions of QOL, varying research methods, measures and study 
designs make results difficult to reconcile. In addition to the limited qualitative 
research conducted in this area, QOL related to transplant-specific factors has also 
lacked investigation.  
Transplant-Related Quality of Life 
Receiving a liver transplant is a traumatic event for a child, with the 
transplantation process invariably involving lengthy hospital admissions, ongoing 
medication, invasive procedures, and great uncertainty about health and longevity. 
Despite the unique experiences of pediatric transplant patients, most studies continue 
to employ generic QOL measures to explore differences from pre- to post-transplant 
or compare their QOL to non-transplant normative samples. Only a small number of 
studies have investigated transplant-specific factors associated with QOL. Weissberg-
Benchell and colleagues (2010) identified several transplant-specific factors relevant 
to the QOL of pediatric recipients of liver, kidney, kidney, heart and small bowel 
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transplantation through focus groups and interviews with pediatric transplant patients 
and their families. Transplant-specific factors found to be important to pediatric 
transplant recipients’ QOL included medication side effects, difficulties with 
medication regimen, social activities, pain and hurt, worry, treatment anxiety, and 
concerns about physical appearance. A study of 342 American pediatric transplant 
recipients, including 90 liver transplant recipients, revealed children experience 
optimal QOL related to medication regimen, and worst QOL related to pain and hurt 
(Weissberg-Benchell, et al., 2010).  
Zamberlan (1992) found that school-aged children who had received a liver 
transplant reported difficulties with socialisation skills, feelings of loneliness, and 
concerns regarding ability to maintain peer relationships. Interestingly, the children 
reported the transplant experience as largely positive, recalling a greater amount of 
happy than unhappy memories of their hospital stay. Wise (2002) interviewed nine 
liver transplant recipients between the aged of 7 and 15 who were at least one year 
post-transplantation with the objective of investigating the overall and everyday 
experiences of the children in relation to liver transplantation. Themes arising from 
this qualitative study included difficulty with peer relationships, with participants 
reporting a desire to fit in with peers and not have attention drawn to their status of 
transplant recipients. The children also reported that unease with physical differences 
such as increased hair growth, jaundice, and scarring, led to attempts to minimise or 
hide physical differences from peers. Medication regimen was not a concern, with 
children reporting ease with integrating medications into their daily routine. Pain and 
hurt concerns were mostly focused on procedural pain such as needles for ongoing 
blood tests, with most children unable to recall details of surgical pain. Children also 
perceived their parents to be overprotective and hyper vigilant in the post-
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transplantation period, and reported this to be incongruent with their desire for 
normalcy in social, academic and home environments. A recent qualitative study 
investigating adolescent liver transplant recipients’ QOL perception identified a 
similar focus on peer relationships and ease with daily medication regimen (R. M. 
Taylor, Franck, Dhawan, & Gibson, 2010). Adolescents were also concerned with 
ongoing health and wellness and the impact of transplantation on their education and 
employment prospects. Distinct from younger children interviewed in other 
qualitative studies (Wise, 2002; Zamberlan, 1992), adolescents reported difficulties 
communicating with medical professionals, and increased anxiety was associated with 
not feeling fully-informed about the state of their health, ESLD, and transplantation. 
Further to transplant-related factors, family functioning has also been posited as 
important to the QOL of children who have received liver transplants (Alonso et al., 
2008; Alonso et al., 2003). 
Family Functioning 
Family functioning in the present study is conceptualised as the frequency of 
disruption to usual family routines, effectiveness of family communication and 
problem solving, family cohesiveness, and how well family members get along 
(Fredericks, et al., 2007). Weisner, Matheson, Coote, and Bernheimer (2004) contend 
that engagement with consistent family routines is integral to a child’s wellbeing. 
Regular family routines teach children about individual and familial patterns of 
behaviour while establishing important developmental and social pathways. This 
offers opportunities of positive psychological experiences that contribute to self-
esteem, such as pleasure, attachment and competence. 
Focusing on the routines of a family provides valuable insight into the 
functioning of a family (Weisner, et al., 2004). A family’s ability to maintain daily 
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routines in the face of major crisis, such as a child undergoing liver transplantation, is 
an important indicator of family strength, cohesion and capacity to cope with stressful 
life events. Moreover, an analysis of family routines may inform areas of potential 
intervention and has meaningful implications for policy and clinical practice. As 
Bernheimer and Weisner (2007) state, it is futile to introduce an intervention that is 
incongruent with the daily routines of a family. Weisner and colleagues (2004) 
suggest that routines affect the wellbeing of all family members, with parents having 
to balance their goals and wishes for themselves and their children with available 
resources and limitations in a way that is congruent with their personal, cultural, and 
moral ethos. The competing interests and individual needs of children, common in 
families of pediatric liver transplant recipients, may interfere with parents’ capacity to 
establish regular family routines.  
Frequent change and unpredictable daily routines are unhelpful for children, and 
compromise the sustainability of family life (Weisner, et al., 2004). Gallimore, Coots, 
Garnier and Guthrie (1996) emphasised the importance of studying the functional 
accommodations made to sustain daily routines, and found that accommodations 
made by families of children with developmental delays are consistently associated 
with specific behavioural characteristics among children. Accommodation is defined 
as the adjustments made by a family in response to the demands of daily life, and 
include actions taken, avoided or delayed in an attempt to sustain a family routine 
(Gallimore, et al., 1996).  
Family functioning of pediatric transplant patients. The QOL of pediatric 
liver transplant patients has received widespread attention, yet the wellbeing of their 
families is less often investigated, leading Alonso and colleagues (2003) to call for 
better assessment of the effect of transplantation on family functioning. Following a 
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period of recuperation in hospital, most children return to the family home within 
weeks of transplantation. Despite the important role of the family and the home 
environment in the short- and long-term recovery after transplantation, there has been 
little investigation of the relationship between family functioning and pediatric 
transplant patients’ QOL. In addition to the emotional consequences of an ESLD 
diagnosis and undergoing the transplant process, parents must quickly begin to 
accommodate their ill child by reshaping daily family routines and reorganising 
resources, family activities, goals, and priorities (Weisner, et al., 2004). An 
understanding of the family environment to which children return following 
transplantation is integral, as a child’s understanding of health and wellbeing is 
shaped within the family context (Manificat, et al., 2003).  
An early study investigating the family routines of 35 pediatric kidney transplant 
recipients concluded that most families returned to normal family functioning within a 
year of transplantation. The study also found that diminished self-esteem among 
children was common, and children and their families feared organ rejection (Korsch 
et al., 1973). Despite this initial interest in the family functioning of transplant 
patients, several decades passed before any further research in this field was 
conducted.  
Other family-related factors of pediatric transplant patients have also been 
researched, including family cohesion and the impact of transplantation on marital 
relationships. Some studies report cohesion among family members of pediatric 
transplant patients to be slightly higher than the general population (Alonso, et al., 
2003), while others cite no difference (Fredericks, et al., 2007). Family cohesion has 
been shown to improve with time elapsed after transplantation (Cole, et al., 2004), 
and low levels of family cohesion are also associated with medication non-adherence, 
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which in turn relates to a significant increase in rejection episodes and hospital 
admissions (Fredericks, et al., 2007; Griffin & Elkin, 2001). The marital relationships 
of parents of pediatric liver transplant patients has also been studied: Kennard, Petrik, 
Stewart, Waller, and Andrews (1990) found that children from intact marriages were 
more likely to successfully adapt following transplantation, while Zitelli and 
colleagues (1988) reported that more than a third of divorced or separated parents of 
pediatric transplant patients claimed the stress of raising a chronically ill child 
contributed to marital discord. However, the results of this early study could be 
indicative of the lower survival rates and contemporary progress in pediatric 
transplantation, as substantial medical advances have been made since the 1980s.  
Two prominent studies have investigated separate aspects of the functioning of 
families of pediatric liver transplant patients. Alonso and colleagues (2003) assessed 
the frequency of activities engaged in by the families of 53 pediatric liver transplant 
recipients, concluding that transplant families participated in limited type and 
frequency of family activities compared to a community sample. Somewhat 
conversely, a larger multi-centre study of 102 patients at two years post-
transplantation reported that transplant families do not experience increased levels of 
family dysfunction (Alonso, et al., 2008). 
Several other studies have also investigated elements of family functioning. 
Fredericks, Lopez, Shieck, and Opipari-Arrigan (2007) measured the functioning of 
pediatric liver transplant patients’ families as part of a larger investigation of 
medication adherence and parental stress following transplantation. Defining family 
functioning in terms of cohesion among family members, results revealed no 
significant differences in the family functioning of transplant patients compared to 
published norms or children experiencing other medical illnesses. Similarly, 
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LoBiondo-Wood, Williams, and McGhee (2004) found no significant change in 
overall functioning of families of pediatric liver transplant patients from pre- to post-
transplant, as measured by the family’s adaptability to change. Further, Stone and 
colleagues (1997) concluded that families of children five to ten years post-
transplantation were participating in normal activities of daily living. The study also 
found that parents were pursuing hobbies and held normal levels of employment. 
Sokal (1995) found that children and families return to a normal life after 
transplantation and enjoy a markedly improved lifestyle, however, these findings 
should be interpreted with caution as the study did not feature any formal 
measurement of family functioning. 
Parents’ experiences of pediatric transplantation may also provide insight into 
family functioning. In a descriptive study, Gold, Kirkpatrick, Fricker, and Zitelli 
(1986) drew on comments from parents attending a hospital-based support group to 
investigate the impact of the transplantation process on parents of children who had 
received heart and liver transplants. Parents described transplantation as far from a 
panacea, defining it as a disease just like ESLD which impacts upon family 
functioning. The main psychosocial issues reported by parents were financial 
difficulties, adapting to new parenting roles, fear of organ rejection or death, and 
readjustment to family structure. Rodrigue and colleagues (1997) suggest that the 
daily adjustments required to accommodate a child post-transplantation may lead to 
severe parental depression and anxiety, especially for mothers who are most often 
primary caregivers. Mothers continue to experience high levels of parenting stress 
several months after transplantation, with demanding tasks such as dealing with 
medication noncompliance, arranging medical follow-up appointments, and enforcing 
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physical activity restrictions while also attending to the needs of other children 
(Rodrigue, et al., 1997).  
Parents of pediatric liver transplant patients also report stress related to ongoing 
medical care, disruption to family routine, and ongoing anxiety related to their child’s 
health (Alonso, et al., 2008). Similarly, an earlier study found significant amounts of 
parental stress among mothers of pediatric transplant recipients, and recommended 
psychosocial follow-up with parents for at least five years following transplantation 
(LoBiondo-Wood, et al., 2004). Parents have also been identified as playing a crucial 
role in maximising medication adherence among pediatric patients (Lurie et al., 
2000), and parents’ readiness for their child’s transition from hospital to home has 
been found to be associated with medication adherence, parent coping difficulty, and 
adherence to medical follow-up (Lerret & Weiss, 2011). This implicit connection 
between parent wellbeing and patient health behaviours further exemplifies the need 
to investigate family functioning, as parents are primarily responsible for the structure 
and organisation of family routines.  
Family Functioning and Quality of Life 
Previous research focusing on children with disabilities has identified an 
important relationship between QOL and family functioning (Gallimore, et al., 1996; 
Weisner, et al., 2004). However, this relationship has not been studied within the 
population of pediatric transplant patients, despite several studies focusing on the 
separate constructs of QOL and family functioning, as detailed in this chapter. Most 
notably, Alonso and colleagues (2003; 2008) investigated factors influencing the 
QOL and family functioning of pediatric liver transplant recipients, yet the 
association between the two variables was not directly tested. 
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While not explored within the pediatric transplant literature, the relationship 
between QOL and family functioning in other clinical populations has received a 
modicum of attention. A study investigating the QOL and psychosocial factors of 
adolescents with implantable cardioverter-defibrillators reported a significant 
correlation between QOL and family functioning, with the authors concluding that the 
adolescents’ QOL is more strongly related to family functioning than illness severity 
(DeMaso et al., 2004). An Australian study investigating the QOL of adolescents with 
cystic fibrosis also found that family characteristics of cohesion, conflict, and 
expressiveness to have a significant impact on QOL (Szyndler, Towns, van Asperen, 
& McKay, 2005). However, an investigation of 236 children with asthma failed to 
identify a significant relationship between asthma-related QOL and family 
functioning, but an association between family functioning and the child’s 
psychological wellbeing was found (Sawyer et al., 2001). No relationship between 
family functioning and QOL was found in a study of 52 adolescents with diabetes 
(Grey, Boland, Yu, Sullivan-Bolyai, & Tamborlane, 1998). Given these inconsistent 
findings, further investigation of the relationship between QOL and family 
functioning is warranted. 
Aims and Research Questions of the Current Study 
The aims of the current study were to investigate the QOL of liver transplant 
recipients, the way in which families adjust to accommodate children following liver 
transplantation, and to explore the relationship between family functioning and QOL. 
Five research questions were posed: 
1. Does the QOL of children who have received liver transplants differ from 
children in the community? 
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2. In which specific QOL areas do pediatric liver transplant recipients experience 
relative deficits? 
3. Does the family functioning of pediatric liver transplant recipients differ from 
other children in the community? 
4. Do family functioning and QOL improve with time-elapsed post-
transplantation? 
5. What is the relationship between family functioning and QOL of pediatric 
liver transplant recipients? 
Method 
Participants 
The parents/caregivers of 65 children participated in the study, representing two 
groups: families of pediatric liver transplant recipients (n = 32), and families of non-
transplant children (n = 33). Most respondents were mothers (61.5%) or fathers 
(30.8%), with a small number of grandparents responding. The average age of 
transplant recipients was 10.10 years (SD = 3.62), with 52% males and 48% females 
comprising the transplant group. Recipients were between 1.1 year and 12 years post-
transplantation (M = 5.31, SD = 3.44). Biliary artesia was the most frequent 
underlying disease precipitating transplant (52%), while other diagnoses included 
alpha-1 antitrypsin deficiency, omithine trans-caramylase (OTC) deficiency, 
fulminant liver failure, and metabolic liver disease. The average number of overnight 
hospital stays for the transplant group in the immediate six months prior to the study 
was 1.20 (SD = 2.27). The non-transplant group of children was slightly younger than 
the transplant group (M = 9.61, SD = 3.57) and comprised 65% males and 35% 
females.  
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Materials 
PedsQLTM 3.0 Transplant Module Parent Report.  The QOL of transplant 
recipients was measured using the PedsQLTM 3.0 Transplant Module Parent Report 
(Weissberg-Benchell, et al., 2010). Forty-six items encompass eight scales (with 
original and current study Cronbach’s α in parentheses, respectively): barriers to 
medical regimen adherence (.94; .85), medication side-effects (.77; .54), social 
relationships and transplant (.95; .84) physical discomfort (.71; .71), worries related to 
health status (.91; .95), anxiety regarding medical procedures (.88; .92), impact of 
transplant on appearance (.80; .81) and communication with medical personnel and 
others about transplant (.92; .87). An overall QOL rating is also derived (.94; .93). 
PedsQL™ 4.0 Parent Report for Children – Generic Core Scales. The QOL 
of non-transplant children was measured using the PedsQLTM 4.0 Parent Report for 
Children – Generic Core Scales (Varni, Seid, & Kurtin, 2001). Twenty-three items 
assess physical, emotional, social and school functioning, in addition to providing an 
overall QOL rating. Original internal consistency and reliability of the measure was 
high (.90). Cronbach’s α for overall QOL in the current study on overall QOL was 
low (.69). This measure has been found to correlate highly with the PedsQL 4.0 
Transplant Module (Weissberg-Benchell, et al., 2010), and was therefore deemed 
appropriate to provide comparisons between the groups. 
Family Accommodations Questionnaire. The Family Accommodations 
Questionnaire (FAQ) (Gavidia-Payne & Tainsh, 2007) was used to measure the extent 
to which families modify or adjust routines to accommodate their children. The FAQ 
was developed on the basis of an interview schedule by Gallimore and colleagues 
(1996), with most previous research investigating family accommodations being of a 
qualitative nature. The questionnaire was completed by both transplant and non-
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transplant families, with respondents asked to rate their agreement to each statement 
on a five point Likert scale. The FAQ comprises 27 items related to nine areas in 
which families may make adjustments to accommodate children (with Cronbach’s α 
for the current study in parentheses): work (.76), services (.70), the family home (.82), 
domestic workload (.86), childcare tasks (.60), assistance from others (.25), child peer 
groups, marital roles (.36), and parent information (.67). A total family functioning 
score is also derived (.90); higher scores indicate more adjustments to family routine, 
with a greater score reflecting less optimal family functioning. 
Qualitative comments. In addition to completing the QOL and family 
functioning measures, parents were invited to share their experiences regarding their 
child’s liver transplantation via a comments page included in the questionnaire pack. 
Procedure 
Approval for this study was obtained from the Royal Children’s Hospital 
(RCH), RMIT University, and the Department of Education and Early Childhood 
Development HRECs. All potential participants received a plain language statement 
detailing the purpose of the research, its aims, and the reason they had been 
approached to participate. An explanation of the voluntary nature of participation and 
participants’ right to withdraw from the study was also included. Written informed 
consent was obtained from parents/caregivers of all children and returned to the 
research team via reply-paid postage.  
Parents of children aged between 3 and 16 years who received a transplant at 
RCH’s Department of Gastroenterology between 1995 and 2010 were identified via 
the hospital’s Clinical Lookup and Results Acknowledgement (CLARA) medical 
records system. Eligible parents were mailed a letter introducing the study (Appendix 
H), followed two weeks later by a pack comprising an information sheet (Appendix 
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I), consent form (Appendix J), questionnaire (Appendix K), and reply-paid envelope. 
A follow-up phone call was made to families who did not return the questionnaire 
within three weeks. A total of 55 transplant families were invited to participate, with a 
return rate of 32 respondents (58%). Patient confidentiality and anonymity were 
assured by all communication with participants and return of surveys being managed 
by a member of the research team who has access to patient records as part of her 
usual employment at RCH. Any identifying information, such as names, was removed 
from the questionnaires prior to data analysis, and consent forms were stored in a 
separate location from questionnaires. In accordance with the procedure of the RCH 
HREC, all families who were invited to participate in the study received a plain-
language summary of results at the conclusion of the study (Appendix L). 
Families of non-transplant children were recruited in collaboration with a 
separate research project conducted through RMIT University. Following approval 
from school principals of primary and secondary schools, packs comprising a plain 
language statement (Appendix M) and set of questionnaires (Appendix N) was 
distributed to parents inviting them to participate in the study. Families from the non-
transplant group who reported a serious childhood illness were not eligible to 
participate. Thirty-three of seventy questionnaire packs were returned, yielding a 47% 
response rate. 
Results 
Preliminary Data Analysis 
Data were analysed using SPSS version 18.0. Prior to data analysis being 
performed, two cases from the transplant group were removed from the sample, as 
they were missing more than 30% of data on at least one scale. Missing values of 
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remaining cases were replaced with the sample mean for that variable, thus providing 
a complete dataset. 
Examinations of the assumptions of normality, homoscedasticity and linearity 
were conducted on the QOL variables. Diversion from normality was detected among 
the following variables: healthy population physical QOL, healthy population social 
QOL, healthy population social QOL; transplant medicines, physical discomfort, 
worries related to health status, anxiety regarding medical procedures, impact of 
transplant on appearance, and communication with medical personnel and others 
about transplant. Variables were not transformed, as variables primarily used for 
analysis, including overall QOL for both transplant and healthy populations, satisfied 
normality requirements, and skewness was expected among variables as previous 
research has identified QOL to generally be rated high among clinical and healthy 
populations. 
Examination of the family functioning scores also revealed deviations from 
normality amongst all variables with the exception of total score, and subscales for 
work, services and marital roles. Transformation did not improve normality of the 
skewed variables, and no further alterations to data were made as skewness of 
variables was expected and the analyses used are robust to normality violations. 
Several multivariate outliers were identified (Mahalanobis’ Distance = p < .05), 
however, the outlying cases were retained in the dataset as the original and 5% 
trimmed means were very similar. No multicollinearity or singularity between 
variables was detected. 
Qualitative data provided via written comments from parents was analysed for 
common themes and given a descriptive label. As less than half the parents from the 
relatively small sample size provided comments, it was deemed suitable to manually 
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identify common themes in place of using formal qualitative data analysis techniques 
(Pallant, 2002). 
Quality of Life Differences Between Transplant and Non-Transplant Children 
An independent samples t-test was conducted to compare the overall QOL 
scores of transplant and non-transplant children. Equal variances were not assumed 
(Levene’s <.001). Results indicated a statistically significant difference in QOL 
scores between transplant (M = 77.79, SD = 13.45) and non-transplant children (M 
=87.32, SD = 6.16), t(39.82) = -3.56, p = .001, η2 =.06. 
Transplant Patients’ Quality of Life and Transplant-Specific Quality of Life  
Caregiver reports of their child’s QOL varied across transplant-specific QOL 
areas. Figure 6 represents caregivers’ ratings of their child’s experiences with 
transplant-related QOL variables. Higher mean scores on each subscale indicate better 
QOL related to that area. The 95% confidence interval corresponding to each variable 
indicates the variance of responses to the subscale, with smaller confidence intervals 
indicating less variability. Scores were highest for QOL associated with medicine-
related side effects (M = 90.93, SD = 10.68) and lowest for QOL associated with 
anxiety about treatment (M = 67.29, SD = 27.84).  
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Figure 6. Parent ratings of pediatric liver transplant recipients’ transplant-related 
areas of QOL 
 
Correlational analyses, summarised in Table 10, indicated significant and strong 
positive relationships between overall QOL and pediatric liver transplant recipients 
and several QOL areas, as measured by the PedsQL Transplant Module. Significant 
positive associations were found between QOL and all variables except for 
communication, indicating that overall QOL increases as scores rise in any one of 
these transplant-specific areas. Conversely, patients’ ease of communication, such as 
being able to understand doctors’ explanations or ease with telling others about the 
transplant, was not associated with QOL benefits. 
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Table 10 
Intercorrelations Between Transplant Patients’ Quality of Life and Quality of Life 
Variables (N = 30) 
 
 QOL MI MII TO PH W TA PA C 
QOL 
 
-         
Medicines I 
(MI) 
.68** -        
Medicines II 
(MII) 
.64** .29 -       
Transplant and 
others (TO) 
.87** .54** .53** -      
Pain and hurt 
(PH) 
.58** .21 .30 .56** -     
Worry (W) .78** .37* .54** .61** .48** -    
Treatment 
anxiety (TA) 
.57** .17 .45* .32 .16 .45* -   
Physical 
appearance 
(PA) 
.64** .36 .30 .64** .38* .36* .25 -  
Communication 
(C) 
.19 .17 -.21 .16 .18 -.23 .06 .20 - 
Note: **p <.01.  *p <.05. 
 
Family Functioning of Transplant and Non-Transplant Children 
A significant difference was detected in the overall functioning of transplant 
and non-transplant families, as measured by the FAQ (Gavidia-Payne & Tainsh, 
2007), t(61) = 2.28, p = .026. The magnitude of the difference was moderate (η2 = 
.07). More alterations to family routines to accommodate children were reported by 
transplant families (M = 68.93, SD = 18.25) in comparison to non-transplant families 
(M = 59.15, SD = 15.78). 
Mean scores on the FAQ subscales, summarised in Table 11, indicate that 
transplant families made more adjustments in all areas except for seeking information 
related to caring for children. However, a one-way between groups MANOVA 
revealed the only difference to reach statistical significance, using the Bonferroni 
adjusted α level of .006, was childcare, F(1, 61) = 8.18, p = .006; η2 = .19. As detailed 
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in Table 11, transplant families reported making significantly more adjustments to 
childcare arrangements than non-transplant families. 
 
Table 11 
Two-Way Multivariate Analysis of the Functioning of Transplant and Non-Transplant 
Families 
 
 
 
 
 
  
 
 
 
 Group 
Transplant Non-transplant 
 
FAQ subscale 
 
df 
df 
error 
 
F 
η
2
 p 
value 
M (SD) M (SD) 
Work 1 61 1.90 .030 .173 2.87 (1.04) 2.54 (.84) 
Services 1 61 2.26 .036 .138 2.52 (1.08) 2.12 (1.04) 
Home & community 1 61 6.42 .095 .014 2.07 (.94) 1.54 (.69) 
Domestic workload 1 61 7.56 .110 .008 2.21 (1.08) 1.55 (.80) 
Childcare 1 61 8.18 .118 .006* 2.63 (1.20) 1.85 (.98) 
Assistance 1 61 5.33 .080 .024 2.45 (.90) 1.92 (.90) 
Child peer groups 1 61 4.99 .076 .029 2.73 (1.41) 2.03 (1.07) 
Marital roles 1 61 4.65 .071 .035 3.38 (.80) 2.97 (.73) 
Parent information 1 61 3.19 .050 .079 2.70 (.77) 3.05 (.80) 
*significant at Bonferroni adjusted level of .006. 
 
Post-Transplantation Associations between Family Functioning and Quality of 
Life 
Correlational analyses were used to investigate improvements in family 
functioning and QOL over time post-transplantation. No relationship was detected 
between time since transplant and QOL, r (n = 30) = -.311, p = .094. To further 
investigate the relationship between time since transplant and QOL, the transplant 
recipients were separated into two groups according to time elapsed since 
transplantation (1-6 years, 7-12 years). Results of an independent t-test showed no 
significant differences in the QOL of the 1-6 years group (M = 79.42, SD = 14.13) 
and the 7-12 years group (M = 73.30, SD = 10.93), t (28) = 1.10, p = .28, η2 = .008.   
A moderate positive correlation was found between family functioning and 
QOL, r (n =30) = -57, p = .01, indicating that less adjustments to family routines are 
associated with QOL improvements. Family functioning improves with time since 
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transplant, r (n = 30) = .395, p = .031. Family functioning and QOL ratings derived 
from this small sample are depicted in Figure 7. 
 
 
Figure 7. Pediatric liver transplant patients’ post-transplantation QOL and adjustment 
to family routine 
 
Qualitative Data 
Parents’ qualitative responses are summarised in Table 12. Several parents 
commented on the improvement in family functioning from pre- to post-
transplantation, noting that their responses would have been vastly different at pre-
transplantation. Parents also commented on employment difficulties and the impact of 
the transplantation process on the parents’ marriage. Anxiety about ongoing medical 
problems was exemplified by a father’s concerns of his son having to return to the 
waitlist should he require another transplant. Two parents commented on how 
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transplantation at an early age was associated with good outcomes. Lastly, 
appreciation of the care provided by RCH was also expressed.  
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Table 12 
Qualitative Responses From Parents of Pediatric Liver Transplant Recipients. 
Theme Respondent Response 
Pre- to post-transplant 
  family functioning 
Mother of 8-year-old girl 
 
Mother 
 
Mother 
“…prior to the transplant it was a very different story and under the family accommodations questions 
almost all answers would have been at the other end of the scale.” 
“Had we been responding back [pre-transplant] our responses would have been swayed towards the 
extreme end of the spectrum, as medical outlook was quite dire months on end.” 
“We dropped everything to care for her in the same way most liver families do.” 
 
Employment Mother of 13-year-old boy 
 
Father of 14-year-old boy 
“I myself is a single parent who brought [child] up, from the age of 4 till transplant, and still now at the 
age of 13. I gave up work for two years after transplant and went through 5 rejections.” 
“My wife can’t work (14 years) due to our son’s illness. I have to work two jobs – one full time, one part 
time.” 
 
Marital problems Mother of 4-year-old boy [Child]’s diagnosis was the trigger for marriage breakdown.” 
 
Anxiety about ongoing 
  medical problems 
Father of 14-year old boy 
 
Mother of 4-year-old boy 
Mother of 12-year-old girl 
“If we have to go through another liver transplant give us some concessions in regarding to waiting list 
priorities.” 
“[Child} has issues with sleeping, lack of appetite and eczema.” 
“…as always the day of transplant and following months are still very raw in our minds.” 
 
Transplantation at early 
  age 
Mother 
 
Father of 8-year-old boy 
“[Child] had his transplant at 18 months old in 2002. Therefore it’s been quite a while and he has learned 
that this is part of his life.” 
“No bother, [child] is only 8 and he had it when he was 10 months old so he doesn’t really know any 
different.” 
 
Experience with 
hospital 
Mother of 5-year-old girl 
 
 
Father of 12-year-old girl 
“My experience with RCH was a positive one – the specialists go above and beyond their duties and all 
supporting staff have been amazing in their care, duties and professionalism. Social workers give great 
advice and often organise and assist you in organizing respite etc to make the continuing journey easier.” 
“Have the support group run by the hospital.” 
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Discussion 
The QOL and family functioning of liver transplant recipients has thus far been 
investigated as separate concepts. A number of studies have examined the QOL of 
young liver transplant patients, with less attention paid to role of family in the post-
transplantation experiences of children. With these areas of previous research in mind, 
the aim of the current study was to investigate the relationship between the QOL and 
family functioning of pediatric liver transplant recipients. Comparisons of the QOL of 
pediatric transplant recipients and other children were also investigated. In order to 
achieve a better understanding of the unique experiences of pediatric transplant 
recipients, the current study also explored the transplant-specific factors associated 
with the QOL of young liver recipients. Findings that the transplantation process is 
associated with relative deficits in both QOL and family functioning suggest a need to 
better understand factors related to the family life of transplant recipients. 
Quality of Life of Transplant and Non-Transplant Children  
Significant differences were observed in parents’ ratings of the QOL of 
pediatric liver transplant recipients and other children in the community. The QOL of 
children who had received a liver transplant was rated as significantly lower than the 
QOL of non-transplant children. This finding is congruent with conclusions drawn 
from several previous studies (Avitzur, et al., 2004; Bucuvalas, et al., 2003; Midgley, 
et al., 2000; Zamberlan, 1992), and the QOL scores obtained for both transplant and 
non-transplant samples are comparable with previous research (Weissberg-Benchell, 
et al., 2010).  
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While the results of the current study support some previous research, findings 
differ from the only other investigation of the QOL of Australian pediatric liver 
transplant recipients (Chin, et al., 1991). Chin and colleagues (1991) reported 
comparable QOL of transplant recipients to other children in the community. A 
possible explanation for this incongruence in findings is the operationalisation and 
measurement of QOL in the earlier study; VABS is designed to measure a person’s 
adaptive level of functioning and assesses communication, daily living, and 
socialisation. Psychological functioning, considered an integral element of QOL, is 
not measured with the VABS. It has not been validated as an adequate measure of 
QOL and does not usually feature in studies of QOL. Current results are also not 
reflective of Taylor and colleagues’ (2005) conclusion of no significant differences in 
the QOL experienced by children who have received liver transplants and other 
children in the community.  
The significant difference in QOL experiences of transplant and non-transplant 
children identified in the current study may be a reflection of the ongoing health 
difficulties and lifestyle restrictions faced by children who have received liver 
transplants. Although a life-saving procedure, it must be remembered that pediatric 
transplant recipients were previously seriously unwell with ESLD to the point at 
which they would not have survived without a transplant. Furthermore, although 
transplantation has benefited from major medical advances, it remains major surgery 
after which significant recovery time is required. Similar to other transplant 
recipients, it is likely that the pediatric liver transplant recipients in the current study 
experience ongoing health difficulties and must adhere to a daily medication regimen. 
As such, the current findings also support the conceptualisation of QOL as a 
subjective construct that is independent of physical health. 
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As parent-proxy was used to assess children’s QOL in the current study, results 
may be reflective not only of children’s QOL, but also parental experiences. Parents 
accompany their children through ESLD and the traumatic experience of 
transplantation, and the impact of such stress on parents is well documented 
(Rodrigue, et al., 1997). One parent’s comment that “the day of transplant and 
following months are still very raw in our minds” illustrates that even if a child is too 
young to completely remember their illness and subsequent transplant, parents are 
unlikely to forget the extent of their child’s illness and the trauma of the 
transplantation process. This in itself has implications for the study of QOL, and 
suggests that the QOL of families should also be investigated. Further consideration 
of the limitations around the use of parent-proxy reports is detailed later in this 
chapter.  
Results of the current study also support the notion that although the QOL of 
pediatric liver transplant recipients is not usually comparable to other children in the 
community, they are able to achieve good QOL outcomes (Alonso, et al., 2003; 
Midgley, et al., 2000). This point is highlighted by comparisons of transplant 
recipients’ QOL to that of children experiencing other chronic illnesses. The average 
score of parent-proxy reports of transplant children’s QOL in the current study 
(77.79) is similar or better than that of diabetes (76.56) (Varni et al., 2003), pediatric 
cancer (72.20) (Varni, Burwinkle, Katz, Meeske, & Dickinson, 2002), asthma (72.44) 
(Varni, Burwinkle, Rapoff, Kamps, & Olson, 2004), and arthritis (70.97) (Varni et al., 
2002). This suggests that although transplant recipients’ QOL is unlikely to reach the 
level of other children in the community, it appears their enjoyment of life is 
comparable to children experiencing other health difficulties. Recent research has also 
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noted similarities between the QOL of children who have undergone liver 
transplantation, renal transplantation, and cancer treatment (Limbers et al., 2011).  
Results of the current study suggest wide variation in the QOL experiences of 
individual transplant patients. The wide variety in QOL experiences of pediatric liver 
transplant patients, as indicated by the substantial standard deviation in scores, is 
consistent with previous research (Weissberg-Benchell, et al., 2010). This indicates 
that while some children’s QOL is rated highly and may in fact reach a comparable 
level of non-transplant children, other children are experiencing a QOL below that of 
their transplant peers and far below that of other children in the community. As 
comparable wide variability of QOL was not observed in the non-transplant group of 
the current study, it may be speculated that such vast differences in the QOL of 
transplant recipients is related to transplant-specific factors. Further research is 
required to identify the relationship between transplant-specific factors and the QOL 
of young transplant patients. 
Transplant-Specific Quality of Life 
Few studies have investigated specific transplant-specific factors, such as 
medication and pain, in relation to the QOL of transplant recipients. The results of the 
current study demonstrate the long-term implications of transplantation on the daily 
lives of young transplant recipients, and suggests that consideration of such factors 
leads to a more comprehensive understanding of the life experiences of young people 
following organ transplantation. Overall, parents of pediatric transplant patients in the 
current study reported children to experience good QOL related to medication 
adherence and side effects, physical appearance, and physical discomfort. Less 
optimal QOL was reported in relation to anxiety about ongoing treatment and peer 
relationships. 
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Medication. Medication is a routine aspect of daily life for transplant patients. 
While medication doses are reduced with improved health and time elapsed post-
transplant, the majority of liver transplant recipients must remain on medication for 
the remainder of their lives (Burra & De Bona, 2007). Possible side effects of 
immunosuppressive medications prescribed after liver transplantation include changes 
in mood, hair loss or hair growth, bone and muscle weakness, stunted growth, nausea, 
vomiting, and diarrhea. Despite life-long medication that may have numerous side 
effects, the young people in the current study were reported to experience the best 
QOL in relation to medication side effects, implying that they are not concerned by 
adverse consequences of medication. This is consistent with previous research in 
which parents of liver transplant recipients identified their children as experiencing 
minimal problems related to medication side effects (Weissberg-Benchell, et al., 
2010).  
Parents of transplant recipients also reported good QOL related to adhering to a 
medication regimen. This is consistent with previous research (Weissberg-Benchell, 
et al., 2010), and also congruent with findings of qualitative research conducted with 
child and adolescent transplant recipients. One child in a previous study likened the 
daily routine of taking medication as ‘just like brushing your teeth’ (R. M. Taylor, et 
al., 2010). It may be that despite the annoyance of a daily medication regimen, the 
perceived burden is less than that of the types and amounts of medication required 
during ESLD and immediately post-transplantation. When considered in the context 
of the extensive surgical and medical histories and severe ESLD experiences endured 
by these children, the requirement of daily dosages of medication may be viewed as a 
relatively small encumbrance. 
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Treatment anxiety. Parents reported that ongoing anxiety about treatment 
impacted most upon pediatric patients’ QOL, indicating that children are most 
worried by ongoing visits to the doctor or hospital, injections and needles, and 
medical procedures. This may be because of the physical discomfort associated with 
procedure, or that continued treatment serves as a painful reminder of ESLD and the 
transplantation process.  
Despite prevalent anxiety about treatment being clearly identified in the current 
study and previous quantitative research (Weissberg-Benchell, et al., 2010), this issue 
has not been widely investigated in other studies. Procedural pain was identified as 
salient to the QOL by several young transplant recipients in Wise’s (2002) study, with 
needles, blood drawing and insertion of nasogastric tubes labeled as frightening parts 
of the hospital experience. Information regarding children’s ongoing worries about 
treatment may inform decisions to make medical procedures brief and infrequent, and 
inform parents and children of the treatment rationale. The delivery format of this 
information is also known to effect children’s and families’ perceptions of medical 
interventions. Previous research has hypothesised that avoidance and anxiety around 
ongoing treatment among pediatric liver transplant recipients is symptomatic of post-
traumatic stress disorder (PTSD) (Shemesh et al., 2000). While most children 
experience anxiety about medical procedures, special attention should be paid to 
children experiencing heightened levels of anxiety following transplantation, as this 
may be evident of greater psychological concerns. Other cognitive and behavioural 
interventions to help children cope with painful procedures may also be useful, 
together with education to inform parents of strategies to best prepare children for 
such procedures (McCarthy, Cool, Petersen, & Bruene, 1996).  
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Peer relationships. Peer relationships were identified as a prevalent concern in 
the lives of pediatric liver transplant recipients. Parents strongly endorsed 
questionnaire items related to others treating their child differently because of illness, 
others not understanding what they have been through, feeling left out, and having 
difficulty talking to others about their illness or transplant. The experiences of the 
children in the current study correspond to those reported in previous studies; liver 
transplant recipients often report difficulty socialising with other children, feelings of 
loneliness, and a desire to not be perceived as different from other children, especially 
upon return to school after a long absence (R. M. Taylor, et al., 2010; Wise, 2002; 
Zamberlan, 1992).  
Results of the current study also provide tentative support to previous studies’ 
speculation of the relationship between young transplant recipients’ physical 
appearance and peer relationships (R. M. Taylor, et al., 2010; Wise, 2002). 
Correlation analyses in the current study indicated that children who experienced 
minimal concerns about physical appearance related to transplantation, such as 
scarring or being embarrassed by others seeing their body, were most likely to 
experience good QOL related to peer relationships. 
Transplant-specific factors and quality of life. Correlational analyses 
identified significant associations between pediatric transplant recipients’ QOL and 
several transplant-related factors. Most saliently, children who had good peer 
relationships were more likely to achieve good QOL outcomes. This preliminary 
finding supports and extends upon previous research by identifying transplant-specific 
factors that are associated with pediatric recipients’ difficulties with peer relations 
(Alonso, et al., 2003; Tornqvist, et al., 1999). Furthermore, children who worried 
about transplant-related issues such as organ rejection and medication were least 
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likely to experience optimal QOL, suggesting the need for clear age-appropriate 
communication with children about transplantation and their current health status. 
Consistent with Fredericks and colleagues’ (2007) finding of medication non-
adherence being related to lower QOL, results of the current study also identified a 
significant association between transplant recipients’ overall QOL and good 
adherence to medication. Whilst causal relationships cannot be demonstrated in the 
current study, these preliminary findings indicate potential areas of future research 
that may ascertain the relative contribution of each of these transplant-related factors 
to pediatric liver transplant recipients’ QOL. Focusing on QOL may be important for 
increasing treatment adherence, and therefore physical health outcomes.  
Family Functioning 
The family functioning of pediatric transplant patients has received scant 
attention in pediatric transplantation literature despite recognition of the important 
role of parents and immediate family members in a child’s recovery following 
transplantation (Fredericks, et al., 2007; Lurie, et al., 2000). The current study 
identified substantial differences in the family functioning of transplant and non-
transplant families, with the families of pediatric liver transplant recipients making 
significantly more adjustments to family routines to accommodate their children.  
Results of the current study support Alonso and colleagues’ findings of 
transplant families experiencing limited type and frequency of family activities 
(2003). However, these findings are contrary to most previous investigations of the 
family functioning of pediatric transplant patients, and refute the early claim by 
Korsch and colleagues (1973) that family life returns to normal following pediatric 
transplantation. Alonso and colleagues’ (2008) conclusion of no difference in the 
family functioning of transplant and non-transplant families is not supported. 
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However, it should be noted that the difference in findings may be due to the distinct 
conceptualisations of family functioning between studies. Furthermore, while the 
current study did not compare the family functioning of families pre- and post-
transplant, anecdotal evidence drawn from parents’ comments suggest the difficulties 
experienced by families with a child awaiting transplantation (Fredericks, et al., 2007; 
LoBiondo-Wood, et al., 2004; Stone, et al., 1997): “we dropped everything to care for 
her in the same way most liver families do”, “had we been responding back [pre-
transplant] our responses would have been swayed towards the extreme end of the 
spectrum”, and “prior to the transplant it was a very different story and under the 
family accommodations questions almost all answers would have been at the other 
end of the scale.” 
Childcare. Parents of pediatric liver transplant recipients reported most demand 
on childcare resources, citing increased need to monitor their child and increased need 
for transportation. The current study is the first to formally identify experiences with 
childcare as a significant difference in the functioning of transplant and non-transplant 
families. This finding emphasises the importance of promoting and supporting 
families post-transplantation. Other factors not explored in this study, such as family 
structure and resources (e.g., financial), as well as parents’ coping strategies, may 
shed further light on how best to support families with childcare difficulties in the 
post-transplantation period. 
Other areas of family functioning. In addition to childcare, several other areas 
of family functioning were investigated in the current study. No significant 
differences were observed between transplant and non-transplant families in the areas 
of employment, services, domestic workload, assistance from others, child peer 
groups, marital roles, or parent information. However, it is noteworthy that parents of 
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liver transplant recipients reported making more accommodations in all areas except 
for parent information, indicating they received adequate information related to their 
child’s health and wellbeing and did not seek out further material. Further, given the 
current study’s small sample size and the likely lack of adequate statistical power to 
detect small differences, the trend of results indicates possible differences to the 
adjustments made by transplant and non-transplant families in the areas of domestic 
workload, assistance from others, and child peer groups. Potential changes made to 
parent relationships and marital roles following pediatric transplantation are aptly 
illustrated by a parent’s comment that her child’s ESLD diagnosis “was the trigger 
for marriage breakdown.” Two comments on the impact of children’s transplantation 
on employment appear to oppose Stone and colleagues’ finding that parents return to 
normal levels of employment following transplantation (Stone, et al., 1997): “I gave 
up work for two years after transplant and went through 5 [organ] rejections”, and 
“my wife can’t work (14 years) due to our son’s illness. I have to work two jobs – one 
full time, one part time.”  
Improvements in Quality of Life and Family Functioning Across Time 
The current study found that QOL improvements are not associated with time-
elapsed post-transplantation. No significant differences were detected between the 
QOL of recipients transplanted 1-6 years ago and 7-12 years ago. However, current 
results show that QOL fluctuates over time following transplantation. This may 
reflect other factors not considered in the current study, including medical stability or 
pre-morbid levels of illness. It may be that QOL plateaus at a certain point in time, 
and lends support to previous findings of rapid QOL benefits being experienced in the 
short-term follow transplantation (Cole, et al., 2004). While it is widely accepted that 
QOL improves from pre- to post-transplant (R. Taylor, et al., 2005), these results are 
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somewhat contrary to Avitzur and colleagues’ finding of the excellent QOL of 
patients ten years after liver transplantation (Avitzur, et al., 2004). 
As expected, the trend of results indicates that families make fewer adjustments 
to routines as time elapses after transplantation. However, the families of patients 
most years post-transplant actually report making more adjustments in comparison to 
those whose child has recently experienced transplantation. As our sample is small 
this may reflect an anomaly in the experiences of a small number of transplant 
families, or may be indicative of a family fatigued after many years of caring for a 
child with a chronic illness. Further research regarding this finding is warranted.  
Relationship Between Quality of Life and Family Functioning 
The current study is the first to directly investigate the relationship between 
QOL and family functioning of pediatric transplant recipients. Results showed an 
association between improved QOL and fewer adjustments to family routines, 
implying that improvement after transplantation may be associated with a child’s 
interaction with the home environment and other family members. This supports the 
hypothesis that adjustments made to family routines is associated with children’s 
wellbeing (Gallimore, et al., 1996; Weisner, et al., 2004), and extends established 
findings of the impact of family functioning on the QOL of children with disabilities 
to organ transplant patients.  
The finding of a significant relationship between family functioning and QOL is 
congruent with two previous investigations of adolescents with cystic fibrosis and 
heart conditions (DeMaso, et al., 2004; Szyndler, et al., 2005), but show 
inconsistencies with previous studies that found no association between the QOL and 
family functioning of children with asthma and diabetes (Grey, et al., 1998; Sawyer, 
et al., 2001). However, it should be noted that such differences might be due to the 
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differences in measures. With preliminary findings of the current study suggesting 
that interventions aimed at providing stable family routines may improve QOL for 
children who have received liver transplants, further research is required to reach a 
better understanding of the inextricable link between QOL and family functioning. 
Such research may inform interventions or the provision of resources to families so 
that they can sustain healthy family routines with accommodating the needs of unwell 
children. 
Limitations of the Current Study and Directions for Future Research 
Several methodological issues limit the conclusions that may be drawn from 
this study. Firstly, this single centre study reflects the unique experiences of liver 
transplant patients from one location in Melbourne, Australia. Participants were at 
different stages of post-transplantation, and it was beyond the scope of the current 
study to control for ongoing medical complications that may impact QOL and family 
functioning. The relatively small sample size derived from the single centre restricted 
the ability to conduct mediation or predictive analyses. The correlational analysis 
used in this study does not allow conclusions to be made about the causal nature of 
the relationship between transplant-specific factors and pediatric transplant patients’ 
QOL. However, it informs several areas of research requiring further investigation 
with larger sample sizes, including young transplant patients’ experiences with peer 
relationships, anxiety about treatment, and medication adherence and side effects. 
Parental assessment was used in this study; while parent insights into family 
functioning are appropriate, previous investigations have indicated difficulties with 
parent-proxy assessment of QOL. Parents of children with chronic illness have been 
found to over-estimate their child’s difficulties (Burra & De Bona, 2007). Tornqvist 
and colleagues (1999) reported that parental concerns and anxieties adversely 
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influenced ratings of their child’s competences, and transplant children have indeed 
been found to rate their QOL as slightly higher than parents’ ratings (Weissberg-
Benchell, et al., 2010). While several studies point to good agreement between parent 
and child reports of QOL and satisfactory conclusions being drawn from parent-proxy 
reports, (Eiser & Morse, 2001; Herjanic, Herjanic, Brown, & Wheatt, 1975; Jokovic, 
Locker, & Guyatt, 2004; Theunissen et al., 1998), future research should ideally 
include the additional perspective of pediatric transplant recipients. Future research 
should also consider the impact of demographic variables on QOL and family 
functioning, as previous research has demonstrated differences in family functioning 
due to characteristics such as socioeconomic status (Alonso, et al., 2008). 
The rate of participation from transplant families in the current study was 
adequate given the single-centre design, however, lack of information about the 
transplant and non-transplant families who declined to participate limits the 
generalisability of findings. Not having the time or capacity to complete and return 
the questionnaire may be an indication of parental stress or inconsistent family 
routines. Alternatively, parents who have concerns for their child’s QOL or the 
wellbeing of their family may have been attracted to participate in the study, possibly 
resulting in a biased sample. Investigation of the demographic characteristics of 
families and medical history who chose not to participate may identify families 
requiring assistance.  
Further opportunities for research in this area of burgeoning interest are 
plentiful. The brief qualitative responses from parents point to interesting hypotheses 
regarding parents’ experiences of transplantation, the impact of pediatric 
transplantation on marriage and employment, and, most pertinently, difficulties with 
gaining appropriate childcare following transplantation. Furthermore, differences in 
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maternal and paternal perceptions of children’s QOL could be investigated. Given the 
wide variability of responses relating to pediatric patients’ QOL, further qualitative 
research would be well placed to investigate the individual experiences of transplant-
related QOL, and quantitative analysis could be used to further explore factors such as 
medical stability that may contribute to recipients’ wellbeing.  
The inclusion of a group of families whose children are currently on the waiting 
list to receive a liver transplant would provide additional information regarding the 
needs of families across the spectrum of pediatric ESLD and liver transplantation. 
Further investigations of family functioning could include explorations of siblings’ 
QOL, as illness and disability impacts upon the experiences of all family members 
(Davis & Gavidia-Payne, 2009). 
Concluding Comments 
The current study has demonstrated the importance of considering family 
functioning when evaluating the QOL of young recipients of liver transplantation. 
Results point to the ongoing challenges faced by pediatric liver transplant recipients 
and their families in the years after transplantation. The QOL of children who receive 
a liver transplant does not reach the same levels of other children, with anxiety about 
ongoing treatment a pertinent concern. This cross-sectional study has also shown the 
significant impact of the transplantation process on families; families make great 
adjustments to accommodate children following transplantation, and find childcare 
especially challenging. The preliminary findings of this study substantiate the need 
for further research to investigate the relationship between QOL and family 
functioning, and implore the need for greater psyhosocial assessment and intervention 
aimed at increasing the functioning of pediatric transplant patients’ families.  
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Chapter 5  
General Discussion 
Quality of life is a heavily researched area within the field of organ 
transplantation, however a strong focus on the general measurement and 
quantification of the QOL of transplant patients has resulted in a lack of attention 
afforded to other aspects of QOL and transplantation. As such, theoretical models 
used to conceptualise QOL and the way in which health professionals perceptions and 
family functioning may impact the lives of transplant patients have received scant 
attention. The aim of this thesis, therefore, was to provide a comprehensive 
investigation of QOL in the field of organ transplantation. Taken together, the 
findings of the three studies provide an overview of the current standing of QOL 
research, and contribute unique knowledge to a growing body of literature dedicated 
to the psychosocial aspects of organ transplantation. The worth of broadening the 
scope of organ transplantation QOL research has been demonstrated by exploring 
QOL from several perspectives and methodological frameworks. Insights from 
transplant patients, health professionals, and the families of pediatric transplant 
patients have contributed to a holistic understanding of this area of research.  
Summary of Findings 
The investigation of the relationship between stress, coping, and QOL presented 
in Study 1 brought together several concepts that have previously been studied as 
separate constructs in the organ transplantation literature. This study built on past 
research that has consistently shown differences between the QOL of transplant 
candidates and recipients, and was the first to explore transplant patients’ QOL using 
the crisis theory model (Moos & Schaefer, 1986). In findings that supported previous 
research, the overall QOL of transplant candidates was found to be significantly lower 
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than that reported by transplant recipients and non-transplant individuals. However, 
differences among the QOL domains was not entirely commensurable with previous 
research, with the trend of results indicating that recipients experience better 
psychological QOL than non-transplant individuals. Overall, this study showed that 
the QOL of transplant patients can be explained in terminology consistent with crisis 
theory: patients who have survived the crisis of end-stage organ failure and the 
process of transplantation appear to have developed coping skills that enable them to 
adequately manage stressful life events following transplantation. While transplant-
related stress was not found to impact upon transplant patients’ QOL, findings 
revealed that transplant patients contend with a variety of transplant-related issues, 
including financial stressors, problems with interpersonal relationships, and concerns 
about future health. Transplantation does not completely eliminate stress, nor is it a 
panacea for the QOL problems of all transplant patients. However, the findings of this 
study add to a convincing body of research supporting transplantation as a viable 
option that has the potential to not only extend the life expectancy of individuals with 
end-stage organ failure, but also to improve QOL. 
Study 2 sought to further broaden the scope of QOL research in the field of 
organ transplantation by investigating QOL issues from the perspective of health 
professionals. Results of this exploratory study revealed inconsistencies between 
health professionals’ attitudes towards QOL and their use of QOL information. Health 
professionals’ largely positive regard for QOL issues was incongruent with behaviour 
related to assessment and information. Findings suggest that a number of factors may 
be important to health professionals’ use of QOL information in clinical practice, 
including lack of training with QOL issues, lack of familiarity with QOL measures, 
and difficulty understanding and applying published research findings. While further 
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research is needed to clarify and extend upon the preliminary findings of this study, 
the overall positive attitude of health professionals towards QOL seems to suggest 
that QOL is currently accepted as an important construct in organ transplantation 
research and practice.  
Study 3 explored a novel aspect of QOL that has received scant attention in the 
organ transplantation literature. The QOL experiences of young transplant patients 
were explored through an investigation of the family functioning and wellbeing of 
pediatric liver transplant recipients. With the home environment posited as important 
to the medical and psychosocial wellbeing of young children following organ 
transplantation (Alonso, et al., 2008), this study sought to examine the QOL of 
pediatric transplant patients and the way in which family routines are adjusted in 
order to accommodate children following transplantation. The QOL of children with 
transplants was found to be significantly lower than that of their non-transplant peers, 
suggesting that ongoing QOL issues remain for young liver transplant recipients. 
Findings of an association between reduced adjustments to family routines and 
improved QOL demonstrate the need to consider the home environment and family 
routines in relation to pediatric transplant patients’ QOL.  
Theoretical Implications 
Despite decades of research focused on the QOL of transplant patients, Study 1 
of this thesis was the first to use a theoretical framework to explore ubiquitous 
findings of low QOL among transplant candidates and comparable QOL between 
transplant recipients and non-transplant individuals. In addition to demonstrating that 
the QOL of transplant patients can be explained by crisis theory, the findings provide 
empirical support for the theoretical underpinnings of the construct of QOL and 
exemplify several of its theoretical aspects, including the subjective nature of QOL 
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and the independence of QOL domains (Orley & Kuyken, 1994). Furthermore, with 
the current studies demonstrating the complex nature of QOL and the multitude of 
factors that contribute to the life quality of transplant patients, there is scope for the 
development of an overall theoretical model of transplant patients’ QOL. 
Subjectivity is a central component to the construct of QOL, and the fact that 
QOL is judged from an individual’s perspective has been used to explain the 
wellbeing and happiness of individuals who may be perceived as less fortunate than 
others and therefore may be expected to experience less optimal QOL (McMillen, 
1999). The findings of Study 1 aptly demonstrate the highly subjective nature of 
QOL; despite probable ongoing health problems and lifestyle restrictions, transplant 
recipients report very good QOL. Similarly, parents of pediatric liver transplant 
recipients in Study 3 reported their children enjoy good levels of QOL, despite the 
serious medical implications of end-stage organ failure and undergoing the stressful 
experiences associated with the transplantation experience. 
Overall, the current research has shown the usefulness of applying a theoretical 
framework to the investigation of the QOL of transplant patients. Furthermore, 
findings lend support to the conceptualisation of QOL as a fluid and subjective 
construct (Felce, 1997).  
Proposed theoretical model of transplant patients’ QOL. On the basis of the 
synthesis of findings in the current thesis, a theoretical model of transplant patients’ 
QOL is proposed. As shown in Figure 8, the proposed conceptual model posits the 
important association of individual characteristics, factors related to the illness 
experience, and the home environment to transplant patients’ QOL. The model 
demonstrates the complexity of QOL, and acknowledges that while QOL is 
subjective, there are many external factors that influence it. Congruent with crisis 
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theory’s supposition of the contribution of stress and coping style to QOL, individual 
characteristics are hypothesised to comprise of subjective and personal factors that 
influence individuals’ QOL by shaping the experience of being a transplant patient. 
Connected to this, illness experience refers to the individuals’ experience of end-stage 
organ failure, and subsequent transplant candidacy and transplant procedure. 
Interactions with health professionals and the health system are also acknowledged as 
important to QOL. The outside layer of the model details the way in which patients’ 
home environment, support systems, family composition, accommodations to family 
routine, and relationship with caregiver may contribute to QOL. The arrows spanning 
the individual characteristics, illness experience, and home environment sections of 
the model indicate the fluid nature of the sections and the interaction between the 
variables. While some of the factors featured in the model have benefitted from 
isolated instances of academic attention, such as coping and individual characteristics, 
other factors require more urgent attention, such as home environment and family 
composition. 
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Figure 8. Proposed theoretical model of transplant patients’ QOL  
 
Implications for Clinical Practice 
Findings of the current studies have several implications for the clinical care of 
transplant patients. For the first time in this field of research, a theoretical model has 
been provided that may be used to guide health professionals when making decisions 
related to patients’ QOL issues. The investigation of transplant patients’ QOL through 
the crisis theory framework has highlighted the importance of considering the 
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relationship between stress, coping, and QOL, in addition to a series of factors that 
may influence QOL. This has implications for both assessment and intervention in the 
clinical care of organ transplant candidates and recipients.  
Assessment. Despite an abundance of past organ transplantation research 
investigating QOL, Study 2 of this thesis was the first to consider this topical issue in 
relation to health professionals and the clinical care of transplant patients. Preliminary 
findings in this area of research show that QOL is held in high regard, however, 
health professionals working with transplant patients appear to be unsure of the role 
or utility of QOL measures. While it seems that health professionals are currently 
unwilling to alter current practices to include formal QOL assessment, the recognition 
among health professionals of the increasing importance of QOL in this field was 
demonstrated by acknowledgement of the need for QOL instruction to be 
incorporated into health professionals’ training.  
Assessment of transplant patients and identification of those patients who may 
not be coping well with the transplantation process is a necessary precursor to any 
intervention. As the results from Study 2 suggest, awareness of QOL issues is an 
integral step in health professionals’ ability to identify and assist patients with 
concerns related to QOL. As Santana and colleagues (2010) demonstrated, assessment 
of QOL in clinical care can be completed without being burdensome in terms of time 
or training. 
Intervention. More than a decade after its original publication, Engle’s (2001) 
statement regarding the total absence of empirical data to inform psychosocial 
interventions for organ transplant patients holds true. Health professionals treating 
transplant patients are left to consult empirical studies from other disciplines or rely 
on general clinical experience when designing and implementing interventions. While 
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few interventions have been detailed in the literature, a focus on QOL interventions 
has long been posited as the next logical stage of transplant research (Barr, et al., 
2003; Burker, et al., 2005; L. Cohen, Littlefield, Kelly, Maurer, & Abbey, 1998; 
Engle, 2001; Golfieri, et al., 2007). Research conducted in other health areas suggests 
the potential positive impact of psychosocial interventions on QOL. Intervention 
research is well established within the oncology field, and interventions involving 
physical exercise, nutrition, and psychoeducation have been found to positively 
influence the QOL of oncology patients (Dow Meneses et al., 2007; Marin Caro, 
Laviano, & Pichard, 2007; Smith, 1996). Further, Callaghan and Li (2002) found that 
pre-surgical coping skills training led to better post-surgery health and QOL outcomes 
and lower levels of anxiety among women undergoing elective hysterectomy. Such 
findings suggest the usefulness of intervention research in the field of organ 
transplantation. 
The increasing calls for intervention research in the field of organ 
transplantation are supported by the findings of a study conducted by Rudis, Rudis, 
Lupo, Safady, and Bonne (2000), the recommendations of which are not yet current 
practice. Rudis and colleagues (2000) designed personal intervention programs for 
transplant patients and their families based on evaluations of life history, mental 
health, compliance to medical regime, health behaviours, and family support systems. 
More than half of the transplant patients in the study required intervention during the 
candidacy period, including crisis intervention for acute mental health reactions, 
ongoing individual and family psychotherapy, and assistance with organising reliable 
social support systems. The number of patients requiring intervention rose to 73% 
following transplantation. While these findings appear to indicate a pressing need for 
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psychosocial interventions among transplant patients, the study did not extend to an 
evaluation of the efficacy of the interventions.  
There are several inherent challenges associated with the design and 
implementation of interventions aimed at improving the QOL of transplants patients. 
First, many transplant candidates are simply too unwell to actively participate in any 
form of individual or group intervention. The locations of transplant centres or 
hospitals with transplant facilities impacts the feasibility of providing ongoing support 
for transplant patients, as patients often travel long distances to attend appointments. 
Second, infrequent contact between health professionals and transplant patients in the 
months and years following transplantation may impact on the frequency of 
psychosocial appointments. Resource shortages, staffing demands, and funding 
restrictions also limit the availability of psychosocial support programs (Dew, 
Goycoolea, et al., 2004). For these reasons, the limited studies that have evaluated 
interventions designed to improve transplant patients’ QOL have not included face-to-
face contact. An internet-based intervention was found to be effective in reducing 
anxiety and hostility among heart transplant recipients, with greater mental health and 
QOL benefits observed in patients who were more frequent users of a website 
featuring discussion boards, psychoeducation material, and online post-transplant 
skills workshops (Dew, Goycoolea, et al., 2004). Further, Napolitano and colleagues 
(2002) found that a telephone-based intervention consisting of emotional support and 
cognitive behavioural techniques was effective in improving lung transplant 
candidates’ general wellbeing and overall QOL. 
While interventions were not detailed in this thesis, the theoretical and empirical 
findings arising from it provide the basis for the development and evaluation of 
interventions designed to assist transplant patients to achieve optimal QOL. The 
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finding in Study 1 that avoidant coping is associated with lower QOL suggests that 
interventions should focus on reducing avoidant coping rather than increasing active 
or problem-based coping skills. Lastly, the results of Study 3 suggests an association 
between pediatric transplant recipients’ QOL and the amount of adjustments made to 
family routine; with this in mind, assisting families with routine tasks such as the 
organisation of childcare or respite may contribute to a better QOL for young 
transplant patients and their families.  
Few interventions for transplant patients have thus far been evaluated, despite 
ongoing findings of psychosocial difficulties among transplant patients. One such 
aspect that presents an immediate opportunity for investigation is the utility and 
effectiveness of support groups. While participation in support groups may not be 
possible for all patients due to geographical distance from the transplant centre or 
hospital, both informal and formal support groups are routinely offered to transplant 
candidates and recipients. Numerous online communities also provide virtual support 
through ‘chat rooms’ and discussion boards. While anecdotally cited as helpful for 
transplant patients, there has been no empirical validation of the potential of support 
groups to contribute to improved QOL (Engle, 2001). Other potential areas of 
research regarding interventions include the impact of physical activity on QOL, as 
transplant recipients who competed in the 1996 US Transplant Games reported higher 
QOL than other transplant patients (Painter, et al., 1997). Given the aforementioned 
difficulties with the implementation of interventions with this population, research in 
this field should seek to overcome distance problems by continuing to offer online 
interventions, or evaluate pre-existing interventions, such as support groups. In 
addition to having the potential to contribute to improving the QOL of transplant 
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patients, a move towards intervention research will also advance the current standing 
of transplantation research. 
Methodological Issues and Limitations 
The three studies contained within this thesis have advanced knowledge of QOL 
in the field of organ transplantation by exploring several different aspects of QOL via 
data collected from diverse groups of informants. However, there are several 
methodological issues and limitations that may affect the generalisability of the 
research findings.  
Sample size and recruitment issues impacted upon the selection of statistical 
analysis techniques employed throughout this thesis. While the overall number of 
participants recruited for Study 1 was adequate, unequal participant numbers in the 
groups of transplant candidates and transplant recipients limited the ability to use the 
framework of crisis theory to explore potential differences in the contribution of stress 
and coping to the QOL of these two groups. Recruiting candidates to research is an 
ongoing problem affecting transplant research; smaller numbers of candidates in 
comparison to transplant recipients, together with high rates of ill health and 
mortality, hamper potential participation from people awaiting organ transplantation. 
Relatively small sample sizes in the other two studies could be counteracted in future 
investigations by designing multi-site research involving a number of hospitals or 
transplant centres. Furthermore, while the exploratory data analysis techniques used 
in Study 2 and Study 3 inform many areas of potential future research, the use of 
predictive statistical models in future research may lead to more definitive results and 
clearer conclusions.  
The current research largely reflects the unique experiences of Australian 
transplant patients, health professionals, and families of pediatric liver transplant 
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recipients. Further research is required to determine the similarities and differences 
between the experiences of this group in comparison to individuals residing in other 
countries. Future research could also consider the different QOL experiences between 
countries with low posthumous donor rates, such as Australia, and those with high 
donor rates where the waiting time to receive an organ transplantation is substantially 
shorter.  
The possible impact of response bias on the results of the three studies should 
also be considered. As participation in all of the studies was voluntary and 
anonymous, individuals with a special interest in QOL or concerns regarding their 
own QOL or that of their child may have been attracted to participate. This is also a 
pertinent concern regarding Study 2, as health professionals with an interest in QOL 
issues may have been more inclined to participate in the study. The characteristics of 
individuals who declined to participate in the studies was not analysed, and therefore 
conclusions cannot be drawn regarding differences between respondents and non-
respondents. As such, potential differences between respondents and non-respondents 
should be considered in further research.  
Other limitations associated with participant selection and statistical analyses 
include not distinguishing between transplant recipients on the basis of cadaveric or 
living donation. Further, due to limited sample size, transplant patients in Study 1 
were not separated according to organ type. As these factors have been shown to 
potentially impact upon QOL, the variables of organ type and form of donation 
should be included in further research (Cotler, et al., 2003; Dew, et al., 1997; Pinson, 
et al., 2000).   
 In terms of research design, investigations of the QOL of transplant patients 
should ideally be longitudinal. Studies in which individuals are followed through the 
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process of candidacy, transplantation and recovery are preferable. However, it is 
especially difficult to conduct longitudinal research with transplant patients, as the 
transplantation process is highly unpredictable and waitlist times vary greatly. An 
alternative to longitudinal research is to incorporate retrospective information 
gathered from pre-transplantation evaluations and psychosocial screenings. However, 
this may also be difficult as records related to psychosocial information vary between 
and within hospitals and transplant teams (Olbrisch, et al., 2002).  
The inclusion of qualitative data in Study 2 and Study 3 allowed insight into the 
experiences of transplant health professionals and transplant families that has not 
previously been featured in the organ transplantation literature. However, the small 
amount of qualitative information collected in the studies limited the use of traditional 
qualitative research interpretive techniques, such as coding. Conducting face-to-face 
interviews or collecting data from focus groups in future studies may result in greater 
use of qualitative data.  
Quantitative measures employed across the three studies generally showed good 
psychometric properties. Two measures, the MD-QOL (Bezjak, et al., 2001) and the 
FAQ (Gavidia-Payne & Tainsh, 2007), were successfully adapted for use in 
transplantation research. Further refinement of these measures and ongoing validation 
studies may also demonstrate their suitability for further use in transplantation 
research. In particular, the FAQ could be used in further research to assess the family 
functioning of other chronically ill children, including pediatric transplant candidates. 
Providing reliable and valid tools with which to investigate QOL issues is likely to 
lead to a broader scope of transplantation research, therefore enabling a deeper 
consideration of the wide range of QOL issues in this field. 
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Directions for Future Research 
Several directions for future research have been identified throughout the 
current thesis. The proliferation of transplantation research presents a number of 
pertinent investigative opportunities related to QOL. The three studies detailed in this 
thesis have the potential to be developed into larger, stand-alone studies, and 
replicating results with a larger sample would provide greater generalisability of 
findings. Future research needs to be theoretically driven and comprehensive, and 
should also consider the emerging area of limb and facial transplantation. 
Organ donation rates. Any investigation of the QOL of organ transplant 
patients would be incomplete without consideration of organ donation rates. While 
this area has received substantial academic attention and Australian rates of 
posthumous donation have recently increased, there remains much scope for research 
into raising organ donation rates (Excell, et al., 2011; Hyde & White, 2007) . The 
QOL benefits of organ transplantation have been established over decades of 
research, with transplant recipients consistently found to experience QOL advantages 
over transplant candidates (Burra & De Bona, 2007). The results of Study 1 extended 
upon this well established finding by demonstrating that transplant recipients report 
similar QOL experiences to the non-transplant population. With this in mind, it may 
be argued that the most efficient and effective way of optimising the QOL of 
individuals with end-stage organ failure is to focus on increasing posthumous organ 
donor rates. Similarly, recent advances in organ transplant surgery have seen a sharp 
rise in the number of living donors. Living donation is now encouraged in a wide 
variety of cases in pediatric transplantation, and adult-to-adult liver and kidney 
transplantation is also becoming increasingly frequent (Levine, 2004; Schiano, et al., 
2001). In addition to saving the lives of many individuals with end-stage organ 
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failure, increased posthumous donor rates may facilitate QOL improvements. 
Previous research has demonstrated the association between increased time on waitlist 
and low QOL, and the psychological impact stemming from the uncertainty of not 
receiving an organ is also well documented (Diaz-Dominguez, et al., 2006; Zipfel, et 
al., 1998). Further research is required to establish the best possible pathways to 
increase posthumous and living donation rates. 
Theoretical investigations. Study 1 demonstrated the efficacy of using a 
theoretical framework to explore the QOL experiences of organ transplant patients.  
Together with the proposed theoretical model of transplant patients’ QOL detailed in 
Figure 8, there are several other theories that could be used to explore the QOL of 
transplant patients. Ventegodt, Merrick, and Andersen (2003) developed a theory of 
QOL based on Maslow’s hierarchy of needs, with the integrative QOL theory 
exploring individuals’ attainment of higher order wellbeing. The inclusion of an 
existential component in Ventegodt and colleagues’ (2003) theory makes it a viable 
framework through which to explore the QOL of individuals who have experienced a 
life-threatening illness, such as end-stage organ failure. Jowsey and colleagues’ 
(2012) investigation of heart transplant recipients’ psychological QOL based on 
Seligman’s theory of attributional style could also be extended to explore other 
domains of QOL among transplant patients across different organ types. Other 
theoretical frameworks used in oncology research proffer explanatory models for the 
QOL of ill individuals. For example, the theory of uncertainty in illness posits the 
contribution of uncertainty to skill development and life quality, while other theories 
pose a link between meaning-making processes and QOL, and the role of expected 
and actual outcomes in the QOL of medical patients (King, 2012).  
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Developing an organ transplantation research agenda. Organ transplantation 
is the beneficiary of a vast amount of academic attention, however, much of the work 
is conducted in isolation and the field lacks collaboration between individual 
researchers and research centres across the various disciplines that investigate the 
QOL of transplant patients.  
Ricordi (2011) advocates the need for greater collaborative research efforts in 
order to meet shared objectives in an efficient and effective manner. A thorough 
review of recent research may be an ideal starting point to inform the most suitable 
direction of future investigations, as a vast amount of QOL research has been 
conducted in the area of organ transplantation since Dew and colleagues’ (1997) 
comprehensive meta-analysis. Such a review could also investigate the impact of 
recent medical advances on QOL, as current transplant patients experience better 
health outcomes than those transplanted in previous decades (Simpson, 2012). 
The extensive corroboration and replication of established QOL findings in the 
transplantation literature has long been criticised, with the repetitive exploration of 
the QOL differences between candidates and recipients purported as detrimental to 
the introduction of new investigative areas (Dew, et al., 1997). As detailed previously, 
many researchers have called for future research to focus on interventions aimed at 
increasing transplant patients’ QOL. With results of Study 2 showing high levels of 
readership of journal articles among those health professionals working in the field of 
organ transplantation, it is pertinent to ensure future published QOL research reflects 
current information rather than continuously confirming established findings. 
Congruent with the findings detailed in Study 1, there is general consensus 
within the literature that transplantation leads to significant QOL improvements, with 
differences readily observed between the QOL experiences of transplant candidates 
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and their recipient counterparts (Burra & De Bona, 2007). However, individual QOL 
differences remain, and most studies report that not all transplant recipients enjoy 
QOL improvements (Bravata, et al., 1999; Falger, Landolt, et al., 2008; Myaskovsky 
et al., 2006). Future research could employ quantitative and qualitative methods to 
investigate the experiences of these clinically distinct individuals, with results likely 
to be useful in informing the design and implementation of interventions specifically 
aimed at improving the QOL of this subset of transplant recipients.  
Similarly, recent research has emphasised the need to ensure future transplant 
research is inclusive and representative of all transplant patients. Schold and 
colleagues’ (2011) evaluation of a US-based registry of transplant recipients from 
which research participants are recruited revealed significant differences between 
recipients who participated in research and those who did not. Factors associated with 
recipient participation include educational status, race and ethnicity, gender, age, 
income, distance to transplant centre or hospital, and the size of the hospital or 
transplant centre at which transplantation surgery was performed. The study 
concluded that transplant recipients who participate in research experience superior 
transplant outcomes, which may suggest that benefit is derived from participation in 
research itself. The findings of systematic differences between participants and non-
participants extols the need to ensure research participants are representative of the 
wider transplant population, thus ensuring the external validity and generalisability of 
study findings. 
Composite Tissue Allotransplantation. Composite Tissue Allotransplantation 
(CTA) is an important area of emerging research. Also known as reconstructive 
surgery, CTA involves the transplantation of any combination of vascularised skin, 
subcutaneous tissue, blood vessels, nerves, muscle, and bone. Encompassing facial 
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and limb transplantation, CTA has been heralded as the next major area of 
transplantation in terms of clinical practice and academic investigation (Edwards & 
Mathes, 2011). The first successful hand transplantation was performed in France in 
November 2005, and has since been followed by several facial transplantations in 
Europe and the US. While difficulties associated with the medical and surgical 
aspects of solid organ transplantation have largely been resolved, CTA techniques are 
in the early stages of development and the surgery is still considered to be 
experimental. Reminiscent of the early stages of solid organ transplantation, the major 
challenge currently impeding the progress of CTA is the need for new 
immunosuppressive medication, as the rejection episodes experienced by facial and 
limb transplant recipients differ substantially from those of organ transplant recipients 
(Edwards & Mathes, 2011). Other challenges include donor availability, financial 
viability, and the development of ethical guidelines regarding informed consent and 
candidate selection (Hautz et al., 2011). 
Unlike solid organ transplantation, CTA is not a life-saving procedure.  Facial 
and limb transplant candidates are not terminally ill, however, individuals in need of 
this extensive reconstructive surgery experience a number of other challenges. Many 
have experienced extensive trauma, burns, or facial tumours that have caused severe 
disfigurement. This may lead to a disrupted sense of identity, diminished self-esteem, 
and functional impairment. Patients with severe facial deformities are often reclusive 
and feel socially inhibited, leading to problems with social relationships and a lack of 
employment opportunities (Hautz, et al., 2011).  
Given the relatively recent introduction of CTA procedures, the psychosocial 
experiences of CTA recipients have not yet been thoroughly researched. Edwards and 
Mathes (2011) state that facial and limb transplantation result in both functional and 
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psychosocial benefits, and other preliminary research has found that CTA improves 
the QOL of recipients by up to 70% (Hautz, et al., 2011). However, QOL research in 
this field is very much in its infancy. Similar to the proliferation of QOL research in 
the field of organ transplantation that began in the 1980s, it is likely that 
investigations of the QOL of CTA recipients will increase with continued refinement 
of CTA medical procedures and associated pharmacological advances. With a 
prospective increase in recipients over the coming decades, there is also scope for the 
development of a CTA-specific QOL measure, which could build upon existing 
measures used to assess the QOL of individuals with facial deformities (Cunningham, 
Garratt, & Hunt, 2000). 
Concluding Comments 
Intense interest in the QOL of organ transplant patients followed the resolution 
of surgical and medical problems that plagued the early era of transplantation 
research. A proliferation of psychosocial research in the field of organ transplantation 
heralded the QOL benefits of the life-saving procedure of transplantation. However, 
despite copious amounts of research in this field, several pertinent aspects of QOL 
have been largely overlooked. Therefore, the current thesis sought to advance the 
understanding of organ transplantation and QOL by extending the scope of traditional 
psychosocial research. Results of three studies provided a holistic view of the current 
standing of QOL research in this field through investigation of issues from the unique 
perspectives of transplant patients, health professionals, and families of pediatric 
transplant recipients. While this research supports the notion of QOL being a 
subjective construct that should be primarily assessed from the viewpoint of the 
transplant patient, the importance of considering the role of others in transplant 
practice and research has been demonstrated by findings related to health 
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professionals’ use of QOL information and the association between family routines 
and the QOL of pediatric liver recipients.  
Overall, it can be concluded that QOL remains an interesting and worthwhile 
concept to consider in relation to organ transplantation. However, in order to further 
advance the understanding of the theoretical and practical aspects of QOL in this 
field, research must diversify its objectives and methodologies. Doing so will ensure 
that the primary aim of facilitating optimal QOL remains a priority in the treatment of 
all organ transplant patients. 
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Appendix A 
Questionnaire (Non-Transplant Population) – Study 1 
 
Demographic information  
 
Please indicate your response by circling or writing your answers: 
 
1. Are you male or female?   Male   Female 
 
2. What is your age (in years)?   …………………… 
 
3. What is your current marital status? 
  Married  Widowed  Never married 
  Divorced  Separated  In a relationship 
 
3. What is your country of residence? …………………… 
 
4. If you are an Australian resident, please state your postcode 
 
      …………………… 
 
5. Please circle your annual household income in your local currency 
     
  less than 10,000   
  10, 000 to 19, 999 
  20, 000 to 29, 999 
  30, 000 to 39, 999 
  40, 000 to 49, 999 
  50, 000 to 59, 999 
60, 000 to 69, 999 
  70, 000 to 79, 999 
  80, 000 to 89, 999 
  90, 000 to 99, 999 
  100, 000 to 150, 000 
  150, 000 plus 
 
6. I have never received an organ transplant, or been on the waiting list to receive an 
organ transplant 
 
True  I have never received an organ transplant, or been on the 
         waiting list to receive an organ transplant 
 
  False  I have received an organ transplant, or been on the waiting list 
          to receive a transplant 
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STRESS IN YOUR LIFE 
 
These questions ask about your feelings and thoughts during the last month.  
 
In the past month how often have you 
 
  Never Almost 
never 
Sometimes Fairly 
often 
Very 
often 
1. Been upset because of 
something that happened 
unexpectedly?  
1 2 3 4 5 
2. Felt that you were unable to 
control the important things in 
your life? 
1 2 3 4 5 
3. Felt nervous or “stressed”? 1 2 3 4 5 
4. Dealt successfully with 
irritating life hassles? 
1 2 3 4 5 
5. Felt that you were effectively 
coping with important 
changes that were occurring 
in your life? 
1 2 3 4 5 
6. Felt confident about your 
ability to handle your personal 
problems? 
1 2 3 4 5 
7. Felt that things were going 
your way? 
1 2 3 4 5 
8. Felt that you would cope with 
all the things that you had to 
do? 
1 2 3 4 5 
9. Been able to control irritations 
in your life? 
1 2 3 4 5 
10. Felt that you were on top of 
things? 
1 2 3 4 5 
11. Been angered because of 
things that happened that 
were outside of your control? 
1 2 3 4 5 
12. Found yourself thinking about 
things that you have to 
accomplish? 
1 2 3 4 5 
13. Been able to control the way 
you spend your time? 
1 2 3 4 5 
14. Felt difficulties were piling up 
so high that you could not 
overcome them? 
1 2 3 4 5 
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COPING WITH STRESS 
 
These items deal with the way you have been coping with the stress in your life. 
Please indicate how often you use each particular way of coping 
 
1 = I don’t do this at all 
2 = I do this a little bit 
3 = I do this a medium amount 
4 = I do this a lot 
 
  Not at all A little 
bit 
A 
medium 
amount 
A lot 
1. I turn to work or other activities to take 
my mind off things 
1 2 3 4 
2. I concentrate my efforts on doing 
something about the situation I’m in 
1 2 3 4 
3. I say to myself “this is not real” 1 2 3 4 
4. I use alcohol or other drugs to make 
myself feel better 
1 2 3 4 
5. I get emotional support from others 1 2 3 4 
6. I give up trying to deal with it 1 2 3 4 
7. I take action to try to make the 
situation better 
1 2 3 4 
8. I refuse to believe that it has 
happened 
1 2 3 4 
9. I say things to let my unpleasant 
feelings escape 
1 2 3 4 
10. I get help and advice from other 
people 
1 2 3 4 
11. I use alcohol or drugs to help me get 
through it 
1 2 3 4 
12. I try to see things in a different light, to 
make it seem more positive 
1 2 3 4 
13. I criticize myself 1 2 3 4 
14. I try to come up with a strategy about 
what to do 
1 2 3 4 
15. I get comfort and understanding from 
someone 
1 2 3 4 
16. I give up the attempt to cope 1 2 3 4 
17. I look for something good in what is 
happening 
1 2 3 4 
18. I make jokes about it 1 2 3 4 
19. I do something to think about it less, 
such as going to the movies, watching 
TV, reading, daydreaming, sleeping, 
or shopping 
1 2 3 4 
20. I accept the reality of the fact that it 
has happened 
1 2 3 4 
21. I express my negative feelings 1 2 3 4 
22. I try to find comfort in my religion or 
spiritual beliefs 
1 2 3 4 
23. I try to get advice or help from other 
people about what to do 
1 2 3 4 
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 Not at all A little 
bit 
A 
medium 
amount 
A lot 
24. I learn to live with it 1 2 3 4 
25. I think hard about what steps to take 1 2 3 4 
26. I blame myself for things that 
happened 
1 2 3 4 
27. I pray or meditate 1 2 3 4 
28. I make fun of the situation 1 2 3 4 
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LIFE SATISFACTION 
 
These questions ask how you feel about your quality of life, health, and other areas 
of your life.  
 
Please keep in mind your standards, hopes, pleasures and concerns. We ask that 
you think about your life in the last two weeks. 
 
  Very 
poor 
Poor Neither 
poor nor 
good 
Good Very 
good 
1. How would you rate your quality 
of life? 
1 2 3 4 5 
2. How satisfied are you with your 
health? 
1 2 3 4 5 
 
The following questions ask about how much you have experienced certain things in 
the last two weeks. 
 
  Not at 
all 
A little A 
medium 
amount 
A lot A 
great 
deal 
3. To what extent do you feel that 
physical pain prevents you from 
doing what you need to do? 
1 2 3 4 5 
4. How much do you need any 
medical treatment to function in 
your daily life? 
1 2 3 4 5 
5. How much do you enjoy life? 1 2 3 4 5 
6. To what extent do you feel your 
life to be meaningful? 
1 2 3 4 5 
7. How well are you able to 
concentrate? 
1 2 3 4 5 
8. How safe do you feel in your daily 
life? 
1 2 3 4 5 
9. How healthy is your physical 
environment? 
1 2 3 4 5 
10. Do you have enough energy for 
everyday life? 
1 2 3 4 5 
11. Are you able to accept your bodily 
appearance? 
1 2 3 4 5 
12. Have you enough money to meet 
your needs? 
1 2 3 4 5 
13. How available to you is the 
information you need in your daily 
life? 
1 2 3 4 5 
14. To what extent do you have the 
opportunity for leisure activities? 
1 2 3 4 5 
15. How well are you able to get 
around physically? 
1 2 3 4 5 
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The following questions ask you to indicate how good or satisfied you have felt about 
various aspects of your life over the last two weeks. 
 
  Very 
dissatisfied 
Dissatisfied Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very 
satisfied 
16. How satisfied are 
you with your 
sleep? 
1 2 3 4 5 
17. How satisfied are 
you with your 
ability to perform 
your daily living 
activities? 
1 2 3 4 5 
18. How satisfied are 
you with your 
capacity to work? 
1 2 3 4 5 
19. How satisfied are 
you with 
yourself? 
1 2 3 4 5 
20. How satisfied are 
you with your 
personal 
relationships? 
1 2 3 4 5 
21. How satisfied are 
you with your sex 
life? 
1 2 3 4 5 
22. How satisfied are 
you with the 
support your get 
from your 
friends? 
1 2 3 4 5 
23. How satisfied are 
you with the 
conditions of your 
living place? 
1 2 3 4 5 
24. How satisfied are 
you with your 
access to health 
services? 
1 2 3 4 5 
 
 
Your participation is greatly appreciated. Thank you. 
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Appendix B 
Questionnaire (Transplant Patients) – Study 1 
 
Demographic information 
 
Please indicate your response by circling or writing your answers 
 
1. Are you male or female?   Male   Female 
 
2. What is your age (in years)?   …………………… 
 
3. What is your current marital status? 
  Married  Widowed  Never married 
  Divorced  Separated  In a relationship 
 
3. What is your country of residence? …………………… 
 
4. If you are an Australian resident, please state your postcode 
 
      …………………… 
 
5. Please circle your annual household income (in your local currency)   
  less than 10,000   
  10, 000 to 19, 999 
  20, 000 to 29, 999 
  30, 000 to 39, 999 
  40, 000 to 49, 999 
  50, 000 to 59, 999 
60, 000 to 69, 999 
  70, 000 to 79, 999 
  80, 000 to 89, 999 
  90, 000 to 99, 999 
  100, 000 to 150, 000 
  150, 000 plus 
 
5. Please select the statement which best describes you: 
(a) I am currently on the waiting list to receive an organ transplant 
How long (in months) have you been on the waiting list to receive a  
transplant? 
 
         …………………………… 
(b) I am the recipient of an organ transplant 
      How long ago (in months) did you receive an organ transplant? 
                        
       …………………………… 
   
6. Lastly, which organ type are you awaiting or have previously received? 
    
Heart   Lung   
Heart & Lung  Pancreas  
Kidney   Liver   
Other (please state) ………………..   
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STRESS IN YOUR LIFE 
 
These questions ask about your feelings and thoughts during the last month.  
 
In the past month how often have you 
 
  Never Almost 
never 
Sometimes Fairly 
often 
Very 
often 
1. Been upset because of 
something that happened 
unexpectedly?  
1 2 3 4 5 
2. Felt that you were unable to 
control the important things in 
your life? 
1 2 3 4 5 
3. Felt nervous or “stressed”? 1 2 3 4 5 
4. Dealt successfully with 
irritating life hassles? 
1 2 3 4 5 
5. Felt that you were effectively 
coping with important 
changes that were occurring 
in your life? 
1 2 3 4 5 
6. Felt confident about your 
ability to handle your personal 
problems? 
1 2 3 4 5 
7. Felt that things were going 
your way? 
1 2 3 4 5 
8. Felt that you could not cope 
with all the things that you 
had to do? 
1 2 3 4 5 
9. Been able to control irritations 
in your life? 
1 2 3 4 5 
10. Felt that you were on top of 
things? 
1 2 3 4 5 
11. Been angered because of 
things that happened that 
were outside of your control? 
1 2 3 4 5 
12. Found yourself thinking about 
thing that you have to 
accomplish? 
1 2 3 4 5 
13. Been able to control the way 
you spend your time? 
1 2 3 4 5 
14. Felt difficulties were piling up 
so high that you could not 
overcome them? 
1 2 3 4 5 
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COPING WITH STRESS 
 
These items deal with the way you have been coping with the stress in your life. 
Please indicate how often you use each particular way of coping. 
 
1 = I don’t do this at all 
2 = I do this a little bit 
3 = I do this a medium amount 
4 = I do this a lot 
 
  Not at all A little 
bit 
A 
medium 
amount 
A lot 
1. I turn to work or other activities to take 
my mind off things 
1 2 3 4 
2. I concentrate my efforts on doing 
something about the situation I’m in 
1 2 3 4 
3. I say to myself “this is not real” 1 2 3 4 
4. I use alcohol or other drugs to make 
myself feel better 
1 2 3 4 
5. I get emotional support from others 1 2 3 4 
6. I give up trying to deal with it 1 2 3 4 
7. I take action to try to make the 
situation better 
1 2 3 4 
8. I refuse to believe that it has 
happened 
1 2 3 4 
9. I say things to let my unpleasant 
feelings escape 
1 2 3 4 
10. I get help and advice from other 
people 
1 2 3 4 
11. I use alcohol or drugs to help me get 
through it 
1 2 3 4 
12. I try to see things in a different light, to 
make it seem more positive 
1 2 3 4 
13. I criticize myself 1 2 3 4 
14. I try to come up with a strategy about 
what to do 
1 2 3 4 
15. I get comfort and understanding from 
someone 
1 2 3 4 
16. I give up the attempt to cope 1 2 3 4 
17. I look for something good in what is 
happening 
1 2 3 4 
18. I make jokes about it 1 2 3 4 
19. I do something to think about it less, 
such as going to the movies, watching 
TV, reading, daydreaming, sleeping, 
or shopping 
1 2 3 4 
20. I accept the reality of the fact that is 
has happened 
1 2 3 4 
21. I express my negative feelings 1 2 3 4 
22. I try to find comfort in my religion or 
spiritual beliefs 
1 2 3 4 
23. I try to get advice or help from other 
people about what to do 
1 2 3 4 
24. I learn to live with it 1 2 3 4 
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Not at all 
 
A little 
bit 
 
A 
medium 
amount 
 
A lot 
25. I think hard about what steps to take 1 2 3 4 
26. I blame myself for things that 
happened 
1 2 3 4 
27. I pray or meditate 1 2 3 4 
28. I make fun of the situation 1 2 3 4 
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TRANSPLANT RELATED STRESS 
 
This scale asks you about some stressful events that you may have experienced as an organ transplant patient. 
These questions ask you to fill out two separate scales: please rate how often you have felt stressed about the event, and how stressful the 
event was. 
  How often? How stressful was this? 
  Never Almost 
never 
Sometimes Fairly 
often 
Very 
often 
Not at all A little  
 
Somewhat Very Extremely 
1. Been pressured or 
inconvenienced by dealings 
with medical insurance 
companies? 
1 2 3 4 5 1 2 3 4 5 
2. Worried about your body 
rejecting the organ 
transplant? 
1 2 3 4 5 1 2 3 4 5 
3. Experienced negative side 
effects from your 
medication? 
1 2 3 4 5 1 2 3 4 5 
4. Not had your medical 
questions answered 
adequately? 
1 2 3 4 5 1 2 3 4 5 
5. Felt that you a burden to 
others? 
1 2 3 4 5 1 2 3 4 5 
6. Worried that you will not 
receive an organ 
transplant? 
1 2 3 4 5 1 2 3 4 5 
7. Lacked energy to do 
everyday activities? 
1 2 3 4 5 1 2 3 4 5 
8. Worried about gaining 
weight? 
1 2 3 4 5 1 2 3 4 5 
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How often? How stressful was this? 
  Never Almost 
never 
Sometimes Fairly 
often 
Very 
often 
Not at all A little  
 
Somewhat Very Extremely 
9. Been under financial strain? 1 2 3 4 5 1 2 3 4 5 
10. Felt that you do not have 
enough support from your 
family and friends? 
1 2 3 4 5 1 2 3 4 5 
11. Been inconvenienced by 
traveling to check-ups and 
medical appointments? 
1 2 3 4 5 1 2 3 4 5 
12. Felt that your relationship 
with significant others in 
your life has changed? 
1 2 3 4 5 1 2 3 4 5 
13. Been limited by dietary 
restrictions? 
1 2 3 4 5 1 2 3 4 5 
14. Worried about contracting 
other illnesses? 
1 2 3 4 5 1 2 3 4 5 
15. Worried about how your 
health will be in the future? 
1 2 3 4 5 1 2 3 4 5 
16. Been pressured or 
inconvenienced by the need 
to comply with doctors’ 
orders? 
1 2 3 4 5 1 2 3 4 5 
17. Noticed changes in your 
appearance? 
1 2 3 4 5 1 2 3 4 5 
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LIFE SATISFACTION 
 
These questions ask how you feel about your quality of life, health, and other areas 
of your life.  
 
Please keep in mind your standards, hopes, pleasures and concerns. We ask that 
you think about your life in the last two weeks. 
 
  Very 
poor 
Poor Neither 
poor nor 
good 
Good Very 
good 
1. How would you rate your quality 
of life? 
1 2 3 4 5 
2. How satisfied are you with your 
health? 
1 2 3 4 5 
 
The following questions ask about how much you have experienced certain things in 
the last two weeks. 
 
  Not at 
all 
A little A 
medium 
amount 
A lot A 
great 
deal 
3. To what extent do you feel that 
physical pain prevents you from 
doing what you need to do? 
1 2 3 4 5 
4. How much do you need any 
medical treatment to function in 
your daily life? 
1 2 3 4 5 
5. How much do you enjoy life? 1 2 3 4 5 
6. To what extent do you feel your 
life to be meaningful? 
 
1 2 3 4 5 
7. How well are you able to 
concentrate? 
1 2 3 4 5 
8. How safe do you feel in your daily 
life? 
1 2 3 4 5 
9. How healthy is your physical 
environment? 
1 2 3 4 5 
10. Do you have enough energy for 
everyday life? 
1 2 3 4 5 
11. Are you able to accept your bodily 
appearance? 
1 2 3 4 5 
12. Have you enough money to meet 
your needs? 
1 2 3 4 5 
13. How available to you is the 
information you need in your daily 
life? 
1 2 3 4 5 
14. To what extent do you have the 
opportunity for leisure activities? 
1 2 3 4 5 
15. How well are you able to get 
around physically? 
1 2 3 4 5 
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The following questions ask you to indicate how good or satisfied you have felt about 
various aspects of your life over the last two weeks. 
 
  Very 
dissatisfied 
Dissatisfied Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very 
satisfied 
16. How satisfied are 
you with your 
sleep? 
1 2 3 4 5 
17. How satisfied are 
you with your 
ability to perform 
your daily living 
activities? 
1 2 3 4 5 
18. How satisfied are 
you with your 
capacity to work? 
1 2 3 4 5 
19. How satisfied are 
you with 
yourself? 
1 2 3 4 5 
20. How satisfied are 
you with your 
personal 
relationships? 
1 2 3 4 5 
21. How satisfied are 
you with your sex 
life? 
1 2 3 4 5 
22. How satisfied are 
you with the 
support your get 
from your 
friends? 
1 2 3 4 5 
23. How satisfied are 
you with the 
conditions of your 
living place? 
1 2 3 4 5 
24. How satisfied are 
you with your 
access to health 
services? 
1 2 3 4 5 
 
 
Your participation is greatly appreciated. Thank you. 
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 Appendix C 
Plain Language Statement (Non-Transplant Population) – Study 1 
 
 
 
Invitation to Participate in a Research Project 
Project Information Statement 
 
Project Title 
Stress, coping, and quality of life. 
 
Investigators 
Bianca Villarosa (Psychology Masters degree student). 
b.villarosa@student.rmit.edu.au 
Dr Mandy Kienhuis (Project Supervisor: Lecturer, Psychology, RMIT 
University). mandy.kienhuis@rmit.edu.au, 03 9925 3019 
 
You are invited to participate in a research project being conducted by RMIT University. 
This information sheet describes the project in ‘plain English’. Please read this sheet 
carefully and be confident that you understand its contents before deciding whether to 
participate. If you have any questions about the study, please contact one of the 
investigators, listed above. 
 
Who is involved in this research project? Why is it being conducted? 
The current study is being undertaken by Bianca Villarosa as part of a Masters of Clinical 
Psychology degree, under the supervision of Dr Mandy Kienhuis. This study has been 
approved by the RMIT Human Research Ethics Committee 
 
Why have you been approached? 
We are seeking participants to complete a questionnaire about stress, coping, and 
satisfaction in several areas of life. 
To participate in this study, you must be aged 18 years or older. Participants must not 
currently be on the transplant waiting list, previously been on the organ transplant waiting 
list, or have received an organ transplant. If you have been a transplant candidate or 
recipient, please contact the investigators to receive the relevant questionnaire.  
 
What is the current study about? 
The current study is investigating the way individuals cope with stress, and how stress 
and coping may affect quality of life. Specifically, we are investigating how organ 
transplant patients cope with the stress associated with being a transplant candidate or 
recipients, and how stress and coping may affect patients’ quality of life. 
 
If I agree to participate, what will I be required to do? 
Participation is completely voluntary. You will be asked to provide general demographic 
information, and complete a short questionnaire about the way you cope with stress, and 
your satisfaction in several areas of your life. All responses are anonymous and kept 
confidential. 
The questionnaire should take approximately 15 minutes to complete. The questionnaire 
is available online or as a hardcopy.  
 
What are the risks or disadvantages associated with participation? 
While unlikely, answering some questions may raise issues of concern for some 
individuals. If you are unduly concerned about your responses, you should contact the 
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investigators, who will discuss your concerns confidentially and suggest appropriate 
follow-up, if necessary. 
What are the benefits associated with participation? 
While there is no direct benefit to participants, it is hoped the current study will provide 
important information about the relationship between stress, coping, and quality of life of 
transplant patients. 
 
What will happen with the information I provide? 
All your responses will be anonymous and will remain confidential. Data will be analysed 
by group only, and as such no identifiable information will be included. Research data will 
be held securely at RMIT for a period of 5 years before being destroyed. This study may 
be submitted for publication, but only group results will be reported and your anonymity is 
assured. 
Because of the nature of this data collection, we are not obtaining written informed 
consent from you. Instead, your return of the questionnaire in the pre-paid envelope, or 
online submission for completion on the internet, is taken as your consent to participate in 
the study.  
 
Security of the website 
Users should be aware that the World Wide Web is an insecure public network that gives 
rise to the potential risk that a user’s transactions are being viewed, intercepted or 
modified by third parties or that data which the user downloads may contain computer 
viruses or other defects. 
 
Security of the data 
This project will use an external site to create, collect and analyse data collected in a 
survey format. The site we are using is surveymonkey.com. If you agree to participate in 
this survey, the responses you provide to the survey will be stored on a host server that is 
used by RMIT University. No personal information will be collected in the survey so none 
will be stored as data. Once we have completed our data collection and analysis, we will 
import the data we collect to the RMIT server where it will be stored securely for a period 
of five (5) years. The data on the RMIT University host server will then be deleted and 
expunged. 
 
What are you my rights as a participant? 
Participation in this study is completely voluntary. You have the right to withdraw anytime 
before returning the questionnaire material. 
 
Whom should I contact if I have any questions? 
You may contact the investigators, Bianca Villarosa (b.villarosa@student.rmit.edu.au), or 
Dr Mandy Kienhuis (mandy.kienhuis@rmit.edu.au). 
 
Thankyou for your interest in this study; your participation is greatly appreciated. 
 
Yours sincerely, 
 
 
……………………………   …………………………… 
Bianca Villarosa    Dr Mandy Kienhuis 
BA, GradDipPsych, PgDipPsych   
 
Any complaints about your participation in this project may be directed to the Executive Officer, RMIT 
Human Research Ethics Committee, Research & Innovation, RMIT, GPO Box 2476V, Melbourne, 3001.    
Details of the complaints procedure are available at:  http://www.rmit.edu.au/research/hrec_complaints 
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Appendix D 
Plain Language Statement (Transplant Patients) – Study 1 
 
 
 
 
Invitation to Participate in a Research Project 
Project Information Statement 
 
Project Title 
Stress, coping, and quality of life. 
 
Investigators 
Bianca Villarosa (Psychology Masters degree student) 
b.villarosa@student.rmit.edu.au 
Dr Mandy Kienhuis (Project Supervisor; Lecturer, Psychology, RMIT University), 
mandy.kienhuis@rmit.edu.au, 9925 3019 
 
You are invited to participate in a research project being conducted by RMIT University. 
This information sheet describes the project in ‘plain English’. Please read this sheet 
carefully and be confident that you understand its contents before deciding whether to 
participate. If you have any questions about the study, please contact one of the 
investigators, listed above. 
 
Who is involved in this research project? Why is it being conducted? 
The current study is being undertaken by Bianca Villarosa as part of a Masters of Clinical 
Psychology degree, under the supervision of Dr Mandy Kienhuis. This study has been 
approved by the RMIT Human Research Ethics Committee. 
 
Why have you been approached? 
We are seeking individuals who are currently waiting for an organ transplant, or have 
previously received an organ transplant.  
Participants must be aged 18 years or older. 
  
What is the current study about? 
The current study is investigating the way individuals cope with stress, and how stress 
and coping may affect quality of life. Specifically, we are investigating how transplant 
patients cope with the stress associated with being a transplant candidate or recipient, 
and how stress and coping may affect quality of life. 
 
If I agree to participate, what will I be required to do? 
Participation is completely voluntary. You will be asked to provide general demographic 
information, and complete a short questionnaire about the way you cope with stress, and 
your satisfaction in several areas of your life. All responses are anonymous and kept 
confidential. 
The questionnaire should take approximately 15 minutes to complete, and is available 
online or as a hardcopy.  
 
What are the risks or disadvantages associated with participation? 
While unlikely, answering some questions may raise issues of concern for some 
individuals. In this case, you should contact the investigators, who will discuss your 
concerns confidentially and suggest appropriate follow-up, if necessary. 
 
 
 215
What are the benefits associated with participation? 
While there is no direct benefit to participants, it is hoped the current study will provide 
important information about the relationship between stress, coping, and quality of life of 
organ transplant patients. 
 
What will happen with the information I provide? 
All your responses will be anonymous and will remain confidential. Data will be analysed 
by group only, and as such no identifiable information will be included. Research data will 
be held securely at RMIT for a period of 5 years before being destroyed. This study may 
be submitted for publication, but only group results will be reported and your anonymity is 
assured. 
Because of the nature of this data collection, we are not obtaining written informed 
consent from you. Instead, your return of the questionnaire in the pre-paid envelope, or 
online submission for completion on the internet, is taken as your consent to participate in 
the study.  
 
Security of the website 
Users should be aware that the World Wide Web is an insecure public network that gives 
rise to the potential risk that a user’s transactions are being viewed, intercepted or 
modified by third parties or that data which the user downloads may contain computer 
viruses or other defects. 
 
Security of the data 
This project will use an external site to create, collect and analyse data collected in a 
survey format. The site we are using is surveymonkey.com. If you agree to participate in 
this survey, the responses you provide to the survey will be stored on a host server that is 
used by RMIT University. No personal information will be collected in the survey so none 
will be stored as data. Once we have completed our data collection and analysis, we will 
import the data we collect to the RMIT server where it will be stored securely for a period 
of five (5) years. The data on the RMIT University host server will then be deleted and 
expunged. 
 
What are my rights as a participant? 
Participation in this study is completely voluntary. You have the right to withdraw anytime 
before returning the questionnaire material. 
 
Whom should I contact if I have any questions? 
You may contact the investigators, Bianca Villarosa (b.villarosa@student.rmit.edu.au), or 
Dr Mandy Kienhuis (mandy.kienhuis@rmit.edu.au). 
 
Thankyou for your interest in this study; your participation is greatly appreciated. 
 
Yours sincerely, 
 
……………………………   …………………………… 
Bianca Villarosa    Dr Mandy Kienhuis 
BA, GradDipPsych, PgDipPsych   
 
 
 
Any complaints about your participation in this project may be directed to the Executive Officer, 
RMIT Human Research Ethics Committee, Research & Innovation, RMIT, GPO Box 2476V, 
Melbourne, 3001.    
Details of the complaints procedure are available at: 
http://www.rmit.edu.au/research/hrec_complaints 
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Appendix E 
Plain Language Statement (Monash Medical Centre Patients) – Study 1 
Participant Information and Consent Form 
RMIT University & Department of Nephrology, Monash Medical Centre 
 
Full Project Title: 
“Stress, coping, and quality of life” 
Principal Researcher:  Dr. Mandy Kienhuis  
Lecturer, RMIT University, Melbourne   
 Email: mandy.kienhuis@rmit.edu.au 
 
Associate Researchers:  Ms. Bianca Villarosa 
Provisional Psychologist – Doctoral Candidate, RMIT   
  University, Melbourne 
    Email: b.villarosa@student.rmit.edu.au 
 
    Associate Professor John Kanellis 
    Director of Transplantation, Monash Medical Centre 
    Email: john.kanellis@med.monash.edu.au 
1. Introduction 
You are invited to take part in this research project being conducted by RMIT University. Your 
contact details have been obtained from the Department of Nephrology, Monash Medical 
Centre. This because we are seeking individuals who are currently waiting to receive an 
organ transplant to complete a questionnaire. The research project aims to investigate the 
stress, coping, and quality of life experienced by organ transplant patients. 
 
This Participant Information and Consent Form tell you about the research project. It explains 
what is involved to help you decide if you want to take part. 
 
Please read this information carefully. Ask questions about anything that you don’t 
understand or want to know more about. Before deciding whether or not to take part, you 
might want to talk about it with a relative, friend, or your local health worker. 
 
Participation in this research is voluntary. If you don’t wish to take part, you don’t have to. 
If you decide you want to take part in the research project, you are asked to provide your 
consent. By doing this you are telling us that you: 
• Understand what you have read; 
• Consent to take part in the research project; 
• Consent to be involved in the procedures described; and 
• Consent to the use of your personal and health information as described. 
This information sheet is yours to keep. 
 
2. What is the purpose of this research project? 
The current study aims to investigate the type of stress experienced by people who are 
waiting for an organ transplant, how they cope with this stress, and their overall quality of life. 
Previous studies have shown that waiting for a transplant is a stressful experience, and it is 
hoped that this research project will build upon previous research to provide 
recommendations for assistance for organ transplant patients. 
It is anticipated that approximately 100 organ transplant candidates will take part in the study. 
Individuals who have already received an organ transplant will also be invited to participate in 
the study, along with people who have never received a transplant. The responses from these 
three groups of individuals will be compared. 
The results of this research will be used by the researcher, Bianca Villarosa, for a research 
thesis as partial fulfilment of the requirements of a Doctoral degree in Clinical Psychology. 
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3. What does participation in this research project involve? 
Participation in this study is completely voluntary, and involves completing the questionnaire 
pack. This should take about 15 minutes. You will be asked to provide general demographic 
information, and complete a short questionnaire about the way you cope with stress, and your 
satisfaction in several areas of your life.  
All responses are anonymous and kept confidential. Your personal records at Monash 
Medical Centre will not be accessed at anytime. This is a stand-alone questionnaire, and you 
will not receive any follow-up phone calls or further correspondence regarding this project. 
There is no financial reimbursement for participating in this project.  
 
4. What are the possible benefits? 
There are no direct benefits to participants who choose to complete and return the survey. 
However, it is hoped that the current study will provide valuable information that may be used 
to design support services for organ transplant patients in the future. 
5. What are the possible risks? 
While unlikely, answering some questions may raise issues of concern for some individuals. In this 
case, you should contact the investigator, who will discuss your concerns confidentially and 
suggest appropriate follow-up, if necessary. 
6. Do I have to take part in this research project? 
Participation in any research project is voluntary. If you do not wish to take part, you do not 
have to. Given the anonymous nature of responses, you will not be able to withdraw consent 
after you have submitted the survey. 
Your decision to take part or not will not affect your relationship with Monash Medical Centre. 
7. How will I be informed of the final results of this research project? 
The researcher will provide the Department of Nephrology at Monash Medical Centre with a 
summary of the research findings approximately six months after final data collection.  
8. What will happen to information about me? 
All your responses will be anonymous and will remain confidential. Data will be analysed by group 
only, and as such no identifiable information will be included. Research data will be held securely 
at RMIT for a period of 7 years before being destroyed. Only the researcher will have access to 
the data. This study may be submitted for publication, but only group results will be reported and 
your anonymity is assured. 
9. Can I access research information kept about me? 
You must be aware that the information collected about you will not be able to be identified, 
as we are not collecting your name or other personal details. Therefore, you will not be able 
to access the information you have provided after submitting the completed questionnaire. 
10. Is this research project approved? 
The ethical aspects of this research project have been approved by the Human Research 
Ethics Committee of Southern Health, incorporating Monash Medical Centre. The project has 
also been approved by the Human Research Ethics Committee of RMIT University. 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. 
11. Consent 
I have read, or have had this document read to me in a language that I understand, and I 
understand the purposes, procedures and risks of this research project as described within it. 
I have had an opportunity to ask questions and I am satisfied with the answers I have 
received. 
I freely agree to participate in this research project, as described.  
Because of the nature of this data collection, we are not obtaining written informed consent from 
you. Instead, your return of the questionnaire in the pre-paid envelope is taken as your consent to 
participate in the study. 
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12. Who can I contact? 
The person you may need to contact will depend on the nature of your query. Therefore, 
please note the following: 
For further information: 
If you want any further information concerning this project or if you have any problems which 
may be related to your involvement in the project (for example, feelings of distress), you can 
contact the principal or associate researcher on 9925 7603 or via email at 
mandy.kienhuis@rmit.edu.au or b.villarosa@student.rmit.edu.au 
For complaints: 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about being a research participant in general, then you may contact:   
Name:  Ms. Malar Thiagarajan 
Position: Director, Research Services 
Telephone: 03 9594 4611 
 
 
 
……………………………..   ……………………………..  …………………………… 
Dr Mandy Kienhuis  Bianca Villarosa  A/Prof John Kanellis 
Principal Researcher  Associate Researcher  Associate Researcher 
 
The information and contact sheets are yours to keep 
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Appendix F 
Questionnaire – Study 2 
 
SECTION 1  Demographics 
 
Please answer the following questions by circling or writing your response 
 
1. Please indicate your gender 
 
 Male  Female  
 
2. What is your age (in years)? 
 
     ……………………………. 
 
3. In which area do you practice?  
 
 Medicine Nursing Social Work  Mental Health 
 
 Physiotherapy   Other (please state)  …………………………… 
 
4. Please indicate your area of expertise (please circle all that apply): 
 
 (i) organ type: 
 
 Cardiac Renal  Lung 
  
 Liver  Other (please state) …………………. 
 
 (ii) clinical population: 
 
 Paediatrics Adults  Combined paediatrics/adults 
 
5. In what year did you complete your professional training: 
 
 Prior to 1980 
 1980 – 1990  
 1991 – 2000 
 2000 onwards 
 
6. In what setting do you practice? (please circle all that apply): 
 
 Hospital 
 Academic institute 
 Other (please state) ……………………………. 
 
7. Main practice responsibilities (please circle all that apply): 
 
 Patient care 
 Administration  
Teaching  
Other (please state) ……………………………. 
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SECTION 2  Quality of Life 
 
1. Quality of life (QOL) may be defined in many different ways. How do you define 
quality of life? 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
SECTION 3  Clinical Experience with Quality of Life Issues  
 
These questions relate to your attitude toward QOL issues and the way in which you 
may use QOL information in clinical practice. 
 
Please indicate your level of agreeability to the statement below by using the 
following scale:  
 
 
Not 
applicable 
Strongly  
disagree 
 
Disagree 
 
Agree 
Strongly 
 agree 
0 1 2 3 4 
 
Attitude toward quality of life issues 
 
  Strongly 
disagree 
 
Disagree 
 
Agree 
Strongly 
agree 
1. Resources currently allocated to QOL 
should be used for basic transplant 
research 
1 2 3 4 
2. Using published QOL information is 
essential to good transplant patient care 
1 2 3 4 
3. QOL is a subjective concept that cannot be 
quantified 
1 2 3 4 
4. New QOL instruments are simply variations 
of previously ineffective tools 
1 2 3 4 
5. Published QOL data are not useful for 
individual patient care 
1 2 3 4 
6. The emphasis on QOL is a passing fad that 
will diminish over time 
1 2 3 4 
7. QOL should be a required outcome 
measure for all Randomised Control Trials 
(RCTs) in transplant research 
1 2 3 4 
8. The role of the health professional as an 
independent decision maker is jeopardized 
by the emphasis on QOL 
1 2 3 4 
9. The emphasis on QOL is warranted in view 
of the lack of success in improving survival 
of transplant patients 
1 2 3 4 
10. Adding QOL to RCTs will make transplant 
patients more willing to participate 
1 2 3 4 
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Strongly 
disagree 
 
Disagree 
 
Agree 
Strongly 
agree 
11. Adding QOL to RCTs in transplantation 
research will decrease health professional 
participation 
1 2 3 4 
12. Most of my patients are willing to accept a 
poor QOL for even a small chance of 
receiving a transplant 
1 2 3 4 
13. Discussing QOL makes patients feel that 
they themselves are cared about, not just 
their disease 
1 2 3 4 
14. My primary responsibility in treating 
transplant patients is to save lives 
1 2 3 4 
15. Follow-up visits are primarily for monitoring 
the health of the patients, and not to assess 
QOL 
1 2 3 4 
16. Attention to QOL makes treatment decisions 
difficult 
1 2 3 4 
17. In my opinion, prolonging survival with poor 
QOL is still a success 
1 2 3 4 
18. The most important benefit of QOL is that 
one can ‘really treat the whole patient’ 
1 2 3 4 
19. When I initiate QOL discussions, my 
patients interpret this to mean that 
transplant is not possible 
1 2 3 4 
20 Having to consider QOL sometimes reduces 
the medical professional’s ability to make 
optimal medical decisions 
1 2 3 4 
 
Clinical use of quality of life resources 
 
21. I generally encourage my patients to 
complete QOL questionnaires 
1 2 3 4 
22. The information that QOL research provides 
about the relative impact of treatment 
options determines my treatment 
recommendation 
1 2 3 4 
23. I rely on my clinical experience to assess 
QOL 
1 2 3 4 
24. I often read studies reporting QOL results 1 2 3 4 
25. I use published QOL results to modify my 
practice patterns 
1 2 3 4 
26. I am more likely to use toxicity information 
than QOL information when making 
treatment decisions 
1 2 3 4 
27. I use formal QOL questionnaires in my 
practice 
1 2 3 4 
28. My decision to initiate QOL discussions 
does not depend on whether the 
circumstances are curative or palliative 
1 2 3 4 
29. When I have to choose between prolonging 
survival or improving QOL, I usually attempt 
to prolong survival 
 
1 2 3 4 
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Strongly 
disagree 
 
Disagree 
 
Agree 
Strongly 
agree 
30. When transplant is possible but unlikely, I 
intend to discuss QOL issues much less 
than when dealing with an incurable 
situation 
1 2 3 4 
31. When a treatment offers a high chance of 
cure in conjunction with potential long-term 
survival, I downplay its negative impact on 
QOL 
1 2 3 4 
32. I do not discuss QOL issues with my 
patients unless they ask about it first 
1 2 3 4 
33. When I feel that QOL considerations are 
important in particular cases, I discuss QOL 
issues with patients even if they did not 
indicate an interest 
1 2 3 4 
34. I use QOL to justify not giving toxic 
treatments that are of questionable benefit 
1 2 3 4 
 
Willingness to use quality of life resources 
 
35. Even if QOL instruments had established 
validity and reliability, I would be reluctant to 
extrapolate the results to my patients 
1 2 3 4 
36. Since quantifying QOL is problematic, I will 
not use QOL data 
1 2 3 4 
37. Even if I were given more resources, I 
would not collect QOL information 
1 2 3 4 
38. If collecting QOL data were less demanding 
of my resources, I would be more willing to 
collect it from my patients 
1 2 3 4 
39. I would not ask ill patients to complete QOL 
questionnaires 
1 2 3 4 
40. If I were responsible for training health-care 
professionals, I would advocate the use of 
formal QOL measures 
1 2 3 4 
41. Generally, I will spend my time on clinical 
care and leave QOL to others 
1 2 3 4 
42. I do not plan to incorporate QOL data in my 
practice 
1 2 3 4 
43. It is likely that I will increase my use of QOL 
in the care of future patients 
1 2 3 4 
44. If QOL results were easier to understand, I 
would be more likely to use them 
1 2 3 4 
45. Even if published QOL results are shown to 
be clinically relevant, I am not likely to use 
them 
1 2 3 4 
46. The more physicians are aware of the 
complexities of analyzing QOL, the less 
likely they will be to use them 
1 2 3 4 
47. I would only be willing to use formal QOL 
assessment if required to do so by my 
institution or regulatory body 
1 2 3 4 
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Appendix G 
Plain Language Statement – Study 2 
 
Project Title 
Transplant patients’ quality of life: Medical professionals’ attitudes and clinical 
experience with quality of life issues. 
 
Investigators 
Bianca Denny (Candidate – Doctor of Psychology)   
    bianca.denny@rmit.edu.au 9925 7742 
A/Prof Susana Gavidia-Payne (Project Supervisor: Lecturer, Psychology, RMIT  
    University) susana.gavidia-payne@rmit.edu.au, 9925 7710 
Dr Mandy Kienhuis (Project Supervisor: Lecturer, Psychology, RMIT University) 
    mandy.kienhuis@rmit.edu.au, 9925 3019 
 
You are invited to participate in a research project being conducted by RMIT University. 
This information sheet describes the project in ‘plain English’. Please read this sheet 
carefully and be confident that you understand its contents before deciding whether to 
participate. If you have any questions about the study, please contact one of the 
investigators, listed above. 
 
Who is involved in this research project? Why is it being conducted? 
The current study is being undertaken by Bianca Denny as part of a Doctor of Clinical 
Psychology degree, under the supervision of Associate Professor Susan Gavidia-Payne 
and Dr Mandy Kienhuis. This study has been approved by the RMIT Human Research 
Ethics Committee. 
 
Why have you been approached? 
We are seeking medical professionals who work with organ transplant patients to share 
their views regarding quality of life issues for transplant patients.  
Participants must be aged 18 years or older. 
  
What is the current study about? 
The current study is investigating medical professionals’ attitudes towards the quality of 
life issues of transplant patients. Further, we are interested in the way in which quality of 
life issues are considered in clinical practice.  
 
If I agree to participate, what will I be required to do? 
Participation is completely voluntary. You will be asked to provide general demographic 
information, and complete a short questionnaire about your attitudes toward quality of life 
issues, clinical experience with transplant patients and quality of life concerns, and your 
awareness and use of research related to the quality of life of transplant patients. All 
responses are anonymous and kept confidential. 
The questionnaire should take approximately 10 minutes to complete, and is available 
online or as a hardcopy.  
 
What are the risks or disadvantages associated with participation? 
While unlikely, answering some questions may raise issues of concern for some 
individuals, as it is necessary to reflect on your own clinical experience and contact with 
patients. In this case, you should contact the investigators, who will discuss your 
concerns confidentially and suggest appropriate follow-up, if necessary. 
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What are the benefits associated with participation? 
While there is no direct benefit to participants, it is hoped the current study will provide 
important information about medical professionals’ experience with quality of life issues. 
Further, it is hoped that results of the study will inform the future direction of transplant 
research related to quality of life considerations. 
 
What will happen with the information I provide? 
All your responses will be anonymous and will remain confidential. Data will be analysed 
by group only, and as such no identifiable information will be included. Research data will 
be held securely at RMIT for a period of 5 years before being destroyed. This study may 
be submitted for publication, but only group results will be reported and your anonymity is 
assured. 
Because of the nature of this data collection, we are not obtaining written informed 
consent from you. Instead, your return of the questionnaire in the pre-paid envelope, or 
online submission for completion on the internet, is taken as your consent to participate in 
the study.  
 
Security of the website 
Users should be aware that the World Wide Web is an insecure public network that gives 
rise to the potential risk that a user’s transactions are being viewed, intercepted or 
modified by third parties or that data which the user downloads may contain computer 
viruses or other defects. 
 
Security of the data 
This project will use an external site to create, collect and analyse data collected in a 
survey format. The site we are using is surveymonkey.com. If you agree to participate in 
this survey, the responses you provide to the survey will be stored on a host server that is 
used by RMIT University. No personal information will be collected in the survey so none 
will be stored as data. Once we have completed our data collection and analysis, we will 
import the data we collect to the RMIT server where it will be stored securely for a period 
of five (5) years. The data on the RMIT University host server will then be deleted and 
expunged. 
 
What are you my rights as a participant? 
Participation in this study is completely voluntary. You have the right to withdraw anytime 
before returning the questionnaire material. 
 
Whom should I contact if I have any questions? 
You may contact the investigators, Bianca Denny, Dr Mandy Kienhuis, or Susana 
Gavidia-Payne, via details listed at the top of this document. 
 
Thankyou for your interest in this study; your participation is greatly appreciated. 
 
Yours sincerely, 
 
 
……………………...       ……………………...             ……………………...     
Bianca Denny 
Doctoral Candidate 
A/Prof Susana Gavidia-Payne Dr. Mandy Kienhuis 
   
Any complaints about your participation in this project may be directed to the 
Executive Officer, RMIT Human Research Ethics Committee, Research & Innovation, 
RMIT, GPO Box 2476V, Melbourne, 3001.    
Details of the complaints procedure are available at: 
http://www.rmit.edu.au/governance/committees/hrec 
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Appendix H 
Introductory Letter to Parents (Transplant Families) – Study 3 
 
 
 
 
 
 
Dear Parent, 
 
We are writing to tell you about an upcoming research project being conducted by 
The Royal Children’s Hospital (RCH) and RMIT University. The research aims to 
investigate the quality of life of children who have received liver transplants, and 
evaluate the impact of the transplantation process on family functioning. 
 
All parents with a child currently aged between 5 and 16 years who have received a 
liver transplant are invited to participate in the study. Participation will involve 
completing one questionnaire. With your consent, we will also access your child’s 
medical record to gather information about your child’s illness, details of their 
transplant, and demographic information. All information will remain anonymous and 
confidential. 
 
You do not have to take part in this project. Declining to participate will not affect your 
access to the best available treatment options and care at The Royal Children’s 
Hospital. 
 
We will be approaching you to invite you to participate in this project in the coming 
weeks. A clinical nurse may approach you in person with further information about 
the study if your child has an upcoming appointment at RCH. Alternatively, we may 
contact you by mail. You may also contact us ahead of your appointment time should 
you to wish to receive further information sooner. 
 
If you do not wish to be contacted again by our research team or have any queries, 
please contact the Principal Investigator, Bianca Denny, on 0432 993 859 or 
bianca.denny@rmit.edu.au. 
 
Yours sincerely 
 
 
Bianca Denny 
Provisional Psychologist 
Principal Investigator 
RMIT University 
A/Prof Winita Hardikar 
Children’s Doctor 
Department of Hepatology 
The Royal Children’s 
Hospital 
Kathe Beyerle 
Transplant Coordinator 
Department of Hepatology 
The Royal Children’s 
Hospital 
 
If you have any concerns about the project, or the way it is being conducted, and would like to 
speak to someone independent of the project, please contact: 
Head of Department, Ethics and Research Department, Human Research Ethics Committee, 
The Royal Children’s Hospital, Telephone: (03) 9345 5044 
HREC Project 
Number: 
31067 
Research Project 
Title: 
Quality of life and family functioning following pediatric liver 
transplantation. 
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Appendix I 
Plain Language Statement (Transplant Families) – Study 3 
 
 
 
 
PARTICIPANT INFORMATION STATEMENT AND CONSENT FORM 
FOR QUESTIONNAIRE/INTERVIEW-BASED RESEARCH 
 
HREC Project 
Number: 
31067 
 
Research Project 
Title: 
Quality of life and family functioning following pediatric liver 
transplantation. 
 
Dear Parent/Caregiver, 
 
You are invited to participate in a research project being conducted by the Royal 
Children’s Hospital (RCH) Liver Transplant Team and RMIT University. The research 
aims to investigate the quality of life of children who have received liver transplants, 
and evaluate the impact of the transplantation process on family functioning. 
 
The Principal Investigator of this project is Bianca Denny from RMIT University. This 
project is part of a degree of Doctor of Psychology. The other investigators of the 
project are Associate Professor Winita Hardikar, Head of Hepatology, and Kathe 
Beyerle, Liver Transplant Coordinator (RCH). 
 
We are asking you to take part because you are the parent of a child who has 
received a liver transplant. If you choose to participate in the study, you will be asked 
to complete a questionnaire, which should take about ten minutes. The questions ask 
about your child’s experiences as a liver transplant patient, and the impact this may 
have had on your family. You will only be required to complete one questionnaire, 
and the investigators will not contact you again regarding the project. We will also 
access your child’s medical record to gather further information related to your child’s 
illness, details of their transplant, and demographic information. All this information 
will remain anonymous and confidential. 
 
We do not expect there to be any direct benefit to you if you take part in this project. 
However, we hope that the information we get from this project may assist in helping 
us to improve the transplant process for other patients and their families in the future. 
 
We do not expect there to be any risks. The only inconvenience is the time to 
complete the questionnaire. If you do experience feelings of distress as a result of 
participating in the study, please contact Dr Susana Gavidia-Payne on 9925 7710. Dr 
Gavidia-Payne is a psychologist who is able to provide support to participants who 
experience distress. 
 
All the information you give us will stay private and will only be used for this research 
project. It will be stored without your name so it cannot be identified by anyone 
except the research team. You have the right to access, and ask correction of, your 
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information in accordance with the Freedom or Information Act 1982 (Vic).  We will 
keep your information for 7 years or until your child is 25 years old and after this time, 
we will destroy it.  The results of the project may be presented at conferences and 
published in professional journals.  The results will not identify you or your family in 
anyway. 
 
A summary of results will be posted to all research participants at the conclusion of 
the study. Results will be of the whole group of participants, and will not make 
reference to any individual respondent. 
 
You do not have to take part in this project. If you do not take part, it will not affect your 
access to the best available treatment options and care from The Royal Children's 
Hospital. You can also choose to withdraw your consent after completing the 
questionnaire, after which time none of your information will be included in the results. If 
you decide to withdraw your consent, please contact a member of the research team. 
 
We hope that you will take part. Please complete the attached consent form and 
questionnaire and return them to us via the enclosed reply paid envelope. One of our 
research team may follow-up with you via a telephone call after you receive the 
questionnaire.  
 
If you have any questions, or would like further information about this project, please 
contact Kathe Beyerle on 9345 7998 or kathe.beyerle@rch.org.au. 
 
 
 
 
Yours sincerely 
 
 
 
 
 
A/Prof Winita Hardikar 
Children’s Doctor 
Department of Hepatology 
The Royal Children’s 
Hospital 
 
Bianca Denny 
Provisional Psychologist 
Principal Investigator 
RMIT University 
Kathe Beyerle 
Transplant Coordinator 
Department of Hepatology 
The Royal Children’s 
Hospital 
 
 
If you have any concerns about the project, or the way it is being conducted, and would like to 
speak to someone independent of the project, please contact: 
 
Head of Department 
Ethics and Research Department 
Human Research Ethics Committee 
The Royal Children’s Hospital 
Telephone: (03) 9345 5044 
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Appendix J 
Consent Form (Transplant Families) – Study 3 
 
 
 
 
 
 
CONSENT FORM FOR PARTICIPANT TO GIVE INFORMED CONSENT 
TO TAKE PART IN A RESEARCH PROJECT 
 
 
HREC Project 
Number: 
31067 
 
Research Project 
Title: 
Quality of life and family functioning following paediatric 
liver transplantation 
 
 
 
I (Participant name)  
 
voluntarily consent to take part in the above research project.  
 
I am the parent of  
[please write your child’s 
name] 
 
 
 
• I believe I understand the purpose, extent and possible effects of my involvement 
in this project. 
• I have had an opportunity to ask questions and I am satisfied with the answers I 
have received. 
• I understand that this project has been approved by The Royal Children’s 
Hospital Human Research Ethics Committee and will be carried out in line with 
the National Statement on Ethical Conduct in Human Research (2007). 
• I understand I will receive a copy of this Participant Information Statement and 
Consent Form. 
 
 
Participant Signature 
 
Date 
 
 
 
I have supplied an Information Statement and Consent Form to the participant who 
has signed above, and believe that they understand the purpose, extent and possible 
effects of their involvement in this project. 
 
Researcher Signature 
 
Date 
 
 
 
Note: All parties signing the Consent Form must date their own signature. 
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Appendix K 
Questionnaire (Transplant Families) – Study 3 
 
Please answer the following questions. 
Remember, you do not have to answer any question that you do not want to. 
Please answer all that you wish to without spending too much time on any one 
question.  
 
FAMILY ACCOMMODATIONS 
 
Family accommodations refer to the adjustments you and your family make for your 
child’s illness. Accommodations can range from major adjustments to family life, 
such as moving house, or day-to-day adjustments, such as having to provide 
increased supervision.  
 
Firstly, please tell us your role in your family (for example, Mum or Dad): 
 
……………………………………… 
  
This questionnaire contains a list of statements about the accommodations you and 
your family may make due to your child’s illness. Please rate the following 
accommodation statements on a scale of 1 to 5: 
 
1 = strongly disagree   2 = disagree   3= neutral   4 = agree   5 = strongly agree 
 
 
 
Strongly  
disagree 
 Strongly  
agree 
 
 
Work 
 
 
 
1. I need to look for jobs that offer flexibility, so that I can look 
after my child 
1 2 3 4 5 
2. I have to work from home to support my child’s needs 1 2 3 4 5 
3. Both my partner and I work so that we can support the 
services and insurance my child requires 
1 2 3 4 5 
4. My partner and I have had to reduce our time spent at 
work to look after our child 
1 2 3 4 5 
5. My partner and/or myself have taken a less desired job 
due to our need for flexibility 
1 2 3 4 5 
 
 
Services 
     
6. Our family had to move so that we were closer to support 
services for our child 
1 2 3 4 5 
7. Effort is required for us to access these services (eg. 
travel, babysitting for other siblings, cost, time, etc.) 
1 2 3 4 5 
8. We have chosen a more expensive service, even if 
inconvenient, to benefit our child 
1 2 3 4 5 
 
 
Home and community 
     
9. For the safety and wellbeing of our child, our family home 
had to be altered 
1 2 3 4 5 
10. Our family home was selected so that we were closer to 
the hospital 
1 2 3 4 5 
11. Our family has had to move house to accommodate our 
child’s needs 
1 2 3 4 5 
12. Around the home, our child requires constant care 1 2 3 4 5 
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Domestic workload 
Strongly  
disagree 
   
Strongly  
agree 
13. We have decided not to have any more children because 
looking after our child has created such a high workload 
1 2 3 4 5 
14. Help had to be hired to help around the house due to our 
child’s needs 
1 2 3 4 5 
15. Our other children have had to start helping around the 
house due to our child’s needs 
1 2 3 4 5 
16. My domestic workload is greatly increased, due to my 
child’s illness 
1 2 3 4 5 
  
Child care tasks 
 
 
 
17. My child requires constant monitoring 1 2 3 4 5 
18. The need for transportation has increased due to my child 1 2 3 4 5 
 
 
Assistance 
     
19. We ask for assistance from our extended family (ie. 
grandparents, aunts, uncles) 
1 2 3 4 5 
20. We pay for our child to have respite care, so that my 
partner and I can spend some time alone 
1 2 3 4 5 
 
 
Child peer groups 
     
21. I have to supervise my child while they are playing with 
other children 
1 2 3 4 5 
 
 
Marital roles 
     
22. We often have conflicts and disruption to our marriage due 
to our child 
1 2 3 4 5 
23. As parents, we share and collaborate on decisions equally 1 2 3 4 5 
 
 
Parent information 
     
24. There are lectures and courses about our child’s illness, 
which we can attend 
1 2 3 4 5 
25. We feel that there are professionals we can approach 
about our child’s illness 
1 2 3 4 5 
26. When we first learnt of our child’s illness, there was plenty 
of information (ie. books, research on internet) available to 
us 
1 2 3 4 5 
27. There are organised programs in the community for our 
child’s illness, where we can go for information 
1 2 3 4 5 
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QUALITY OF LIFE 
 
Children who have had a transplant sometimes have special problems. On the 
following pages is a list of things that might be a problem for your child. Please tell 
us how much of a problem each one has been for your child during the past ONE 
month by circling: 
 
0 if it is never a problem 
1 if it is almost never a problem 
2 if it is sometimes a problem 
3 if it is often a problem 
4 if it is almost always a problem 
 
There are no right or wrong answers. 
 
In the past ONE month, how much of a problem has your child had with… 
 
About his/her medicines I Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Medicines making him/her feel sick 0 1 2 3 4 
2. Medicines making him/her feel 
grumpy 
0 1 2 3 4 
3. Forgetting to take his/her medicine 0 1 2 3 4 
4. Not wanting to take his/her 
medicines 
0 1 2 3 4 
5. Difficulty swallowing medicines 0 1 2 3 4 
6. Not liking the taste of his/her 
medicines 
0 1 2 3 4 
7. Not liking having to take his/her 
medicines all the times 
0 1 2 3 4 
8. Difficulty fitting medicines into 
his/her day 
0 1 2 3 4 
9. Getting angry when he/she has to 
take his/her medications 
0 1 2 3 4 
 
   
About his/her medicines II Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Medicines making his/her stomach 
bloated 
0 1 2 3 4 
2. Medicines making his/her face look 
puffy 
0 1 2 3 4 
3. Medicines making his/her teeth look 
different 
0 1 2 3 4 
4. Medicines making him/her gain 
weight 
0 1 2 3 4 
5. Medicines making him/her hairy 0 1 2 3 4 
6. Medicines making his/her gums 
swollen 
0 1 2 3 4 
7. Medicines keeping him/her from 
growing 
0 1 2 3 4 
8. Medicines giving him/her acne 0 1 2 3 4 
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Transplant and others Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Other people treating him/her 
differently because of his/her illness 
0 1 2 3 4 
2. Feeling different than other kids 
his/her age because he/she has had 
a transplant 
0 1 2 3 4 
3. His/her parents not letting him/her 
do what he/she wants to do 
because of his/her transplant 
0 1 2 3 4 
4. Other people not understanding 
what he/she has been through 
0 1 2 3 4 
5. Feeling left out of things because of 
his/her illness 
0 1 2 3 4 
6. Difficulty talking to other people 
about his/her illness 
0 1 2 3 4 
7. His/her parents nagging him/her to 
take his/her medications 
0 1 2 3 4 
8. His/her doctors nagging him/her to 
take his/her medications 
0 1 2 3 4 
 
 
Pain and hurt Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Getting stomachaches 0 1 2 3 4 
2. Getting headaches 0 1 2 3 4 
3. Getting backaches 0 1 2 3 4 
 
 
Worry Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Worrying about side effects from 
his/her medicines 
0 1 2 3 4 
2. Worry about whether or not his/her 
medicines are working 
0 1 2 3 4 
3. Worrying that something is wrong 
when he/she doesn’t feel well 
0 1 2 3 4 
4. Worrying that his/her doctor will find 
something wrong with him/her 
0 1 2 3 4 
5. Worrying about whether or not 
his/her transplant is working 
0 1 2 3 4 
6. Worrying that he/she will have to 
have another transplant 
0 1 2 3 4 
7. Worrying that he/she won’t be able 
to do the things he/she used to 
because of the transplant 
0 1 2 3 4 
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Treatment anxiety Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Getting anxious about seeing the 
doctor 
0 1 2 3 4 
2. Getting anxious about going to the 
hospital 
0 1 2 3 4 
3. Getting anxious about having 
needle sticks (ie., injections, blood 
tests, IV’s) 
0 1 2 3 4 
4. Getting anxious about when he/she 
has to have medical 
treatments/procedures (ie., biopsy) 
0 1 2 3 4 
 
 
Perceived physical appearance Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Not liking other people to see 
his/her scars 
0 1 2 3 4 
2. Worrying that his/her medicines will 
change the way he/she looks 
0 1 2 3 4 
3. Being embarrassed when other 
people see his/her body 
0 1 2 3 4 
 
 
Communication Never Almost 
Never 
Some- 
times 
Often Almost 
Always 
1. Difficulty telling the doctors and 
nurses how he/she feels 
0 1 2 3 4 
2. Difficulty asking the doctors and 
nurses questions 
0 1 2 3 4 
3. Difficulty explaining his/her 
transplant to other people 
0 1 2 3 4 
4. Difficulty understanding what the 
doctors and nurses are telling 
him/her 
0 1 2 3 4 
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YOUR COMMENTS 
 
We are interested in your experience of participating in this research project. If you 
would like to do so, please use the space below to share your thoughts or suggest 
improvements.  
 
Alternatively, you may contact the Kathe Beyerle via email – 
kathe.beyerle@rch.org.au. Participants experiencing feelings of distress following 
completing this survey may contact Dr Susana Gavidia-Payne on 9925 7710. 
 
Thank you for your time.  
Your participation is greatly appreciated. 
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Appendix L 
Results Letter to Parents – Study 3 
 
 
 
 
 
HREC Project 
Number: 
 
31067 
 
Research Project 
Title: 
Quality of life and family functioning following paediatric liver 
transplantation. 
 
Dear Parent/Caregiver 
 
In 2011 we contacted you regarding a research project being conducted by the Royal 
Children’s Hospital (RCH) Liver Transplant Team and RMIT University. The research 
investigated the quality of life of children who have received a liver transplant, and 
evaluated the impact of the transplantation process on family routines. 
 
We are pleased to announce that the research project is now finished. Thank you to 
all the parents and caregivers who contributed to the study. A total of 32 families 
participated. 
 
We found that: 
• Families of liver transplant recipients make more changes to their family 
routines to accommodate their children in comparison to other families in the 
community.  
• Finding appropriate childcare was the most common concern for parents of 
liver transplant recipients. 
• Adjustments to family routines decreased as years passed after 
transplantation. 
• Families who reported making fewer adjustments to routines also reported 
experiencing a higher quality of life. 
 
We hope to publish the results of this study in the near future. Any publication will 
include results of the whole group of participants, and will not make reference to 
individual respondents. If you would like to receive a copy of the publication, or have 
any other queries, please contact Kathe Beyerle on 9345 7998 or 
kathe.beyerle@rch.org.au. 
 
A/Prof Winita Hardikar 
Children’s Doctor 
Department of Hepatology 
The Royal Children’s 
Hospital 
 
Bianca Denny 
Provisional Psychologist 
Principal Investigator 
RMIT University 
 
Kathe Beyerle 
Transplant Coordinator 
Department of Hepatology 
The Royal Children’s 
Hospital 
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PO Box 71 
Bundoora VIC 3083 
Australia 
Tel. +61 3 Error! 
Unknown document 
property name. 
 
Appendix M 
Plain Language Statement (Non-Transplant Families) – Study 3 
 
 
 
 
 
INVITATION TO PARTICIPATE IN A RESEARCH PROJECT 
 
PROJECT INFORMATION STATEMENT 
 
Project Title: 
Family Functioning and Children's Health Related Quality of Life in Liver Transplant and 
Healthy Families 
 
Investigators: 
• Miss Ancuta Cora (Bachelor of Applied Science (Psychology) (Honours), 
ancuta.cora@student.rmit.edu.au) 
• Associate Professor Susana Gavidia-Payne (Research Supervisor: Associate 
Professor, Health Sciences, RMIT University, susana.gavidia-payne@rmit.edu.au, 
9925-7710) 
 
Dear parent or guardian,  
You are invited to participate in a research project being conducted by RMIT University. This 
information sheet describes the project in straightforward language, or ‘plain English’. 
Please read this sheet carefully and make sure that you understand its contents before 
deciding whether to participate. If you have any questions about the project, please ask one 
of the investigators. 
 
Who is involved in this research project? Why is it being conducted? 
This research project is being conducted by Ancuta Cora and her supervisor Susana Gavidia-
Payne, and is part of Ancuta Cora’s degree (Bachelor of Applied Science (Psychology) 
(Honours)) at RMIT University.  
The RMIT Human Research Ethics Committee and the Department of Education Ethics 
Committee have approved this project.  
 
Why have you been approached? 
You have been invited to participate in this research project, as you are a parent or guardian 
of a child between 5 and 16 years. You have been selected randomly. We are hoping to 
recruit approximately 200 families with healthy children in this age bracket.  
 
What is the project about? What are the questions being addressed?  
Former research has shown that children who have had a liver transplantation tend to have 
poorer health related quality of life (physically, mentally, and socially) compared to healthy 
children. Also, research has investigated what types of accommodations families of children 
with transplants tend to make in order to increase family functioning. The aim of this 
research is to identify if family functioning and children’s health related quality of life is 
different between two groups of families; (1) families of children who have undergone a 
liver transplant; and (2) families of healthy children.  
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If I agree to participate, what will I be required to do? 
If you agree to participate in this research, you will be required to complete a questionnaire 
booklet, which can be filled out at home and returned to the investigators in a replied paid 
envelope. The questionnaire booklet will ask a few general questions about your family and 
yourself. There will be only two questionnaires, both of which will require you to circle a 
number that represents how much you disagree or agree with a statement. For example, 
you will be required to show on a 5-point scale how true the following statement is “My 
child requires constant monitoring”. The questionnaire booklet will take approximately 15 
minutes to complete. You are welcome to look at the questions on the questionnaire to 
decide if you want to participate. There will be no other inconvenient aspects to this 
research, other than taking the time to complete and post the questionnaire booklet.  
 
What are the risks associated with participation? 
Engaging in this research does not present any perceived risks outside normal day-to-day 
activities. However, if you are unduly concerned about any of the items, or if you find 
participation in the project distressing, you should contact Associate Professor Susana 
Gavidia-Payne as soon as convenient. Associate Professor Susana Gavidia-Payne will discuss 
your concerns with you confidentially and suggest appropriate follow up, if necessary.  
 
What are the benefits associated with participation? 
There are no direct benefits in participating in this study. However, the findings of this 
project will assist us in identifying if family functioning influences children’s health related 
quality of life, and whether family functioning and children’s health related quality of life is 
different between transplant families and healthy families. This research project could 
inform and improve health services and interventions for families whose children experience 
a liver transplant. 
 
What will happen to the information I provide? 
Participation in this research does not require identifiable information, and is therefore 
anonymous. All provided information will be treated confidentially with only the current 
investigators, and investigators of the liver transplant sample, having access to the 
information. Any information that you provide can be disclosed only if (1) it is to protect 
you, your child or others from harm, (2) a court order is produced, or (3) you provide the 
researcher with written permission. The group data will appear in a student report and 
perhaps a journal article at most. All research information will be locked in a filing cabinet at 
RMIT University for a period of five years before being destroyed.  
 
What are my rights as a participant? 
Participation in this research implies given consent and is completely voluntary. You have 
the right to withdraw your participation at any time without prejudice. You have the right to 
have any unprocessed data withdrawn and destroyed, provided it can be readily identified. 
You also have the right to have any questions answered at any time. Also, if participants 
would like a report about the outcomes of this project, they are welcome to contact any of 
the investigators.  
 
Who should I contact if I have any questions? 
If you have any questions about this project, please contact Associate Professor Susana 
Gavidia-Payne on susana.gavidia-payne@rmit.edu.au or 9925-7710.  
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What other issues should I be aware of before deciding whether to participate? 
There are no other obvious ethical issues that need addressing. All we ask is that you please 
provide the most honest response you can and if you have any concerns please contact the 
supervisor. Otherwise we hope you have a great experience participating in this research 
project.  
 
Yours sincerely, 
 
 
 
Ancuta Cora 
Bachelor of Applied Science (Psychology) (Honours) 
                     
 
 
 
Associate Professor Susana Gavidia-Payne                         
Bachelor of Psychology, Master of Science, Ph.D  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Any complaints about your participation in this project may be directed to the Executive Officer, RMIT Human 
Research Ethics Committee, Research & Innovation, RMIT, GPO Box 2476V, Melbourne, 3001.  
Details of the complaints procedure are available on the ‘Complaints with respect to participation in research at 
RMIT’ page 
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Appendix N 
Questionnaire Pack (Non-Transplant Families) – Study 3 
 
 
 
 
 
 
RESEARCH PROJECT 
 
Family Functioning and Children’s 
Health Related Quality of Life 
 
 
 
 
 
 
PARENT QUESTIONNAIRE BOOKLET 
 
Code: 
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Questionnaire Information 
 
Thank you for your interest in this research project. This questionnaire booklet has questions 
about: 
 
* You and your family 
* The family accommodations you make for your child 
* Your perceptions of your child’s health related quality of life 
 
Your name will not be required and all information provided in this booklet will be kept 
confidential. There are no right or wrong answers, so please answer all the statements as 
quickly as possible. Also, please remember that this booklet is to be completed for one child 
only. If you have more than one child, please select the child between the ages of 5 and 16 
years of age, or if you have more than one child in this age group either select a child at 
random or request additional booklets. If you have any questions about this booklet, please 
contact Ancuta Cora or Associate Professor Susana Gavidia-Payne.  
 
General Information About Myself and My Family 
 
Firstly, we would like to ask you a few questions about you and your family. We will use this 
information to generally describe the people who responded to our questionnaire. We will 
describe people in groups, never as individuals, so your answers will be kept confidential. 
Please tick the appropriate box or fill in one answer per question.  
 
1. What is your relationship to the child participating in this study?  
  Father    Mother    Other (Please Specify) ............................ 
2. What is your highest level of education completed?  
  Less than Year 12    High school graduate, Year 12  
  TAFE graduate    Undergraduate qualifications    
  Postgraduate qualifications    Other (Please specify)  .......................................... 
3. What is your marital status? 
  Married    Defacto    Divorced    Widowed   
4. What is your postcode? ...........................  
5. What is your employment status?  
  Full time    Part time    Unemployed but looking  
  Unemployed    Retired    Stay at home parent or caregiver  
  Other (Please specify) .................................... 
6. What was your total household income from all sources for the past year? Be sure to 
include income from all sources (such as child support). 
  Less than $25, 000    Between $25,001 and $45,000    
  Between $45,001 and $55,000    Between $55,001 and   
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 $75,000    Greater than $75,001 
7. What is the gender of your child? 
  Female    Male 
8. What is your child’s age in years and months? ............................... 
9. How many siblings (brothers and sisters) does your child have? 
  One    Two    Three or more 
10. Who is the primary caregiver for your child?  
  Yourself    Your partner    Both  
  Other (Please specify) ................................. 
11. What is the name of the school your child currently attends? 
 .................................................................................................... 
12. What grade/year is he/she in? ............................... 
13. If applicable, has your child experienced a serious illness or long-term hospitalisation?  
  No    Yes   (If yes, please specify) .............................................................................. 
 
My Child in My Family 
 
In this next section of the booklet we would like you to think about your family 
accommodations. Family accommodations refer to the adjustments you and your family 
makes to cater for your child’s health and well-being. Accommodations can range from 
major adjustments to family life, such as moving house, or day-to-day adjustments, such as 
having to provide increased supervision.  
 
The questions in this section contain a number of statements about your family’s 
accommodations. Please read each statement carefully and decide how well it describes 
your family. You should answer according to how you currently see your family. There are no 
right or wrong responses. Please rate the following accommodation statements on a scale of 
1 to 5 by circling: 
 
1 = strongly disagree, 
2 = disagree, 
3= neutral, 
4 = agree, 
5 = strongly agree 
 
  Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
 Work      
1 I need to look for jobs that offer 
flexibility, so that I can look after my 
child 
1 2 3 4 5 
2 I have to work from home to support 
my child’s needs 
1 2 3 4 5 
  Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
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3 Both my partner and I work so that we 
can support the services and insurance 
my child requires 
1 2 3 4 5 
4 My partner and I have had to reduce 
our time spent at work to look after 
our child 
1 2 3 4 5 
5 My partner and/or myself have taken a 
less desired job due to our need for 
flexibility 
1 2 3 4 5 
 Services/Programs      
6 Our family had to move so that we 
were closer to support 
services/programs for our child 
1 2 3 4 5 
7 Effort is required for us to access these 
services/programs (e.g. travel, 
babysitting for other siblings, cost, 
time, etc.) 
1 2 3 4 5 
8 We have chosen a more expensive 
service/program, even if inconvenient, 
to benefit our child 
1 2 3 4 5 
 Home and community      
9 For the safety and wellbeing of our 
child, our family home had to be 
altered 
1 2 3 4 5 
10 Our family home was selected so that 
we were closer to a hospital 
1 2 3 4 5 
11 Our family has had to move house to 
accommodate our child’s needs 
1 2 3 4 5 
12 Around the home, our child requires 
constant care 
1 2 3 4 5 
 Domestic workload      
13 We have decided not to have any more 
children because looking after our 
child has created such a high workload 
1 2 3 4 5 
14 Help had to be hired to help around 
the house due to our child’s needs 
1 2 3 4 5 
15 Our other children have had to start 
helping around the house due to our 
child’s needs 
1 2 3 4 5 
16 My domestic workload is greatly 
increased, due to my child’s health 
1 2 3 4 5 
 Child care tasks      
17 My child requires constant monitoring 1 2 3 4 5 
18 The need for transportation has 
increased due to my child 
1 2 3 4 5 
 Assistance      
19 We ask for assistance from our 
extended family (i.e. grandparents, 
aunts, uncles) 
1 2 3 4 5 
20 We pay for our child to have respite 
care, so that my partner and I can 
1 2 3 4 5 
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spend some time alone 
  Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
 Child peer groups      
21 I have to supervise my child while they 
are playing with other children 
1 2 3 4 5 
 Marital roles      
22 We often have conflicts and disruption 
to our marriage due to our child 
1 2 3 4 5 
23 As parents, we share and collaborate 
on decisions equally 
1 2 3 4 5 
 Parent information      
24 There are lectures and courses about 
our child’s health, which we can attend 
1 2 3 4 5 
25 We feel that there are professionals 
we can approach about our child’s 
health 
1 2 3 4 5 
26 When we first learnt of our child’s 
health, there was plenty of information 
(i.e. books, research on internet) 
available to us 
1 2 3 4 5 
27 There are organised programs in the 
community for our child’s health, 
where we can go for information 
1 2 3 4 5 
 
 
 
My Child’s Quality of Life 
 
In this next section of the booklet we would like you to think about your child’s health 
related quality of life and answer a few statements. Please read each statement carefully 
and decide how well it might be a problem for your child. There are no right or wrong 
responses. Please tell us how much of a problem each one has been for your child during the 
past one month by circling: 
 
0 = if it is never a problem, 
1 = if it is almost never a problem, 
2 = if it is sometimes a problem, 
3 = if it is often a problem, 
4 = if it is almost always a problem 
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Never 
Almost 
Never Some-
times 
Often 
Almost 
Always 
 Physical functioning (problems with…) 
 
 
 
 
 
1 Walking more than 100 meters 0 1 2 3 4 
2 Running 0 1 2 3 4 
3 Participating in sports activity or exercise 0 1 2 3 4 
4 Lifting something heavy 0 1 2 3 4 
5 Taking a bath or shower by him or herself 0 1 2 3 4 
6 Doing chores around the house 0 1 2 3 4 
7 Having aches or pains 0 1 2 3 4 
8 Having a low energy level 0 1 2 3 4 
 Emotional functioning (problems with…)      
9 Feeling afraid or scared 0 1 2 3 4 
10 Feeling sad 0 1 2 3 4 
11 Feeling angry 0 1 2 3 4 
12 Having trouble sleeping 0 1 2 3 4 
13 Worrying about what will happen to him or 
her 
0 1 2 3 4 
 Social functioning (problems with…)      
14 Getting along with other children 0 1 2 3 4 
15 Other kids not wanting to be his or her friend 0 1 2 3 4 
16 Getting teased by other children 0 1 2 3 4 
17 Not being able to do things that other children 
his or her age can do 
0 1 2 3 4 
18 Keeping up when playing with other children 0 1 2 3 4 
 School functioning (problems with…)      
19 Paying attention in class 0 1 2 3 4 
20 Forgetting things 0 1 2 3 4 
21 Keeping up with schoolwork 0 1 2 3 4 
22 Missing school because of not feeling well 0 1 2 3 4 
23 Missing school to go to the doctor or hospital 0 1 2 3 4 
 
You have finished this booklet. Thank you for your time! Please return the completed 
booklet in the supplied envelope.  
 
Thanks again! 
 
 
 
